Summit Midstream Partners, LP Reports First Quarter 2021 Financial and Operating Results

– First quarter 2021 net income of $9.0 million, adjusted EBITDA of $60.4 million and Distributable Cash Flow (“DCF”) of $46.2 million

– First quarter 2021 operating expenses reflect a reduction of $4.3 million relative to 4Q 2020, driven by proactive expense management initiatives implemented across the organization in late 2020

– Connected new four well Utica Shale pad site in March 2021, ahead of schedule; wells flowing approximately 20% above original expectations

– Reduced revolving credit facility balance in 1Q 2021 by $55 million, or nearly 40% of SMLP’s full year 2021 debt reduction guidance target

– Closed $175 million of non-recourse senior secured credit facilities, which will be used to fund the vast majority of Summit’s remaining investment in Double E

– Commenced Double E construction in 1Q 2021; project is progressing on schedule and in-line with $425 million cost estimate (8/8ths); estimated in-service date in the fourth quarter of 2021

– Subsequent to March 31, 2021, exchanged $18.7 million face value of Series A Preferred Units and eliminated $2.5 million of accrued unpaid distributions, for approximately 560,000 SMLP common units, representing an implied discount at closing of approximately 42%

PR Newswire

HOUSTON, May 7, 2021 /PRNewswire/ — Summit Midstream Partners, LP (NYSE: SMLP) (“Summit”, “SMLP” or the “Partnership”) announced today its financial and operating results for the three months ended March 31, 2021, including net income of $9.0 million, adjusted EBITDA of $60.4 million and DCF of $46.2 million. Operated natural gas volume throughput averaged 1,346 million cubic feet per day (“MMcf/d”) and liquids volume throughput averaged 65 thousand barrels per day (“Mbbl/d”). Operated natural gas volumes decreased 6.3% relative to the fourth quarter of 2020, largely due to natural production declines and impacts from severe winter weather in some segments, partially offset by volumes from six new well connections during the quarter in the Utica Shale and Permian segments. Quarterly liquids volume throughput decreased by 8.5% relative to the fourth quarter of 2020 as there were no new liquids wells connected during the quarter.

Heath Deneke, President, Chief Executive Officer and Chairman, commented, “Summit’s financial results exceeded internal expectations for the quarter with $60.4 million of adjusted EBITDA, largely due to our continued focus on reducing operating expenses, together with strong performance from a new Utica pad which came online in March, ahead of schedule, and at initial production rates that exceeded expectations by nearly 20%. While it is still early, these wells continue to materially outperform original expectations underlying our 2021 financial guidance.”

“With respect to our expense improvement, towards the end of 2020, we implemented structural and organizational changes across our business, aimed at further streamlining operations and minimizing costs. The first quarter of 2021 is the first period in which the majority of these savings materialized and is evidenced by approximately $4.9 million lower operating expenses than our quarterly average in 2020. I want to thank the entire Summit team for the continuous improvement mindset and commitment to continue to find ways to improve our operating efficiency and effectiveness, without compromising our commitment to safety, compliance, the environment and providing excellent service for our customers.”

“We remain focused on executing the second phase of our balance sheet transformation initiatives, which includes addressing our 2022 debt maturities and capturing discounts where available on other fixed capital obligations. During the first quarter, we utilized our internally generated cash flow, together with $8 million of cash received from the sale of surplus compressor equipment, to reduce our revolving credit facility balance by $55 million. This paydown represents nearly 40% of our 2021 debt reduction guidance and we remain on track to generate sufficient cash, after interest expense and capital expenditures, to reduce outstanding indebtedness this year by approximately $130 million to $150 million.”

“In March, we launched a Series A preferred equity for SMLP common equity exchange, with the intention of enhancing common equity value by reducing principal at discounts to face value and eliminating accumulated unpaid distributions. This transaction was successful and upon closing in April, we exchanged $18.7 million Series A preferred units, or approximately 11.5% of the outstanding Series A preferred units, for approximately 560,000 SMLP common units with a value of approximately $12.3 million, and we eliminated $2.5 million of accrued unpaid distributions.”

“Addressing our 2022 debt maturities is a top priority for Summit today. We are actively working on a holistic solution for our senior unsecured notes and revolving credit facility that mature in 2022 and we have generated strong interest from numerous banks and bond investors regarding our refinancing solution. Our goals are to not only extend our 2022 debt maturities, but also to provide a significant amount of additional financial flexibility over the coming years to continue to improve the balance sheet and transform the overall business. We are very excited about the progress we’ve made on the refinancing efforts to date and look forward to providing additional details ahead of our next scheduled earnings call.”

“We achieved several key milestones on the Double E project during the first quarter, including closing $175 million of non-recourse senior secured credit facilities and commencing construction activities, which were both critical steps towards remaining on schedule. Our wholly owned, unrestricted subsidiary, Summit Permian Transmission, LLC, utilized the credit facilities to fund all of Summit’s $4.6 million investment in Double E in the first quarter, and we expect that these credit facilities will fund the vast majority of Summit’s remaining Double E capital commitment. All of the pipeline and rights-of-way have been procured and pipeline construction is underway. We continue to expect that Double E will be completed at or below the current $425 million cost estimate (8/8ths), of which, approximately $35 million remains in unidentified project contingency. We continue to expect Double E to be commissioned in the fourth quarter of 2021.”

“Overall, Summit is off to a strong start to 2021 and I continue to be encouraged by a number of positive market developments that could be a catalyst for increased customer activity on our systems later in the year. At this point however, we are maintaining our full year 2021 adjusted EBITDA range of $210 million to $230 million for the year.”

First Quarter 2021 Business Highlights
In the first quarter of 2021, SMLP’s average daily natural gas throughput for its operated systems decreased 6.3% to 1,346 MMcf/d, and liquids volumes decreased 8.5% to 65 Mbbl/d, relative to the fourth quarter of 2020. SMLP’s customers had approximately 29 DUCs in inventory upstream of its systems as of March 31, 2021, with visible line of sight to completions for the majority of these DUCs in the second and third quarters of the year.


Core Focus Areas

:

  • Core Focus Areas generated combined quarterly segment adjusted EBITDA of $31.5 million and had combined capital expenditures of $2.3 million in the first quarter of 2021.
  • Utica Shale segment adjusted EBITDA totaled $7.7 million in the first quarter of 2021, a $1.0 million decrease from the fourth quarter of 2020, which was driven by natural production declines on existing wells connected to the SMU system. In March, a new four well pad that is subject to our previously announced gathering agreement amendment to incentivize accelerated upstream activity, was turned-in-line. These four wells have been outperforming expectations by nearly 20% and are currently flowing in excess of 190 MMcf/d. There were six DUCs in the Utica Shale segment at the end of the first quarter, which were all turned-in-line in April of 2021.
  • Ohio Gathering segment adjusted EBITDA totaled $6.9 million in the first quarter of 2021, a $1.6 million decrease from the fourth quarter of 2020, driven by 10.2% lower volume throughput. There were four wells connected during the quarter, which partially offset natural production declines. At the end of the quarter, there were five DUCs, three of which came online in April and two that are expected to be turned-in-line by the end of the third quarter of 2021.
  • Williston Basin segment adjusted EBITDA totaled $10.8 million in the first quarter of 2021, a 5.5% decrease from the fourth quarter of 2020, primarily as a result of reduced volume throughput and impacts from an MVC that expired at the end of 2020, offset partially by lower operating expenses. No new wells were connected during the quarter, resulting in decreased volume throughput of 2 MMcf/d for natural gas and 6 Mbbl/d for liquids. There were eight DUCs in inventory behind our Williston Basin systems as of March 31, 2021, and all are expected to be turned-in-line by the end of the third quarter of 2021.
  • DJ Basin segment adjusted EBITDA totaled $5.3 million in the first quarter of 2021, a 20.6% increase from the fourth quarter of 2020 due to positive impacts from cost reductions and a change in customer volume mix, resulting in increased revenue from processing activities. Quarterly volume throughput decreased by approximately 2 MMcf/d, or 8.0%, primarily due to natural production declines. As of March 31, 2021, there were no DUCs behind our DJ Basin infrastructure expected to be turned-in-line in the near-term.
  • Permian Basin segment adjusted EBITDA totaled $0.7 million in the first quarter of 2021, an increase of approximately $0.6 million compared to the prior quarter, largely due to reduced operating expenses, despite a volume decrease of approximately 12.1%. Two wells were turned-in-line during the quarter; however, natural production declines combined with lower producer volumes due to severe winter weather during part of the quarter caused volume throughput to be approximately 4 MMcf/d lower than the fourth quarter of 2020. Now that these two wells have been turned-in-line, all new wells contemplated in our full year 2021 guidance have been connected.


Legacy Areas

:

  • Legacy Areas generated $34.7 million of combined segment adjusted EBITDA in the first quarter of 2021 and had combined capital expenditures of $0.3 million.
  • Piceance Basin segment adjusted EBITDA totaled $21.0 million in the first quarter of 2021, a $1.0 million decrease from the fourth quarter of 2020, primarily due to increased spend on operations and maintenance activities and property taxes as well as impacts from lower volume throughput. Lower volume throughput of 7 MMcf/d, or 2.0%, compared to the fourth quarter of 2020, was primarily a result of natural production declines.
  • Barnett Shale segment adjusted EBITDA totaled $8.0 million in the first quarter of 2021, a 5.2% increase from the fourth quarter of 2020, primarily due to customer margin mix and lower operating expenses. Throughput volumes decreased by 4.4% due to natural production declines, which was offset partially by increased volumes from workovers and recompletions of existing wells. Our customers have 8 new wells that are either being drilled or awaiting completion behind our system that we expect to be turned-in-line in the third quarter of 2021.
  • Marcellus Shale segment adjusted EBITDA totaled $5.6 million in the first quarter of 2021, a 3.2% decrease relative to the fourth quarter of 2020, driven primarily by an 8.9% decrease in volume throughput to 337 MMcf/d as a result of natural production declines. Our anchor customer had nine DUCs in inventory behind our Marcellus Shale infrastructure at the end of the first quarter, all of which we expect will be turned-in-line during the second quarter of 2021.

The following table presents average daily throughput by reportable segment for the periods indicated:


Three
 
months
 
ended March
 
31,


2021


2020


Average daily throughput (MMcf/d):

Utica Shale

410

222

Williston Basin

12

14

DJ Basin

23

32

Permian Basin

29

33

Piceance Basin

340

383

Barnett Shale

195

233

Marcellus Shale

337

364


Aggregate average daily throughput


1,346


1,281


Average daily throughput (Mbbl/d):

Williston Basin

65

98


Aggregate average daily throughput


65


98


Ohio Gathering average daily throughput


    (MMcf/d) (1)


558


610

__________

(1)  Gross basis, represents 100% of volume throughput for Ohio Gathering, subject to a one-month lag.

The following table presents adjusted EBITDA by reportable segment for the periods indicated:


Three
 
months
 
ended March
 
31,


2021


2020


(In thousands)


Reportable segment adjusted EBITDA (1):

Utica Shale

$

7,719

$

5,928

Ohio Gathering (2)

6,872

7,939

Williston Basin

10,805

16,192

DJ Basin

5,347

5,911

Permian Basin

709

1,581

Piceance Basin

21,034

23,557

Barnett Shale

8,016

8,760

Marcellus Shale

5,602

5,320

Total

$

66,104

$

75,188

Less:  Corporate and Other (3)

5,661

9,286

Adjusted EBITDA

$

60,443

$

65,902

__________

(1)

We define segment adjusted EBITDA as total revenues less total costs and expenses, plus (i) other income excluding interest income, (ii) our proportional adjusted EBITDA for equity method investees, (iii) depreciation and amortization, (iv) adjustments related to MVC shortfall payments, (v) adjustments related to capital reimbursement activity, (vi) unit-based and noncash compensation, (vii) impairments and (viii) other noncash expenses or losses, less other noncash income or gains.

(2)

Represents our proportional share of adjusted EBITDA for Ohio Gathering, subject to a one-month lag. We define proportional adjusted EBITDA for our equity method investees as the product of (i) total revenues less total expenses, excluding impairments and other noncash income or expense items and (ii) amortization for deferred contract costs; multiplied by our ownership interest in Ohio Gathering during the respective period.

(3)

 Corporate and Other represents those results that are not specifically attributable to a reportable segment (such as Double E) or that have not been allocated to our reportable segments, including certain general and administrative expense items and natural gas and crude oil marketing services.

 

Capital Expenditures
Capital expenditures totaled $2.6 million in the first quarter of 2021, inclusive of maintenance capital expenditures of $0.9 million. Capital expenditures in the first quarter of 2021 were primarily related to growth projects to connect new pad sites in our Utica Shale segment.


Three
 
months
 
ended March
 
31,


2021


2020


(In thousands)


Cash paid for capital expenditures (1):

Utica Shale

$

1,517

$

909

Williston Basin

301

4,943

DJ Basin

300

6,298

Permian Basin

210

3,281

Piceance Basin

93

346

Barnett Shale

60

657

Marcellus Shale

106

422

Total reportable segment capital expenditures

2,587

16,856

Corporate and Other

23

1,727

Total cash paid for capital expenditures

$

2,610

$

18,583

__________

(1) Excludes cash paid for capital expenditures by Ohio Gathering and Double E (after June 2019) due to equity method accounting.

Capital & Liquidity
As of March 31, 2021, SMLP had $275.9 million of undrawn commitments under its $1.1 billion revolving credit facility, after accounting for $22.1 million of issued, but undrawn letters of credit. Subject to covenant limits, our available borrowing capacity at March 31, 2021 totaled approximately $115.0 million. SMLP also had $16.2 million of unrestricted cash on hand as of March 31, 2021.

Based upon the terms of SMLP’s revolving credit facility, and total outstanding debt, net of cash, of $1.28 billion (inclusive of $493.5 million of senior unsecured notes), SMLP’s total leverage ratio and first lien leverage ratio (as defined in the credit agreement) as of March 31, 2021, were 5.0 to 1.0 and 3.1 to 1.0, respectively, relative to maximum threshold limits of 5.75 to 1.0 and 3.50 to 1.0.

Double E Update
On March 8, 2021, SMLP’s wholly-owned, unrestricted subsidiary, Summit Permian Transmission, LLC, closed on $175 million of commercial bank credit facilities, which it utilized to fund cash investments of $4.6 million in the first quarter of 2021, to finance the development of its 70% equity investment in the Double E pipeline project. These credit facilities are non-recourse to SMLP and are expected to fund the vast majority of SMLP’s remaining investment in Double E. SMLP’s 70% share of the total expected Double E capital costs continues to be approximately $300 million, of which approximately $136 million had been funded from inception of the project through March 31, 2021. Construction activities on Double E commenced in the first quarter of 2021 and the project continues to progress on schedule, with an estimated in-service date of the fourth quarter of 2021.

MVC Shortfall Payments
SMLP billed its customers $11.4 million in the first quarter of 2021 related to MVC shortfalls. For those customers that do not have MVC shortfall credit banking mechanisms in their gathering agreements, the MVC shortfall payments are accounted for as gathering revenue in the period in which they are earned. In the first quarter of 2021, SMLP recognized $13.5 million of gathering revenue associated with MVC shortfall payments. SMLP had no adjustments to MVC shortfall payments in the first quarter of 2021 related to shortfall payment adjustments. SMLP’s MVC shortfall payment mechanisms contributed $13.5 million of total adjusted EBITDA in the first quarter of 2021.


Three
 
months
 
ended March
 
31, 2021


MVC Billings


Gathering
revenue


Adjustments
to MVC
shortfall
payments


Net impact
to adjusted
EBITDA


(In thousands)


Net change in deferred revenue related to MVC


   shortfall payments:

Piceance Basin

$

3,663

$

3,663

$

$

3,663


Total net change


$


3,663


$


3,663


$




$


3,663


MVC shortfall payment adjustments:

Williston Basin

$

$

2,145

$

$

2,145

Piceance Basin

6,164

6,164

6,164

Marcellus Shale

1,551

1,551

1,551


Total MVC shortfall payment adjustments


$


7,715


$


9,860


$




$


9,860


Total (1)


$


11,378


$


13,523


$




$


13,523

__________

(1) Exclusive of Ohio Gathering due to equity method accounting.

 

Quarterly Distribution
The board of directors of SMLP’s general partner continues to suspend cash distributions payable on its common units and on its 9.50% Series A fixed-to-floating rate cumulative redeemable perpetual preferred units for the period ended March 31, 2021. Unpaid distributions on the Series A preferred units will continue to accrue.

First Quarter 2021 Earnings Call Information
SMLP will host a conference call at 10:00 a.m. Eastern on Friday, May 7, 2021, to discuss its quarterly operating and financial results. Interested parties may participate in the call by dialing 847-585-4405 or toll-free 888-771-4371 and entering the passcode 50148779. The conference call, live webcast and archive of the call can be accessed through the Investors section of SMLP’s website at www.summitmidstream.com.

Upcoming Investor Conference
Members of SMLP’s senior management team will virtually attend the 2021 EIC Investor Conference: Connecting the Energy Value Chain on May 19, 2021. Presentation materials associated with this event will be accessible through the Investors section of SMLP’s website at www.summitmidstream.com in advance of the conference.

Use of Non-GAAP Financial Measures
We report financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). We also present adjusted EBITDA, a non-GAAP financial measure. We define adjusted EBITDA as net income or loss, plus interest expense, income tax expense, depreciation and amortization, our proportional adjusted EBITDA for equity method investees, adjustments related to MVC shortfall payments, adjustments related to capital reimbursement activity, unit-based and noncash compensation, impairments, items of income or loss that we characterize as unrepresentative of our ongoing operations and other noncash expenses or losses, less interest income, income tax benefit, income (loss) from equity method investees and other noncash income or gains. Because adjusted EBITDA may be defined differently by other entities in our industry, our definition of this non-GAAP financial measure may not be comparable to similarly titled measures of other entities, thereby diminishing its utility.

Management uses adjusted EBITDA in making financial, operating and planning decisions and in evaluating our financial performance. Furthermore, management believes that adjusted EBITDA may provide external users of our financial statements, such as investors, commercial banks, research analysts and others, with additional meaningful comparisons between current results and results of prior periods as they are expected to be reflective of our core ongoing business.

Adjusted EBITDA is used as a supplemental financial measure by external users of our financial statements such as investors, commercial banks, research analysts and others.

Adjusted EBITDA is used to assess:

  • the ability of our assets to generate cash sufficient to make future potential cash distributions and support our indebtedness;
  • the financial performance of our assets without regard to financing methods, capital structure or historical cost basis;
  • our operating performance and return on capital as compared to those of other entities in the midstream energy sector, without regard to financing or capital structure;
  • the attractiveness of capital projects and acquisitions and the overall rates of return on alternative investment opportunities; and
  • the financial performance of our assets without regard to (i) income or loss from equity method investees, (ii) the impact of the timing of minimum volume commitments shortfall payments under our gathering agreements or (iii) the timing of impairments or other income or expense items that we characterize as unrepresentative of our ongoing operations.

Adjusted EBITDA has limitations as an analytical tool and investors should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. For example:

  • certain items excluded from adjusted EBITDA are significant components in understanding and assessing an entity’s financial performance, such as an entity’s cost of capital and tax structure;
  • adjusted EBITDA does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments;
  • adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; and
  • although depreciation and amortization are noncash charges, the assets being depreciated and amortized will often have to be replaced in the future, and adjusted EBITDA does not reflect any cash requirements for such replacements.

We compensate for the limitations of adjusted EBITDA as an analytical tool by reviewing the comparable GAAP financial measures, understanding the differences between the financial measures and incorporating these data points into our decision-making process.

We do not provide the GAAP financial measures of net income or loss or net cash provided by operating activities on a forward-looking basis because we are unable to predict, without unreasonable effort, certain components thereof including, but not limited to, (i) income or loss from equity method investees and (ii) asset impairments. These items are inherently uncertain and depend on various factors, many of which are beyond our control. As such, any associated estimate and its impact on our GAAP performance and cash flow measures could vary materially based on a variety of acceptable management assumptions.

About Summit Midstream Partners, LP
SMLP is a value-oriented limited partnership focused on developing, owning and operating midstream energy infrastructure assets that are strategically located in the core producing areas of unconventional resource basins, primarily shale formations, in the continental United States. SMLP provides natural gas, crude oil and produced water gathering, processing and transportation services pursuant to primarily long-term, fee-based agreements with customers and counterparties in six unconventional resource basins: (i) the Appalachian Basin, which includes the Utica and Marcellus shale formations in Ohio and West Virginia; (ii) the Williston Basin, which includes the Bakken and Three Forks shale formations in North Dakota; (iii) the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; (iv) the Permian Basin, which includes the Bone Spring and Wolfcamp formations in New Mexico; (v) the Fort Worth Basin, which includes the Barnett Shale formation in Texas; and (vi) the Piceance Basin, which includes the Mesaverde formation as well as the Mancos and Niobrara shale formations in Colorado. SMLP has an equity investment in Double E Pipeline, LLC, which is developing natural gas transmission infrastructure that will provide transportation service from multiple receipt points in the Delaware Basin to various delivery points in and around the Waha Hub in Texas. SMLP also has an equity investment in Ohio Gathering, which operates extensive natural gas gathering and condensate stabilization infrastructure in the Utica Shale in Ohio. SMLP is headquartered in Houston, Texas.

Forward-Looking Statements
This press release includes certain statements concerning expectations for the future that are forward-looking within the meaning of the federal securities laws. Forward-looking statements include, without limitation, any statement that may project, indicate or imply future results, events, performance or achievements and may contain the words “expect,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “will be,” “will continue,” “will likely result,” and similar expressions, or future conditional verbs such as “may,” “will,” “should,” “would,” and “could.” In addition, any statement concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies and possible actions taken by us or our subsidiaries are also forward-looking statements. Forward-looking statements also contain known and unknown risks and uncertainties (many of which are difficult to predict and beyond management’s control) that may cause SMLP’s actual results in future periods to differ materially from anticipated or projected results. An extensive list of specific material risks and uncertainties affecting SMLP is contained in its 2020 Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on March 4, 2021, as amended and updated from time to time. Any forward-looking statements in this press release are made as of the date of this press release and SMLP undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

 


SUMMIT MIDSTREAM PARTNERS, LP AND SUBSIDIARIES


UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS


March
 
31,


December
 
31,


2021


2020


(In thousands)


ASSETS

Cash and cash equivalents

$

16,233

$

15,544

Restricted cash

8,067

Accounts receivable, net

54,301

61,932

Other current assets

12,167

4,623

Total current assets

90,768

82,099

Property, plant and equipment, net

1,788,222

1,817,546

Intangible assets, net

192,378

199,566

Investment in equity method investees

394,405

392,740

Other noncurrent assets

6,792

7,866

TOTAL ASSETS

$

2,472,565

$

2,499,817


LIABILITIES AND CAPITAL

Trade accounts payable

$

15,873

$

11,878

Accrued expenses

11,666

13,036

Deferred revenue

10,017

9,988

Ad valorem taxes payable

7,589

9,086

Accrued compensation and employee benefits

4,481

9,658

Accrued interest

8,512

8,007

Accrued environmental remediation

1,885

1,392

Other current liabilities

14,682

5,363

Total current liabilities

74,705

68,408

Long-term debt

1,304,918

1,347,326

Noncurrent deferred revenue

47,644

48,250

Noncurrent accrued environmental remediation

1,368

1,537

Other noncurrent liabilities

21,700

21,747

Total liabilities

1,450,335

1,487,268


Mezzanine Capital

Subsidiary Series A Preferred Units

93,590

89,658


Partners’ Capital

Series A Preferred Units

178,712

174,425

Common limited partner capital

749,928

748,466

Total partners’ capital

928,640

922,891

TOTAL LIABILITIES AND CAPITAL

$

2,472,565

$

2,499,817

 


SUMMIT MIDSTREAM PARTNERS, LP AND SUBSIDIARIES


UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS


Three
 
months
 
ended March
 
31,


2021


2020


(In thousands, except per-unit amounts)


Revenues:

Gathering services and related fees

$

70,348

$

83,792

Natural gas, NGLs and condensate sales

20,763

13,780

Other revenues

8,207

7,331

Total revenues

99,318

104,903


Costs and expenses:

Cost of natural gas and NGLs

20,476

8,225

Operation and maintenance

16,593

21,811

General and administrative (1)

10,344

16,561

Depreciation and amortization

28,511

29,666

Transaction costs

11

(Gain) loss on asset sales, net

(136)

115

Long-lived asset impairment

1,492

3,821

Total costs and expenses

77,280

80,210

Other income (expense), net

55

(427)

Interest expense

(13,953)

(23,828)

Loss on ECP Warrants and other

(1,481)

Income before income taxes and

    equity method investment income

6,659

438

Income tax benefit

14

13

Income from equity method investees

2,315

3,311

Net income

$

8,988

$

3,762


Net income (loss) per limited partner unit:

Common unit – basic

$

0.13

$

(0.80)

Common unit – diluted

$

0.12

$

(0.80)


Weighted-average limited partner units outstanding:

Common units – basic

6,125

3,021

Common units – diluted

6,260

3,021

__________

(1) For the three months ended March 31, 2021, the amount includes $0.7 million of restructuring expenses and $0.2 million of severance expenses. For the three months ended March 31, 2020, the amount includes $2.8 million of restructuring expenses. 

 


SUMMIT MIDSTREAM PARTNERS, LP AND SUBSIDIARIES


UNAUDITED OTHER FINANCIAL AND OPERATING DATA


Three
 
months
 
ended March
 
31,


2021


2020


(Dollars in thousands)


Other financial data:

Net income

$

8,988

$

3,762

Net cash provided by operating activities

$

51,430

$

70,201

Capital expenditures

$

2,610

$

18,583

Contributions to equity method investees

$

5,619

$

58,033

Adjusted EBITDA

$

60,443

$

65,902

Cash flow available for distributions (1)

$

46,163

$

38,048

Distributions

$

$


Operating data:

Aggregate average daily throughput – natural

    gas (MMcf/d)

1,346

1,281

Aggregate average daily throughput – liquids (Mbbl/d)

65

98

Ohio Gathering average daily throughput (MMcf/d) (2)

558

610

__________

(1)  Cash flow available for distributions is also referred to as Distributable Cash Flow, or DCF.
(2)  Gross basis, represents 100% of volume throughput for Ohio Gathering, subject to a one-month lag.

 


SUMMIT MIDSTREAM PARTNERS, LP AND SUBSIDIARIES


UNAUDITED RECONCILIATIONS TO NON-GAAP FINANCIAL MEASURES


Three
 
months
 
ended March
 
31,


2021


2020


(In thousands)


Reconciliations of net income or loss to


    adjusted EBITDA and distributable


    cash flow:

Net income

$

8,988

$

3,762


Add:

Interest expense

13,953

23,828

Income tax benefit

(14)

(13)

Depreciation and amortization (1)

28,746

29,900

Proportional adjusted EBITDA for equity

    method investees (2)

6,872

7,939

Adjustments related to MVC shortfall

    payments (3)

(5,442)

Adjustments related to capital reimbursement

    activity (4)

(1,245)

(211)

Unit-based and noncash compensation

1,967

2,723

(Gain) loss on asset sales, net

(136)

115

Long-lived asset impairment

1,492

3,821

Other, net (5)

2,135

2,791


Less:

Income from equity method investees

2,315

3,311

Adjusted EBITDA

$

60,443

$

65,902


Less:

Cash interest paid

12,885

19,660

Cash paid for taxes

Senior notes interest adjustment (6)

512

3,063

Maintenance capital expenditures

883

5,131

Cash flow available for distributions (7)

$

46,163

$

38,048

Distributions

$

$

__________

(1) Includes the amortization expense associated with our favorable gas gathering contracts as reported in other revenues.
(2) Reflects our proportionate share of Ohio Gathering adjusted EBITDA, subject to a one-month lag.
(3) Adjustments related to MVC shortfall payments are recognized ratably over the term of the associated MVC.
(4) Adjustments related to capital reimbursement activity represent contributions in aid of construction revenue recognized in accordance with Accounting Standards Update No. 2014-09 Revenue from Contracts with Customers (“Topic 606”).
(5) Represents items of income or loss that we characterize as unrepresentative of our ongoing operations. For the three months ended March 31, 2021, the amount includes $1.5 million loss related to the change in the fair value of our derivatives, $0.7 million of restructuring expenses and $0.2 million of severance expenses. For the three months ended March 31, 2020, the amount represents restructuring expenses.
(6) Senior notes interest adjustment represents the net of interest expense accrued and paid during the period. Interest on the 5.5% senior notes is paid in cash semi-annually in arrears on February 15 and August 15 until maturity in August 2022. Interest on the 5.75% senior notes is paid in cash semi-annually in arrears on April 15 and October 15 until maturity in April 2025.
(7) Represents cash flow available for distribution to preferred and common unitholders. Common distributions cannot be paid unless all accrued preferred distributions are paid. Cash flow available for distributions is also referred to as Distributable Cash Flow, or DCF.

 


SUMMIT MIDSTREAM PARTNERS, LP AND SUBSIDIARIES


UNAUDITED RECONCILIATIONS TO NON-GAAP FINANCIAL MEASURES


Three
 
months
 
ended March
 
31,


2021


2020


(In thousands)


Reconciliation of net cash provided by operating activities to adjusted


    EBITDA and distributable cash flow:

Net cash provided by operating activities

$

51,430

$

70,201


Add:

Interest expense, excluding amortization of debt issuance costs

12,236

22,246

Income tax benefit

(14)

(13)

Loss on ECP warrants and other

(1,481)

Changes in operating assets and liabilities

(2,933)

(23,642)

Proportional adjusted EBITDA for equity method investees (1)

6,872

7,939

Adjustments related to MVC shortfall payments (2)

(5,442)

Adjustments related to capital reimbursement activity (3)

(1,245)

(211)

Other, net (4)

2,135

2,791


Less:

Distributions from equity method investees

6,268

7,494

Noncash lease expense

289

473

Adjusted EBITDA

$

60,443

$

65,902


Less:

Cash interest paid

12,885

19,660

Cash paid for taxes

Senior notes interest adjustment (5)

512

3,063

Maintenance capital expenditures

883

5,131

Cash flow available for distributions (6)

$

46,163

$

38,048

__________

(1) Reflects our proportionate share of Ohio Gathering adjusted EBITDA, subject to a one-month lag.
(2) Adjustments related to MVC shortfall payments are recognized ratably over the term of the associated MVC.
(3) Adjustments related to capital reimbursement activity represent contributions in aid of construction revenue recognized in accordance with Accounting Standards Update No. 2014-09 Revenue from Contracts with Customers (“Topic 606”).
(4) Represents items of income or loss that we characterize as unrepresentative of our ongoing operations. For the three months ended March 31, 2021, the amount includes $1.5 million loss related to the change in the fair value of our derivatives, $0.7 million of restructuring expenses and $0.2 million of severance expenses. For the three months ended March 31, 2020, the amount represents restructuring expenses.
(5) Senior notes interest adjustment represents the net of interest expense accrued and paid during the period. Interest on the 5.5% senior notes is paid in cash semi-annually in arrears on February 15 and August 15 until maturity in August 2022. Interest on the 5.75% senior notes is paid in cash semi-annually in arrears on April 15 and October 15 until maturity in April 2025.
(6) Represents cash flow available for distribution to preferred and common unitholders. Common distributions cannot be paid unless all accrued preferred distributions are paid. Cash flow available for distributions is also referred to as Distributable Cash Flow, or DCF.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/summit-midstream-partners-lp-reports-first-quarter-2021-financial-and-operating-results-301286367.html

SOURCE Summit Midstream Partners, LP

Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine

NEW YORK and MAINZ, GERMANY, May 7, 2021 (GLOBE NEWSWIRE)Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older. Data to support the BLA will be submitted by the Companies to the FDA on a rolling basis over the coming weeks, with a request for Priority Review. The Prescription Drug User Fee Act (PDUFA) goal date for a decision by the FDA will be set once the BLA is complete and formally accepted for review by the agency.

The Pfizer-BioNTech COVID-19 vaccine is currently available in the U.S. under an Emergency Use Authorization (EUA) granted by the FDA on December 11, 2020. Since then, the Companies have delivered more than 170 million doses of the vaccine across the U.S. Submission of a BLA, which requires longer-term follow-up data for acceptance and approval, is the next step in the rigorous FDA review process. 

“We are proud of the tremendous progress we’ve made since December in delivering vaccines to millions of Americans, in collaboration with the U.S. Government,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “We look forward to working with the FDA to complete this rolling submission and support their review, with the goal of securing full regulatory approval of the vaccine in the coming months.”

“Following the successful delivery of more than 170 million doses to the U.S. population in just a few months, the BLA submission is an important cornerstone of achieving long-term herd immunity and containing COVID-19 in the future,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “We are pleased to work with U.S. regulators to seek approval of our COVID-19 vaccine based on our pivotal Phase 3 trial and follow-up data.”

Pfizer and BioNTech initiated the BLA by submitting the nonclinical and clinical data needed to support licensure of the COVID-19 vaccine for use in individuals 16 years of age and older. This includes the most recent analyses from the pivotal Phase 3 clinical trial, where the vaccine’s efficacy and favorable safety profile were observed up to 6 months after the second dose. The Companies will submit the required manufacturing and facility data for licensure in the coming weeks to complete the BLA. 

Pfizer and BioNTech also have submitted an application to expand the current EUA for their COVID-19 vaccine to include individuals 12 to 15 years of age. The Companies intend to submit a supplemental BLA to support licensure of the vaccine in this age group once the required data 6 months after the second vaccine dose are available.

The Pfizer-BioNTech COVID-19 vaccine, which is based on BioNTech proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the European Union, and the holder of emergency use authorizations or equivalent in the United States (together with Pfizer), United Kingdom, Canada and other countries in advance of a planned application for full marketing authorizations in these countries.

The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564 (b) (1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see Emergency Use Authorization (EUA) Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) and Full EUA Prescribing Information available at www.cvdvaccine-us.com.

AUTHORIZED USE IN THE U.S.:

The Pfizer-BioNTech COVID-19 vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.

IMPORTANT SAFETY INFORMATION FROM U.S. FDA EMERGENCY USE AUTHORIZATION PRESCRIBING INFORMATION:

  • Do not administer Pfizer-BioNTech COVID-19 vaccine to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the Pfizer-BioNTech COVID-19 vaccine.
  • Appropriate medical treatment used to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of Pfizer- BioNTech COVID-19 vaccine.
  • Monitor Pfizer-BioNTech COVID-19 vaccine recipients for the occurrence of immediate adverse reactions according to the Centers for Disease Control and Prevention guidelines (https://www.cdc.gov/vaccines/covid-19/).
  • Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Pfizer-BioNTech COVID-19 vaccine.
  • The Pfizer-BioNTech COVID-19 vaccine may not protect all vaccine recipients.
  • In clinical studies, adverse reactions in participants 16 years of age and older included pain at the injection site (84.1%), fatigue (62.9%), headache (55.1%), muscle pain (38.3%), chills (31.9%), joint pain (23.6%), fever (14.2%), injection site swelling (10.5%), injection site redness (9.5%), nausea (1.1%), malaise (0.5%), and lymphadenopathy (0.3%).
  • Severe allergic reactions, including anaphylaxis, have been reported following the Pfizer-BioNTech COVID-19 vaccine during mass vaccination outside of clinical trials.
  • Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 vaccine.
  • Available data on Pfizer-BioNTech COVID-19 vaccine administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy.
  • Data are not available to assess the effects of Pfizer-BioNTech COVID-19 vaccine on the breastfed infant or on milk production/excretion.
  • There are no data available on the interchangeability of the Pfizer-BioNTech COVID-19 vaccine with other COVID-19 vaccines to complete the vaccination series. Individuals who have received one dose of Pfizer-BioNTech COVID-19 vaccine should receive a second dose of Pfizer-BioNTech COVID-19 vaccine to complete the vaccination series.
  • Vaccination providers must report Adverse Events in accordance with the Fact Sheet to VAERS at https://vaers.hhs.gov/reportevent.html or by calling 1-800-822-7967. The reports should include the words “Pfizer-BioNTech COVID-19 Vaccine EUA” in the description section of the report.
  • Vaccination providers should review the Fact Sheet for Information to Provide to Vaccine Recipients/Caregivers and Mandatory Requirements for Pfizer-BioNTech COVID-19 Vaccine Administration Under Emergency Use Authorization.

Please see Emergency Use Authorization (EUA) Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) including Full EUA Prescribing Information available at www.cvdvaccine-us.com

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Pfizer Disclosure Notice
The information contained in this release is as of May 7, 2021. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.

This release contains forward-looking information about Pfizer’s efforts to combat COVID-19, the collaboration between BioNTech and Pfizer to develop a COVID-19 vaccine, the BNT162 mRNA vaccine program and the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) (including qualitative assessments of available data, potential benefits, expectations for clinical trials, a rolling submission of a Biologics License Application (BLA) with the FDA for BNT162b2, the anticipated timing of regulatory submissions, regulatory approvals or authorizations and anticipated manufacturing, distribution and supply), involving substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as risks associated with preclinical and clinical data (including the Phase 3 data), including the possibility of unfavorable new preclinical, clinical or safety data and further analyses of existing preclinical, clinical or safety data; the ability to produce comparable clinical or other results, including the rate of vaccine effectiveness and safety and tolerability profile observed to date, in additional analyses of the Phase 3 trial and additional studies or in larger, more diverse populations upon commercialization; the ability of BNT162b2 to prevent COVID-19 caused by emerging virus variants; the risk that more widespread use of the vaccine will lead to new information about efficacy,  safety, or other developments, including the risk of additional adverse reactions, some of which may be serious; the risk that preclinical and clinical trial data are subject to differing interpretations and assessments, including during the peer review/publication process, in the scientific community generally, and by regulatory authorities; whether and when additional data from the BNT162 mRNA vaccine program will be published in scientific journal publications and, if so, when and with what modifications and interpretations; whether regulatory authorities will be satisfied with the design of and results from these and any future preclinical and clinical studies; whether and when the submission of the BLA for BNT162b2 in the U.S. will be completed and accepted for review and whether and when other biologics license and/or emergency use authorization applications or amendments to any such applications may be filed in particular jurisdictions for BNT162b2 or any other potential vaccines that may arise from the BNT162 program, and if obtained, whether or when such emergency use authorization or licenses will expire or terminate; whether and when the BLA for BNT162b2 in the U.S. and any other applications that may be pending or filed for BNT162b2 (including any requested amendments to the emergency use or conditional marketing authorizations) or other vaccines that may result from the BNT162 program may be approved by particular regulatory authorities, which will depend on myriad factors, including making a determination as to whether the vaccine’s benefits outweigh its known risks and determination of the vaccine’s efficacy and, if approved, whether it will be commercially successful; decisions by regulatory authorities impacting labeling or marketing, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of a vaccine, including development of products or therapies by other companies; disruptions in the relationships between us and our collaboration partners, clinical trial sites or third-party suppliers; the risk that demand for any products may be reduced or no longer exist; risks related to the availability of raw materials to manufacture a vaccine; challenges related to our vaccine’s ultra-low temperature formulation, two-dose schedule and attendant storage, distribution and administration requirements, including risks related to storage and handling after delivery by Pfizer; the risk that we may not be able to successfully develop other vaccine formulations, booster doses or new variant-specific vaccines; the risk that we may not be able to create or scale up manufacturing capacity on a timely basis or maintain access to logistics or supply channels commensurate with global demand for our vaccine, which would negatively impact our ability to supply the estimated numbers of doses of our vaccine within the projected time periods as previously indicated; whether and when additional supply agreements will be reached; uncertainties regarding the ability to obtain recommendations from vaccine advisory or technical committees and other public health authorities and uncertainties regarding the commercial impact of any such recommendations; challenges related to public vaccine confidence or awareness; uncertainties regarding the impact of COVID-19 on Pfizer’s business, operations and financial results; and competitive developments.

A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

About BioNTech

Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit www.BioNTech.de.

BioNTech Forward-looking Statements
This press release contains “forward-looking statements” of BioNTech within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but may not be limited to, statements concerning: BioNTech’s efforts to combat COVID-19; the collaboration between BioNTech and Pfizer to develop a COVID-19 vaccine (including a potential second booster dose of BNT162b2 and/or a potential booster dose of a variation of BNT162b2 having a modified mRNA sequence); the potential of BNT162b2 for adolescents 12 to 15 years of age, evaluation of BNT162b2 in children 6 months to 11 years old, anticipated timing of regulatory submissions, regulatory approvals or authorizations, including the Biologics License Application, and anticipated manufacturing, distribution and supply; our expectations regarding the potential characteristics of BNT162b2 in our clinical trials and/or in commercial use based on data observations to date; the ability of BNT162b2 to prevent COVID-19 caused by emerging virus variants; the expected time point for additional readouts on efficacy data of BNT162b2 in our clinical trials; the nature of the clinical data, which is subject to ongoing peer review, regulatory review and market interpretation; the timing for submission of data for, or receipt of, any marketing approval, including the Biologics License Application, or Emergency Use Authorization; our contemplated shipping and storage plan, including our estimated product shelf life at various temperatures; the risk that demand for any products may be reduced or no longer exist; the ability of BioNTech to supply the quantities of BNT162 to support clinical development and market demand, including our production estimates for 2021; and challenges related to public vaccine confidence or awareness. Any forward-looking statements in this press release are based on BioNTech’s current expectations and beliefs of future events, and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the ability to meet the pre-defined endpoints in clinical trials; competition to create a vaccine for COVID-19; the ability to produce comparable clinical or other results, including our stated rate of vaccine effectiveness and safety and tolerability profile observed to date, in the remainder of the trial or in larger, more diverse populations upon commercialization; the ability to effectively scale our productions capabilities; and other potential difficulties.

For a discussion of these and other risks and uncertainties, see BioNTech’s Annual Report on Form 20-F for the Year Ended December 31, 2020, filed with the SEC on March 30, 2021, which is available on the SEC’s website at www.sec.gov. All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law.

Pfizer Contacts:

Media Relations
Amy Rose
+1 (212) 733-7410
[email protected]

Investor Relations
Chuck Triano
+1 (212) 733-3901
[email protected]

BioNTech Contacts:

Media Relations
Jasmina Alatovic
+49 (0)6131 9084 1513
[email protected]

Investor Relations
Sylke Maas, Ph.D.
+49 (0)6131 9084 1074
[email protected]


 



Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID-19 Vaccine

Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID-19 Vaccine

NEW YORK & MAINZ, Germany–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older. Data to support the BLA will be submitted by the companies to the FDA on a rolling basis over the coming weeks, with a request for Priority Review. The Prescription Drug User Fee Act (PDUFA) goal date for a decision by the FDA will be set once the BLA is complete and formally accepted for review by the agency.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210507005259/en/

The Pfizer-BioNTech COVID-19 Vaccine is currently available in the U.S. under an Emergency Use Authorization (EUA) granted by the FDA on December 11, 2020. Since then, the companies have delivered more than 170million doses of the vaccine across the U.S. Submission of a BLA, which requires longer-term follow-up data for acceptance and approval, is the next step in the rigorous FDA review process.

“We are proud of the tremendous progress we’ve made since December in delivering vaccines to millions of Americans, in collaboration with the U.S. Government,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “We look forward to working with the FDA to complete this rolling submission and support their review, with the goal of securing full regulatory approval of the vaccine in the coming months.”

“Following the successful delivery of more than 170 million doses to the U.S. population in just a few months, the BLA submission is an important cornerstone of achieving long-term herd immunity and containing COVID-19 in the future,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “We are pleased to work with U.S. regulators to seek approval of our COVID-19 vaccine based on our pivotal Phase 3 trial and follow-up data.”

Pfizer and BioNTech initiated the BLA by submitting the nonclinical and clinical data needed to support licensure of the COVID-19 vaccine for use in individuals 16 years of age and older. This includes the most recent analyses from the pivotal Phase 3 clinical trial, where the vaccine’s efficacy and favorable safety profile were observed up to six months after the second dose. The companies will submit the required manufacturing and facility data for licensure in the coming weeks to complete the BLA.

Pfizer and BioNTech also have submitted an application to expand the current EUA for their COVID-19 vaccine to include individuals 12 to 15 years of age. The companies intend to submit a supplemental BLA to support licensure of the vaccine in this age group once the required data six months after the second vaccine dose are available.

The Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the European Union, and the holder of emergency use authorizations or equivalent in the United States (together with Pfizer), United Kingdom, Canada and other countries in advance of a planned application for full marketing authorizations in these countries.

The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564 (b) (1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. Please see Emergency Use Authorization (EUA) Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) and Full EUA Prescribing Information available at www.cvdvaccine-us.com.

AUTHORIZED USE IN THE U.S.:

The Pfizer-BioNTech COVID19 Vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.

IMPORTANT SAFETY INFORMATION FROM U.S. FDA EMERGENCY USE AUTHORIZATION PRESCRIBING INFORMATION:

  • Do not administer Pfizer-BioNTech COVID-19 Vaccine to individuals with known history of a severe allergic reaction (e.g., anaphylaxis) to any component of the Pfizer-BioNTech COVID-19 Vaccine.
  • Appropriate medical treatment used to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of Pfizer- BioNTech COVID-19 Vaccine.

    Monitor Pfizer-BioNTech COVID-19 Vaccine recipients for the occurrence of immediate adverse reactions according to the Centers for Disease Control and Prevention guidelines (https://www.cdc.gov/vaccines/covid-19/).
  • Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Pfizer-BioNTech COVID-19 Vaccine.
  • The Pfizer-BioNTech COVID-19 Vaccine may not protect all vaccine recipients.
  • In clinical studies, adverse reactions in participants 16 years of age and older included pain at the injection site (84.1%), fatigue (62.9%), headache (55.1%), muscle pain (38.3%), chills (31.9%), joint pain (23.6%), fever (14.2%), injection site swelling (10.5%), injection site redness (9.5%), nausea (1.1%), malaise (0.5%), and lymphadenopathy (0.3%).
  • Severe allergic reactions, including anaphylaxis, have been reported following the Pfizer-BioNTech COVID-19 Vaccine during mass vaccination outside of clinical trials.

    Additional adverse reactions, some of which may be serious, may become apparent with more widespread use of the Pfizer-BioNTech COVID-19 Vaccine.
  • Available data on Pfizer-BioNTech COVID-19 Vaccine administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy.
  • Data are not available to assess the effects of Pfizer-BioNTech COVID-19 Vaccine on the breastfed infant or on milk production/excretion.
  • There are no data available on the interchangeability of the Pfizer-BioNTech COVID-19 Vaccine with other COVID-19 vaccines to complete the vaccination series. Individuals who have received one dose of Pfizer-BioNTech COVID-19 Vaccine should receive a second dose of Pfizer-BioNTech COVID-19 Vaccine to complete the vaccination series.
  • Vaccination providers must report Adverse Events in accordance with the Fact Sheet to VAERS at https://vaers.hhs.gov/reportevent.htmlor by calling 1-800-822-7967. The reports should include the words “Pfizer-BioNTech COVID-19 Vaccine EUA” in the description section of the report.
  • Vaccination providers should review the Fact Sheet for Information to Provide to Vaccine Recipients/Caregivers and Mandatory Requirements for Pfizer-BioNTech COVID-19 Vaccine Administration Under Emergency Use Authorization.

Please see Emergency Use Authorization (EUA) Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) including Full EUA Prescribing Information available at www.cvdvaccine-us.com.

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Pfizer Disclosure Notice

The information contained in this release is as of May 7, 2021. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.

This release contains forward-looking information about Pfizer’s efforts to combat COVID-19, the collaboration between BioNTech and Pfizer to develop a COVID-19 vaccine, the BNT162 mRNA vaccine program and the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) (including qualitative assessments of available data, potential benefits, expectations for clinical trials, a rolling submission of a Biologics License Application (BLA) with the FDA for BNT162b2, the anticipated timing of regulatory submissions, regulatory approvals or authorizations and anticipated manufacturing, distribution and supply), involving substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as risks associated with preclinical and clinical data (including the Phase 3 data), including the possibility of unfavorable new preclinical, clinical or safety data and further analyses of existing preclinical, clinical or safety data; the ability to produce comparable clinical or other results, including the rate of vaccine effectiveness and safety and tolerability profile observed to date, in additional analyses of the Phase 3 trial and additional studies or in larger, more diverse populations upon commercialization; the ability of BNT162b2 to prevent COVID-19 caused by emerging virus variants; the risk that more widespread use of the vaccine will lead to new information about efficacy, safety, or other developments, including the risk of additional adverse reactions, some of which may be serious;the risk that preclinical and clinical trial data are subject to differing interpretations and assessments, including during the peer review/publication process, in the scientific community generally, and by regulatory authorities; whether and when additional data from the BNT162 mRNA vaccine program will be published in scientific journal publications and, if so, when and with what modifications and interpretations; whether regulatory authorities will be satisfied with the design of and results from these and any future preclinical and clinical studies; whether and when the submission of the BLA for BNT162b2 in the U.S. will be completed and accepted for review and whether and when other biologics license and/or emergency use authorization applications or amendments to any such applications may be filed in particular jurisdictions for BNT162b2 or any other potential vaccines that may arise from the BNT162 program, and if obtained, whether or when such emergency use authorization or licenses will expire or terminate; whether and when the BLA for BNT162b2 in the U.S. and any other applications that may be pending or filed for BNT162b2 (including any requested amendments to the emergency use or conditional marketing authorizations) or other vaccines that may result from the BNT162 program may be approved by particular regulatory authorities, which will depend on myriad factors, including making a determination as to whether the vaccine’s benefits outweigh its known risks and determination of the vaccine’s efficacy and, if approved, whether it will be commercially successful; decisions by regulatory authorities impacting labeling or marketing, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of a vaccine, including development of products or therapies by other companies; disruptions in the relationships between us and our collaboration partners, clinical trial sites or third-party suppliers; the risk that demand for any products may be reduced or no longer exist; risks related to the availability of raw materials to manufacture a vaccine; challenges related to our vaccine’s ultra-low temperature formulation, two-dose schedule and attendant storage, distribution and administration requirements, including risks related to storage and handling after delivery by Pfizer; the risk that we may not be able to successfully develop other vaccine formulations, booster doses or new variant-specific vaccines; the risk that we may not be able to create or scale up manufacturing capacity on a timely basis or maintain access to logistics or supply channels commensurate with global demand for our vaccine, which would negatively impact our ability to supply the estimated numbers of doses of our vaccine within the projected time periods as previously indicated; whether and when additional supply agreements will be reached; uncertainties regarding the ability to obtain recommendations from vaccine advisory or technical committees and other public health authorities and uncertainties regarding the commercial impact of any such recommendations; challenges related to public vaccine confidence or awareness; uncertainties regarding the impact of COVID-19 on Pfizer’s business, operations and financial results; and competitive developments.

A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.

About BioNTech

Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit www.BioNTech.de.

BioNTech Forward-looking Statements

This press release contains “forward-looking statements” of BioNTech within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but may not be limited to, statements concerning: BioNTech’s efforts to combat COVID-19; the collaboration between BioNTech and Pfizer to develop a COVID-19 vaccine (including a potential second booster dose of BNT162b2 and/or a potential booster dose of a variation of BNT162b2 having a modified mRNA sequence); the potential of BNT162b2 for adolescents 12 to 15 years of age, evaluation of BNT162b2 in children 6 months to 11 years old, anticipated timing of regulatory submissions, regulatory approvals or authorizations, including the Biologics License Application, and anticipated manufacturing, distribution and supply); our expectations regarding the potential characteristics of BNT162b2 in our clinical trials and/or in commercial use based on data observations to date; the ability of BNT162b2 to prevent COVID-19 caused by emerging virus variants; the expected time point for additional readouts on efficacy data of BNT162b2 in our clinical trials; the nature of the clinical data, which is subject to ongoing peer review, regulatory review and market interpretation; the timing for submission of data for, or receipt of, any marketing approval, including the Biologics License Application, or Emergency Use Authorization; our contemplated shipping and storage plan, including our estimated product shelf life at various temperatures; the risk that demand for any products may be reduced or no longer exist; the ability of BioNTech to supply the quantities of BNT162 to support clinical development and market demand, including our production estimates for 2021; and challenges related to public vaccine confidence or awareness. Any forward-looking statements in this press release are based on BioNTech’s current expectations and beliefs of future events, and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the ability to meet the pre-defined endpoints in clinical trials; competition to create a vaccine for COVID-19; the ability to produce comparable clinical or other results, including our stated rate of vaccine effectiveness and safety and tolerability profile observed to date, in the remainder of the trial or in larger, more diverse populations upon commercialization; the ability to effectively scale our productions capabilities; and other potential difficulties.

For a discussion of these and other risks and uncertainties, see BioNTech’s Annual Report on Form 20-F for the Year Ended December 31, 2020, filed with the SEC on March 30, 2021, which is available on the SEC’s website at www.sec.gov. All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law.

Pfizer Contacts:

Media Relations

Amy Rose

+1 (212) 733-7410

[email protected]

Investor Relations

Chuck Triano

+1 (212) 733-3901

[email protected]

BioNTech Contacts:

Media Relations

Jasmina Alatovic

+49 (0)6131 9084 1513

[email protected]

Investor Relations

Sylke Maas, Ph.D.

+49 (0)6131 9084 1074

[email protected]

KEYWORDS: Germany Europe United States North America New York

INDUSTRY KEYWORDS: Health FDA Infectious Diseases Clinical Trials Pharmaceutical Biotechnology

MEDIA:

Logo
Logo
Logo
Logo

TELUS International Reports First Quarter 2021 Results, Continued Strong Revenue Growth and Operating Performance; Provides Full Year Outlook

TELUS International Reports First Quarter 2021 Results, Continued Strong Revenue Growth and Operating Performance; Provides Full Year Outlook

Revenue of $505 million, up 57% year-over-year, driven by robust, double-digit organic growth, as well as strong contributions from recent acquisitions

Acquisitions, digital, client mix, and efficiencies drove Adjusted EBITDA of $129 million, up 90% year-over-year; Net Income of $3 million and diluted EPS of $0.01

Adjusted diluted EPS of $0.23 was 229% higher year-over-year

Debt repayment with IPO proceeds, combined with additional repayments from cash provided by operating activities, enabled significant de-leveraging

Outlook for double-digit revenue and Adjusted EBITDA growth reflective of confidence in the continuation of strong operating momentum

VANCOUVER, British Columbia–(BUSINESS WIRE)–
TELUS International (NYSE and TSX: TIXT), a digital customer experience innovator that designs, builds, and delivers next-generation solutions for global and disruptive brands, today released its results for the first quarter ended March 31, 2021. TELUS International is a subsidiary of TELUS Corporation (TSX: T, NYSE: TU). All figures in this news release, and elsewhere in the TELUS International disclosures, are in U.S. dollars, unless specified otherwise, and relate only to TELUS International results and measures.

“In the first quarter of 2021, TELUS International continued to demonstrate remarkable resilience in our performance, underpinned by the diversity of our digital capabilities in growing through a challenging business environment. We expanded relationships with our existing clients, won new clients, and created incremental opportunities from exciting adjacencies such as progressing the integration of our newly acquired data annotation capabilities,” said Jeff Puritt, president and CEO of TELUS International. “We are uniquely positioned to harness our end-to-end digital capabilities and long-standing differentiated caring culture to drive further benefits from the digital transformation tailwinds that have accelerated in the market, resulting in increasing demand from existing and new clients alike.”

Jeff emphasized that, “Our consistent focus on partnering with substantial, sustainable business customers rather than seeking short-term pandemic-driven opportunities, positions us well for a meaningful growth trajectory over the near, medium and longer term. This quarter, we enjoyed notable new client wins for digital solutions and content moderation services, and growth across all key verticals, particularly in Tech & Games. Our diverse capabilities are already now further strengthened with the acquisition of Lionbridge AI. This integration is progressing well and we are confident in our ability to realize the full potential of this next-gen offering, amplified by our adjacent digital capabilities that create a unique competitive advantage relative to other data annotation providers.”

“The TELUS International brand also continues to garner increased visibility in the industry with recent recognition by leading industry analyst firms, Gartner, Everest Group and NelsonHall with respect to our digital CX services and delivery, content moderation and trust and safety competencies. We were also named a Leader on IAOP’s Global 100 List for the fifth consecutive year, highlighting our ability to innovate and our commitment to Corporate Social Responsibility programs,” continued Jeff. “This third-party recognition reflects the tremendous dedication and engagement of our team members across the globe, despite the challenges of the ongoing pandemic.”

Vanessa Kanu, CFO said, “In the first quarter of 2021, we delivered 57% revenue growth, driven by acquisition uplift, and 20% organic revenue growth, underpinned by our diverse digital service offerings and capabilities. Adjusted diluted EPS, which excludes the impact of certain charges, was $0.23, up 229% from the first quarter of last year, reflecting our continued momentum with existing and new clients, our scale efficiencies, and contributions from accretive acquisitions.”

“We have also made excellent progress in strengthening our balance sheet and have again demonstrated our ability to de-lever quickly following strategic acquisitions. Using the cash proceeds from our IPO of $493 million, combined with additional repayments from cash provided by operating activities, TELUS International was able to repay $530 million of debt in the first quarter, and as expected, we now sit comfortably within our target leverage range, providing significant available liquidity for potential future acquisitions to complement our double digit organic revenue growth,” continued Vanessa. “Looking ahead, our management team expects TI will continue to deliver strong performance in 2021, as signaled by the full year outlook we have provided today. We believe our strong profitability profile creates additional headroom to invest even more in our business to further accelerate our revenue growth trajectory.”

Provided below are financial and operating highlights that include certain non-GAAP measures. Reconciliations to GAAP measures under IFRS are provided at the end of this news release.

Q1 2021 vs. Q1 2020 highlights

  • Revenue of $505 million, up 57%, due to contributions from acquisitions, with organic growth of 20% (which includes a 4% favourable foreign currency impact), driven by growth from existing and new clients, with continued strong momentum in Tech and Games in particular, as well as good growth in Communications & Media and eCommerce & Fintech.
  • Net income of $3 million and Diluted EPS of $0.01, compared with $11 million and $0.05 in the prior year, respectively. Net income margin was 0.6%. Net income and Diluted EPS include the impact of share-based compensation, acquisition and integration charges and amortization of purchased intangible assets, among other items. Adjusted net income, which excludes the impact of these items, was 293% higher at $59 million.
  • Adjusted EBITDA of $129 million, up 90%, and Adjusted EBITDA margin of 25.5%, an improvement of 440 basis points, driven by revenue growth noted above and contributions from acquisitions, digital and favourable client mix. Adjusted diluted EPS was $0.23 which was 229% higher.
  • Net Debt to Adjusted EBITDA Leverage Ratio as per credit agreement of 2.7x, within the target range of 2 to 3x, reflecting $530 million in debt repayments using the IPO proceeds of $493 million and additional repayments from cash from operations.
  • Team member count was 51,387 as of March 31, 2021, an increase of 11%, reflecting organic growth in certain geographies and acquisitions in the prior year.

For a discussion of our first quarter 2021 results of operations, see management’s discussion and analysis of results of operations and financial condition, and financial statements and notes, on SEDAR and on Form 6-K on EDGAR with the SEC. Please visit telusinternational.com/investors for additional information.

Outlook

 

Full-Year 2021 Outlook*

Full-Year 2020 Reported

Revenue (millions)

$2,150 to 2,190

$1,582

Adjusted EBITDA (millions)

$523 to 533

$391

Adjusted diluted EPS

$0.90 to 0.95

$0.71

* Excludes the impact of potential future acquisitions

Q1 2021 investor call

TELUS International will host a conference call today, May 7, 2021 at 10:30 a.m. (ET) / 7:30 a.m. (PT), where management will review the Q1 2021 results and outlook, followed by a question and answer session with pre-qualified analysts. A webcast of the conference call will be streamed live on the TELUS International Investor Relations website at: https://www.telusinternational.com/investors/news-events and a replay will also be available on the website following the conference call.

Non-GAAP and other financial disclosures

This news release includes non-GAAP financial information, with further explanation and reconciliation to GAAP measures as outlined later in this release. We report certain non-GAAP measures used in the management analysis of our performance, but these generally do not have a standardized meaning and may not be comparable with similar measures presented by other issuers. For definitions and more information on the use of the non-GAAP measures, please see our first quarter 2021 management’s discussion and analysis of results of operations and financial condition, and financial statements and notes, on SEDAR and on Form 6-K on EDGAR with the SEC.

Cautionary note regarding forward-looking statements

This news release contains forward-looking statements concerning our financial outlook for the full year 2021 results, our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our business, results of operations and financial condition. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “aim”, “anticipate”, “assume”, “believe”, “contemplate”, “continue”, “could”, “due”, “estimate”, “expect”, “goal”, “intend”, “may”, “objective”, “plan”, “predict”, “potential”, “positioned”, “seek”, “should”, “target”, “will”, “would” and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology.

These forward-looking statements are based on our current expectations, estimates, forecasts and projections about our business and the industry in which we operate and management’s beliefs and assumptions, and are not guarantees of future performance or development and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control.

Specifically, we made several assumptions underlying our financial outlook for the full year 2021 results, including key assumptions in relation to: our ability to execute our growth strategy, including by expanding services offered to existing clients and attracting new clients; our ability to maintain our corporate culture and competitiveness of our service offerings; our ability to attract and retain talent; our ability to integrate, and realize the benefits of, our acquisition of Lionbridge AI; the relative growth rate and size of our target industry verticals; our projected operating and capital expenditure requirements; and the impact of the COVID-19 pandemic on our business, financial condition, financial performance and liquidity.

Risk factors that may cause actual results to differ materially from current expectations include, among other things:

  • We face intense competition from companies that offer services similar to ours.
  • Our ability to grow and maintain our profitability could be materially affected if changes in technology and client expectations outpace our service offerings and the development of our internal tools and processes.
  • If we cannot maintain our culture as we grow, our services, financial performance and business may be harmed.
  • Our business and financial results could be adversely affected by economic and geopolitical conditions and the effects of these conditions on our clients’ businesses and demand for our services.
  • Two clients account for a significant portion of our revenue and loss of or reduction in business from, or consolidation of, these or any other major clients could have a material adverse effect.
  • Our growth prospects are dependent upon attracting and retaining enough qualified team members to support our operations, as competition for highly skilled personnel is intense.
  • Our business and financial results have been, and in the future may be, adversely impacted by the COVID-19 pandemic.
  • Our business would be adversely affected if individuals providing data annotation services through the crowdsourcing solutions we provide with our recently completed acquisition of Lionbridge AI were classified as employees and not as independent contractors.
  • We may be unable to successfully identify, complete, integrate and realize the benefits of acquisitions or manage the associated risks.
  • Cyber-attacks or unauthorized disclosure resulting in access to sensitive or confidential information and data of our clients or their end customers could have a negative impact on our reputation and client confidence.
  • Our business may not develop in ways that we currently anticipate due to negative public reaction to offshore outsourcing, proposed legislation or otherwise.
  • Our ability to meet the expectations of clients of our content moderation services may be adversely impacted due to factors beyond our control and our content moderation team members may suffer adverse emotional or cognitive effects in the course of performing their work.
  • The dual-class structure that is contained in our articles has the effect of concentrating voting control and the ability to influence corporate matters with TELUS Corporation.
  • TELUS Corporation will, for the foreseeable future, control the direction of our business.

These risk factors are also listed and fully described in our “Risk Factors” section of the Annual Report for the year ended December 31, 2020, available on SEDAR and on Form 20-F on EDGAR with the SEC.

TELUS International (Cda) Inc.

 

Condensed Interim Consolidated Statements of Income and Other Comprehensive Income (Loss)

(unaudited)

     

 

 

Three months

Periods ended March 31 (US$ millions except earnings per share)

 

2021

 

2020

 

 

 

 

 

 

REVENUE

 

$

505

 

$

322

 

 

 

 

 

 

OPERATING EXPENSES

 

 

 

 

 

Salaries and benefits

 

 

282

 

 

206

Goods and services purchased

 

 

94

 

 

48

Share-based compensation

 

 

26

 

 

2

Acquisition, integration and other

 

 

5

 

 

19

Depreciation

 

 

27

 

 

21

Amortization of intangible assets

 

 

36

 

 

13

 

 

 

470

 

 

309

 

 

 

 

 

 

OPERATING INCOME

 

 

35

 

 

13

 

 

 

 

 

 

OTHER (INCOME) EXPENSES

 

 

 

 

 

Changes in business combination-related provisions

 

 

 

 

(23)

Interest expense

 

 

14

 

 

13

Foreign exchange loss

 

 

3

 

 

INCOME BEFORE INCOME TAXES

 

 

18

 

 

23

Income tax expense

 

 

15

 

 

12

NET INCOME

 

 

3

 

 

11

 

 

 

 

 

 

OTHER COMPREHENSIVE INCOME (LOSS)

 

 

 

 

 

Items that may subsequently be reclassified to income

 

 

 

 

 

Change in unrealized fair value of derivatives designated as held-for-hedging

 

 

21

 

 

(4)

Exchange differences arising from translation of foreign operations

 

 

(33)

 

 

(12)

 

 

 

(12)

 

 

(16)

COMPREHENSIVE LOSS

 

$

(9)

 

$

(5)

 

 

 

 

 

 

EARNINGS PER SHARE

 

 

 

 

 

Basic

 

$

0.01

 

$

0.05

Diluted

 

$

0.01

 

$

0.05

 

 

 

 

 

 

TOTAL WEIGHTED AVERAGE SHARES OUTSTANDING (millions)

 

 

 

 

 

Basic

 

 

257

 

 

209

Diluted

 

 

259

 

 

210

TELUS International (Cda) Inc.

 

Condensed Interim Consolidated Statements of Financial Position

 

As at (US$ millions)

 

March 31, 2021

(unaudited)

 

December 31, 2020

(audited)

 

 

 

 

 

ASSETS

 

 

 

 

Current assets

 

 

 

 

Cash and cash equivalents

 

$

117

 

$

153

Accounts receivable

 

 

346

 

 

303

Due from affiliated companies

 

 

49

 

 

49

Income and other taxes receivable

 

 

14

 

 

18

Prepaid expenses

 

 

40

 

 

23

Current derivative assets

 

 

1

 

 

2

 

 

 

567

 

 

548

Non-current assets

 

 

 

 

Property, plant and equipment, net

 

 

358

 

 

362

Intangible assets, net

 

 

1,235

 

 

1,294

Goodwill

 

 

1,456

 

 

1,487

Deferred income taxes

 

 

19

 

 

7

Other long-term assets

 

 

25

 

 

34

 

 

 

3,093

 

 

3,184

Total assets

 

$

3,660

 

$

3,732

 

 

 

 

 

LIABILITIES AND OWNERS’ EQUITY

 

 

 

 

Current liabilities

 

 

 

 

Accounts payable and accrued liabilities

 

$

281

 

$

254

Due to affiliated companies

 

 

39

 

 

31

Income and other taxes payable

 

 

82

 

 

101

Advance billings and customer deposits

 

 

4

 

 

8

Current portion of provisions

 

 

12

 

 

17

Current maturities of long-term debt

 

 

94

 

 

92

Current portion of derivative liabilities

 

 

3

 

 

1

 

 

 

515

 

 

504

Non-current liabilities

 

 

 

 

Provisions

 

 

17

 

 

20

Long-term debt

 

 

1,137

 

 

1,674

Derivative liabilities

 

 

35

 

 

57

Deferred income taxes

 

 

344

 

 

353

Other long-term liabilities

 

 

7

 

 

13

 

 

 

1,540

 

 

2,117

Total liabilities

 

 

2,055

 

 

2,621

 

 

 

 

 

Owners’ equity

 

 

1,605

 

 

1,111

Total liabilities and owners’ equity

 

$

3,660

 

$

3,732

TELUS International (Cda) Inc.

 

Condensed Interim Consolidated Statements of Cash Flows

(unaudited)

 

 

Three months

Periods ended March 31 (US$ millions)

 

2021

 

2020

OPERATING ACTIVITIES

 

 

 

 

Net income

 

$

3

 

$

11

Adjustments:

 

 

 

 

Depreciation and amortization

 

 

63

 

 

34

Interest expense

 

 

14

 

 

13

Income tax expense

 

 

15

 

 

12

Share-based compensation

 

 

26

 

 

2

Changes in business combination-related provisions

 

 

 

 

(23)

Change in market value of derivatives and other adjustments

 

 

29

 

 

Net change in non-cash operating working capital

 

 

(53)

 

 

24

Share-based compensation payments

 

 

(17)

 

 

Interest paid

 

 

(9)

 

 

(8)

Income taxes paid, net

 

 

(35)

 

 

(31)

Cash provided by operating activities

 

 

36

 

 

34

INVESTING ACTIVITIES

 

 

 

 

Cash payments for capital assets

 

 

(14)

 

 

(1)

Cash payments for acquisitions, net

 

 

 

 

(805)

Cash used in investing activities

 

 

(14)

 

 

(806)

FINANCING ACTIVITIES

 

 

 

 

Shares issued

 

 

525

 

 

284

Share issuance costs

 

 

(32)

 

 

Repayment of long-term debt

 

 

(547)

 

 

(589)

Long-term debt issued

 

 

 

 

1,145

Cash (used in) provided by financing activities

 

 

(54)

 

 

840

Effect of exchange rate changes on cash and cash equivalents

 

 

(4)

 

 

CASH POSITION

 

 

 

 

(Decrease) increase in cash and cash equivalents

 

 

(36)

 

 

68

Cash and cash equivalents, beginning of period

 

 

153

 

 

80

Cash and cash equivalents, end of period

 

$

117

 

$

148

Non-GAAP reconciliations  

 

Three Months (unaudited)

Periods ended March 31

 

2021

 

2020

(US$ millions, except per share amounts)

 

 

 

 

Net income

 

$

3

 

$

11

Add back (deduct):

 

 

Changes in business combination-related provisions

 

 

 

 

(23)

Acquisition, integration and other 

 

 

5

 

 

19

Share-based compensation

 

 

26

 

 

2

Foreign exchange loss

 

 

3

 

 

Amortization of purchased intangible assets

 

 

33

 

 

12

Tax effect of the adjustments above 

 

 

(11)

 

 

(6)

TI Adjusted Net Income

 

$

59

 

$

15

TI Adjusted Basic Earnings Per Share

 

$

0.23

 

$

0.07

TI Adjusted Diluted Earnings Per Share

 

$

0.23

 

$

0.07

 

 

 

 

 

Three Months (unaudited)

Periods ended March 31 (US$ millions)

 

2021

 

2020

 

 

 

Net income

 

$

3

 

$

11

Add back (deduct):

 

 

Changes in business combination-related provisions

 

 

 

 

(23)

Acquisition, integration and other 

 

 

5

 

 

19

Share-based compensation

 

 

26

 

 

2

Foreign exchange loss

 

 

3

 

 

Depreciation and amortization

 

 

63

 

 

34

Interest expense

 

 

14

 

 

13

Income taxes

 

 

15

 

 

12

TI Adjusted EBITDA

 

$

129

 

$

68

 

 

 

Periods ended March 31 (US$ millions)

 

Three Months (unaudited)

 

2021

 

2020

 

 

Cash provided by operating activities

 

$

36

 

$

34

Less: capital expenditures

 

 

(18)

 

 

(13)

TI Free Cash Flow

 

$

18

 

$

21

 

 

 

 

As at (US$ millions except for ratio)

 

March 31, 2021

 

December 31, 2020

 

(unaudited)

 

(unaudited)

 

 

Outstanding credit facility

 

$

1,038

 

$

1,568

Contingent facility utilization

 

 

7

 

 

7

Net derivative

 

 

37

 

 

56

Cash balance1

 

 

(100)

 

 

(100)

Net Debt as per credit agreement

 

$

982

 

$

1,531

TI Adjusted EBITDA

 

$

129

 

$

391

Adjustments to annualize TI Adjusted EBITDA and other adjustments as per credit agreement

 

$

241

 

$

(20)

Net Debt to Adjusted EBITDA Leverage Ratio as per credit agreement

 

 

2.7

 

 

4.1

1Maximum cash balances of $100 million is used for the period ended March 31, 2021 in accordance with the credit agreement.

About TELUS International

TELUS International (NYSE & TSX: TIXT) designs, builds and delivers next-generation digital solutions to enhance the customer experience (CX) for global and disruptive brands. The company’s services support the full lifecycle of its clients’ digital transformation journeys and enable them to more quickly embrace next-generation digital technologies to deliver better business outcomes. TELUS International’s integrated solutions and capabilities span digital strategy, innovation, consulting and design, digital transformation and IT lifecycle solutions, data annotation and intelligent automation, and omnichannel CX solutions that include content moderation, trust and safety solutions and other managed solutions. Fueling all stages of company growth, TELUS International partners with brands across high growth industry verticals, including tech and games, communications and media, eCommerce and fintech, healthcare, and travel and hospitality. TELUS International has a unique and differentiated culture that places people and a shared set of values at the forefront of everything we do. We believe that continuously investing in our culture and operating as a socially responsible company builds stronger relationships with our team members and clients, and positively impacts the communities in which we operate. Learn more at: telusinternational.com.

TELUS International Investor Relations

Jason Mayr

(604) 695-3455

[email protected]

TELUS International Media Relations

Ali Wilson

(604) 328-7093

[email protected]

KEYWORDS: United States North America Canada

INDUSTRY KEYWORDS: Consulting Data Management Professional Services Technology Software

MEDIA:

Logo
Logo

TELUS reports operational and financial results for first quarter 2021


Industry-leading customer net additions of 145,000, reflecting strong demand for our superior connected experiences, innovative product set and premium bundled offerings


Industry-leading mobility loading with mobile phone net additions of 31,000, an increase of 10,000 over the prior year, backed by the best customer experience and world-leading churn, along with 63,000 connected device net additions, up 14,000 over last year 


Industry-best fixed customer net additions of 51,000, up 15,000 over the prior year, powered by TELUS PureFibre and world-leading customer loyalty


 Continued strong momentum in TELUS International combined with impressive annual outlook, reflecting contributions from acquisitions, as well as strong organic customer growth 


TELUS Health services revenue was up a robust 10 per cent, driven by accelerated demand for virtual care, which has


seen Canadian members nearly triple over the past 12 months to 2.0 million, reducing exposure and delivering improved health outcomes


First quarter consolidated revenue and EBITDA growth of 8.9 per cent and 1.9 per cent respectively, showcasing continued resilience and strength in execution excellence, in the midst of an unprecedented operating environment


Free cash flow updated to approximately $750 million, reflecting the strategic acceleration of our broadband network investment program


Quarterly dividend increased to $0.3162 per share, up 8.6 per cent over the prior year

VANCOUVER, British Columbia, May 07, 2021 (GLOBE NEWSWIRE) — TELUS Corporation today released its unaudited results for the first quarter of 2021. Consolidated operating revenues and other income increased by 8.9 per cent over the same period a year ago to $4.0 billion. Earnings before interest, income taxes, depreciation and amortization (EBITDA) increased by 3.7 per cent to $1.5 billion while Adjusted EBITDA was higher by 1.9 per cent. This growth reflects: i) higher fixed data service margins resulting from subscriber base growth and expanded services; ii) growth in our mobile subscriber base and mobile equipment margins; iii) growth from business acquisitions (net of associated support costs); iv) an increased contribution from our Digitally-led customer experiences – TELUS International (DLCX) segment from business acquisitions and expanded services; and v) enhanced cost efficiency programs. This growth was partly offset by the non-recurrence of the comparative period’s decrease of a provision related to written put options to acquire the remaining non-controlling interest of an acquired subsidiary, the lingering impacts of the COVID-19 pandemic, lower legacy fixed voice and legacy fixed data services, and higher employee benefits expense.

“TELUS once again achieved strong operational and financial results in the first quarter, in both of our operating segments of TELUS Technology Solutions (TTech) and Digitally-Led Customer Experiences – TELUS International (DLCX),” said Darren Entwistle, President and CEO. “Our continued execution excellence, realized against the backdrop of an unprecedented operating environment, was characterized by the ongoing combination of robust, high-quality and profitable customer growth, alongside strong financial results across our business. This solid performance reflects the effectiveness of our world-leading performance culture, underpinned by our highly engaged team, and their dedication and passion for delivering outstanding connected experiences. This contributed to industry-leading customer net additions of 145,000 and leading customer loyalty across our key mobile and fixed product lines. Notably, mobile phone, internet, Optik TV and Smart Home Security churn were all once again below one per cent in the first quarter, whilst postpaid churn is now in its eighth consecutive year of industry-best churn below one per cent.” 

“Furthermore, our results are buttressed by our highly differentiated and potent asset mix geared towards high-growth, technology-oriented verticals. Indeed, for the full year 2021, TELUS International today announced that it is targeting double-digit revenue and EBITDA growth, showcasing the significant global opportunities it has to drive digital transformation journeys for its existing and prospective clients, and enable them to more quickly embrace next-generation digital technologies to deliver better business outcomes.”

“Meanwhile, within our health portfolio, we are leveraging our technology leadership to deliver improved health outcomes for citizens through access to better health information. While the pandemic has disrupted the operations of our TELUS Health Care Centres since March 2020, our diversified virtual care offerings continue to grow to meet the healthcare needs of Canadians, including the accelerated adoption of virtual consultations as reflected in our growing virtual care user base. In the first quarter, Health services revenue was up a robust 10 per cent, driven by accelerated demand for virtual care, which has seen its number of members nearly triple over the past 12 months to 2 million, whilst clinic visits and preventative health services moderated substantially through pandemic-related lockdowns. We are confident that the increased healthcare related disclosure, which we are introducing today, will provide meaningful insight into the valuable asset we are creating as a world-leading provider of digital healthcare technology solutions.”

“Our first quarter performance was backed by strong digital capabilities and superior service offerings over our world-leading wireless and fibre broadband networks,” added Darren. “At a time when network connectivity is more important than ever, TELUS was again recognized as the best mobile network in Canada for the ninth time in UK-based Opensignal’s Mobile Network Experience Report February 2021. TELUS took first place for Video Experience, Voice App Experience, Download Speed Experience, Upload Speed Experience, and tied for first in 4G Availability, 4G Coverage Experience, and Games Experience. Opensignal further acknowledged our next-generation 5G network with six awards for superiority in respect of speed and coverage in their Canada 5G User Experience Report. Similarly, Canada-based Tutela named TELUS the best mobile experience provider in Canada in their Canada: State of Mobile Network March 2021 report. In addition, Seattle-based Ookla subsequently named TELUS the fastest mobile operator in Canada for the third quarter in a row in their Global Index Market Analysis for Q1 2021.”

“TELUS’ network leadership will be significantly bolstered by our accelerated broadband investment program, announced in March,” further commented Darren. “Our successful $1.3 billion equity offering will underpin the unique strategic opportunity we have to pull-forward the expansion of TELUS’ leading PureFibre network in Alberta, British Columbia and Eastern Quebec, as well as an accelerated roll-out of our national 5G network and digital experience. Investing from a position of strength and leadership, these transformational investments will significantly bolster TELUS’ leading customer experience and competitive position, including the enablement of up to 225,000 additional rural and urban premises with fibre technology, and enhancing the speed and coverage of our world-leading wireless network. These generational investments will fuel enhanced customer growth and operating efficiencies, supported by the accelerated de-commissioning of our copper infrastructure. This will drive positive cash flow benefits as TELUS completes the expedited build, alongside a faster than expected reduction in capital expenditures beginning in 2023. Importantly, this initiative will further support the advancement of our financial and operational performance, strengthening our confidence in the robust outlook for our business and the long-term sustainability of our industry-leading dividend growth program, now in its eleventh year.”

“Our TELUS team continues to give, with their hearts and their hands, to support Canada’s COVID-19 relief efforts,” expressed Darren. “By way of example, nearly 1,800 TELUS team members are supporting the health and well-being of our fellow citizens through the Government of B.C.’s Immunize B.C. initiative. Due in part to our team’s efforts, we have been able to significantly accelerate the phased vaccination rollout, including more than one million vaccination appointment bookings for eligible British Columbians, providing hope of better days ahead. We are offering further support through eight of our 13 Health for Good mobile clinics across Canada, which provided over 500 vaccinations in the first quarter, as well as close to 18,000 COVID-19 assessments for marginalized populations since the start of the pandemic. Similarly, through our Mobility for Good program, we are providing wireless connectivity to youth leaving foster care and low-income seniors, two groups within our community that continue to be disproportionately impacted by the pandemic. Since its inception, the program has supported 24,000 Canadians, further demonstrating that Canadians can count on the TELUS team, day-in and day-out.”

Doug French, Executive Vice-president and CFO said, “Our first quarter results announced today demonstrate the resiliency of our business, our leading execution and the critical importance of providing world-leading broadband experiences along with superior bundled solutions. These results are further enhanced by the strength and diversity of our fast-growing asset mix centred around higher-valued technology oriented sectors. In that regard, our TELUS International, TELUS Health and TELUS Agriculture assets all delivered strong revenue growth driven in part by recent acquisitions, as well as organic growth, as those businesses successfully drive new customer growth.”

Doug added “With our strategic decision to pull forward capital expenditures to accelerate our broadband build program, focused on enhancing our fibre and 5G network coverage over the next 18 months, today we are increasing our capital expenditure guidance for 2021 by $750 million to approximately $3.5 billion. As a result of this pull forward of capital investments, we now expect free cash flow to be approximately $750 million in 2021, while our growth targets for consolidated revenue and Adjusted EBITDA for the full year remain unchanged. Additionally, upon completion of our accelerated broadband build in 2022, we anticipate capital expenditures to decline to $2.5 billion or less, beginning in 2023.”

“Based on our healthy balance sheet position, combined with confidence in our sustainable future free cash flow growth, today we announced a dividend increase to $0.3162 per share. We are excited for the long-term outlook of our business. Indeed, in Canada, we have exciting opportunities in front of us to support the economic recovery, leveraging our world-leading networks that will enable new growth opportunities and unlock new revenue streams. Furthermore, our international businesses are benefiting from a growing global economy and have significant opportunities to drive technology innovation as they look to deliver superior customer experiences and digitize workflows,” concluded Doug.

In the quarter, we added 145,000 new customer additions, up 39,000 over last year, and inclusive of 31,000 mobile phones, 63,000 connected devices, in addition to 33,000 internet, 11,000 TV and 17,000 security customer connections. This was partly offset by low residential voice losses of 10,000. Our total TTech subscriber base of 16.1 million is up 5.5 per cent over the last twelve months, reflecting a 3.3 per cent increase in our mobile phones subscriber base to approximately 9.0 million, and a 17 per cent increase to our connected devices subscriber base to approximately 1.9 million. Additionally, our internet connections grew by 7.4 per cent over the last twelve months to approximately 2.2 million customers, our TV subscriber base increased by 5 per cent to approximately 1.2 million, and our security customer base expanded by 16 per cent to 724,000.

Free cash flow of $321 million decreased by $224 million or 41 per cent over the same period a year ago, resulting primarily from: i) increased income tax payments, as income tax instalment payments in the first quarter of 2020 were deferred into the third quarter of 2020 as permitted by several government jurisdictions as part of their COVID-19 pandemic responses; ii) the timing related to device subsidy repayments and associated revenue recognition and our TELUS Easy Payment device financing program; iii) higher lease principal payments; iv) higher restructuring and other costs disbursements; v) higher interest paid; and vi) higher capital expenditures. These factors were partly offset by higher EBITDA. Excluding cash taxes, free cash flow of $541 million decreased by $128 million or 19 per cent.

Consolidated capital expenditures increased by $20 million in the first quarter of 2021, due to increased investments in our 5G network, the accelerated purchase of equipment and higher capital expenditures to support subscriber growth, and accelerated investments to increase system capacity and reliability. These increases were partially offset by the timing of our fibre build activities. With our ongoing investments, we are advancing wireless speeds and coverage that enabled our 5G network launch, continuing to connect additional homes and businesses directly to our fibre-optic technology, and supporting systems reliability and operational efficiency and effectiveness efforts. These investments also support our internet, TV and security subscriber growth, address our customers’ demand for faster internet speeds, and extend the reach and functionality of our business, healthcare and agriculture solutions.

At the end of the quarter, our TELUS PureFibre network covered over 2.5 million premises, reflecting an increase of approximately 240,000 fibre premises over the last twelve months. By March 31, 2021, our 5G network covered more than 10.6 million Canadians, representing over 28 per cent of the population.

For the quarter, net income of $333 million decreased by 5.7 per cent over the same period last year and Basic earnings per share (EPS) of $0.25 decreased by 11 per cent. These declines are driven by increased depreciation and amortization; non-recurrence of the comparative period’s decrease of a provision related to written put options to acquire the remaining non-controlling interest of an acquired subsidiary; the lingering impacts of the COVID-19 pandemic; lower legacy fixed voice and legacy fixed data services; higher employee benefits expense; and, as it relates to EPS, higher shares outstanding.

When excluding the effects of restructuring and other costs, income tax-related adjustments, other equity losses related to real estate joint ventures, and non-controlling interests, adjusted net income of $359 million decreased by $41 million or 10 per cent in the first quarter of 2021, while adjusted basic EPS of $0.27 was down 16 per cent.

Consolidated Financial Highlights      
C$ millions, except footnotes and unless noted otherwise Three months ended
March 31
Per cent  
(unaudited) 2021 2020 change  
Operating revenues and other income 4,024 3,694 8.9  
Operating expenses before depreciation and amortization 2,563 2,285 12.2  
EBITDA(1) 1,461 1,409 3.7  
Adjusted EBITDA(1)(2) 1,503 1,475 1.9  
Net income 333 353 (5.7 )
Adjusted net income(1) 359 400 (10.3 )
Net income attributable to common shares 331 350 (5.4 )
Basic EPS ($) 0.25 0.28 (10.7 )
Adjusted basic EPS(1) ($) 0.27 0.32 (15.6 )
Capital expenditures(3) 685 665 3.0  
Free cash flow(1) 321 545 (41.1 )
Total subscriber connections(4) (thousands) 16,072 15,241 5.5  

(1) EBITDA, Adjusted EBITDA, Adjusted net income, Adjusted basic EPS and Free cash flow are non-GAAP measures and do not have any standardized meaning prescribed by IFRS-IASB. For further definitions and explanations of these measures, see ‘Non-GAAP and other financial measures’ in this news release.
(2) Adjusted EBITDA for the first quarters of 2021 and 2020 excludes restructuring and other costs of $41 million and $60 million respectively, and other equity losses related to real estate joint ventures of $1 million and $6 million respectively.
(3) Capital expenditures include assets purchased, excluding right-of-use lease assets, but not yet paid for, and consequently differ from Cash payments for capital assets, excluding spectrum licences, as reported in the interim consolidated financial statements. Refer to Note 31 in our interim consolidated financial statements for further information.
(4) The sum of active mobile phone subscribers, connected device subscribers, internet subscribers, residential voice subscribers, TV subscribers and security subscribers, measured at the end of the respective periods based on information in billing and other source systems. During the third quarter of 2020, we adjusted cumulative subscriber connections to add approximately 31,000 security subscribers as a result of a business acquisition. Effective January 1, 2021 with retrospective application to January 1, 2020, in alignment with our segment reporting changes, we made a retroactive adjustment to remove internal network service revenue and approximately 29,000 subscribers from our mobile phone subscriber base and associated operating statistics (ABPU/ARPU and churn). Effective January 1, 2021 on a prospective basis, following an in-depth review of customer accounts within a legacy subscriber provisioning system to be decommissioned, we adjusted our internet subscriber base to remove 16,000 subscribers.

First Quarter 2021 Operating Highlights

Commencing with the three-month period ended March 31, 2021, we have now transitioned to our new segment reporting structure and have recast comparative amounts on a comparable basis.

The TELUS technology solutions (TTech) segment includes: network revenues and equipment sales arising from mobile technologies; data revenues (which include internet protocol; television; hosting, managed information technology and cloud-based services; software, data management and data analytics-driven smart food-chain technologies; and home and business security); certain healthcare software and technology solutions; voice and other telecommunications services revenues; and equipment sales.

The Digitally-led customer experiences – TELUS International (DLCX) segment is comprised of digital customer experience and digital-enablement transformation, including artificial intelligence and content management solutions, provided by TELUS International.

As noted in Section 1.2 of our 2020 annual MD&A, the COVID-19 pandemic, which emerged in the first quarter of 2020, continued to have a pervasive global impact throughout the balance of 2020 and into 2021. The nature of the pandemic and the uncertainty of its magnitude, length and the time to recovery are not currently able to be estimated. Therefore, results described below may not be indicative of future trends, as the COVID-19 pandemic prevents us and our customers from operating in the normal course of business in certain areas while we continue to adjust our mode of operations to continue delivering on our customers first priorities and social purpose. Our results discussed below are compared to the equivalent period in 2020 unless otherwise indicated.

TELUS technology solutions (TTech)

  • TTech external operating revenues and other income increased by $197 million or 6.0 per cent in the first quarter of 2021, from the increase in mobile and fixed equipment and other service revenues, fixed data services revenues, and health services revenues, as described below.
  • TTech EBITDA increased by $35 million or 2.7 per cent in the first quarter of 2021, while Adjusted EBITDA increased by $23 million or 1.8 per cent, which reflected an increase in direct contribution from mobile and fixed products and services as outlined below, and savings achieved from the enhanced cost-savings initiatives in response to the economic impacts of the pandemic. These impacts were partially offset by higher employee benefits expense and other costs related to business acquisitions and growth in business operations.

Mobile products and services

  • Mobile network revenue decreased by $8 million or 0.5 per cent in the first quarter of 2021, due to declining mobile phone ARPU primarily from reduced roaming related to travel restrictions and chargeable data usage revenue, as discussed below, partly offset by growth of 5.5 per cent in the mobile phones and connected devices subscriber base over the past 12 months, in addition to growth in monthly recurring charges reflecting a greater mix of high-value customer additions and selection of higher-tier mobile plans.
  • Mobile equipment and other service revenues increased by $100 million in the first quarter of 2021, reflecting higher handset upgrade volumes and higher-value smartphones in the sales mix. Handset upgrade volumes increased as a result of the successful execution of our customers first initiatives, including the enhanced capabilities of our digital footprint, and suppressed handset upgrade volumes throughout 2020 manifesting in increased demand in the first quarter of 2021.
  • TTech mobile products and services direct contribution increased by $23 million or 1.7 per cent in the first quarter of 2021, due to higher equipment margins, lower commissions expenses as we continue to drive customer transactions to digital channels in addition to lower contracted volumes in prior periods, and lower roaming expenses, partly offset by lower network revenues as described above.
  • Mobile phone ABPU was $68.79 in the first quarter of 2021, a decrease of $3.19 or 4.4 per cent. This decrease reflects the lingering impacts caused by the COVID-19 pandemic including: (i) significantly reduced roaming revenue from changing customer behaviour related to travel restrictions; (ii) customers reducing their general shopping habits in retail outlets since the start of the pandemic, along with mandated capacity restrictions, which has hindered customer opportunities for device upgrades and the upgrade or selection of higher-tier plans; and (iii) decreases in chargeable data usage, as more people work from home and offload their mobile device traffic onto Wi-Fi networks. Mobile phone ABPU was also impacted by continued declines in chargeable data usage and the impact of the competitive environment putting pressure on base rate plan prices in the current and prior periods. The decline in mobile phone ABPU was partly offset by growth in monthly recurring charges reflecting a greater mix of high-value customer additions and selection of higher-tier mobile plans, in addition to higher-value smartphones in the sales mix in the current and prior periods.
  • Mobile phone ARPU was $56.10 in the first quarter of 2021, a decrease of $2.14 or 3.7 per cent, representing the third consecutive quarter of moderating year-over-year decline. Mobile phone ARPU was impacted by the same items noted above for mobile phone ABPU, with the exception of: (i) our TELUS Easy Payment device financing program; (ii) devices with subsidies; and (iii) contracted device upgrades.
  • Mobile phone gross additions were 270,000 in the first quarter of 2021, an increase of 5,000, as growth in high-value customer additions, successful promotions including the bundling of our mobility and home services, expanded channels, and the enhanced capabilities of our digital footprint have more than offset the estimated impacts of the pandemic such as customers reducing their general shopping habits in retail outlets along with mandated capacity restrictions.
  • Mobile phone net additions were 31,000 in the first quarter of 2021, an increase of 10,000, as our strong execution in our digital sales channels, successful efforts to drive high-value customer additions and lower churn more than offset the estimated impacts of the pandemic.
  • Our mobile phone churn rate was 0.89 per cent in the first quarter of 2021, compared to 0.94 per cent in the first quarter of 2020. The decrease reflects the estimated impacts of the pandemic, including changing customer behaviour due to travel restrictions and customers reducing their general shopping habits in retail outlets since the start of the pandemic, along with mandated capacity restrictions. This was in addition to the utilization of our TELUS Easy Payment device financing program, Peace of Mind endless data plans, Bring-It-Back program and TELUS Family Discount offerings, our successful bundling of mobility and home services, and our focus on executing customers first initiatives and upgrade volume programs, as well as our leading network quality.
  • Connected device net additions were 63,000 in the first quarter of 2021, an increase of 14,000, primarily due to increased demand for IoT solutions. Connected device net additions are inclusive of approximately 10,000 tablet net losses in the first quarter of 2021 which was flat compared to the prior year.

Fixed products and services

  • Fixed data services revenues increased by $102 million in the first quarter of 2021. The increase was driven by: (i) increased internet and third wave data service revenues, reflecting a 7.4 per cent increase in our internet subscribers over the past 12 months and higher revenue per customer resulting from internet speed upgrades, larger data usage internet rate plans and rate changes; (ii) increased revenues from smart food-chain technology, driven by business acquisitions; (iii) increased revenues from home and business security driven by expanded services and customer growth; and (iv) higher TV revenues, reflecting subscriber growth of 5.0 per cent over the past 12 months. This growth was partly offset by the ongoing decline in legacy data service revenues.
  • Fixed voice services revenues decreased by $22 million in the first quarter of 2021, reflecting the ongoing decline in legacy voice revenues resulting from technological substitution, greater use of inclusive long distance plans and price plan changes. Declines were moderated with our utilization of bundled product offerings, successful retention efforts and the migration from legacy to IP services offerings. The decline in residential voice subscribers over the past 12 months was limited to 3.1 per cent, compared to a 3.7 per cent decline in residential voice subscribers for the 12 month period ended March 31, 2020.
  • Fixed equipment and other services revenues increased by $11 million in the first quarter of 2021, reflecting a higher volume of home and business security equipment sales and data equipment sales.
  • TTech fixed product and services direct contribution increased by $44 million or 4.2 per cent in the first quarter of 2021, due to growth in margins of internet and smart food-chain technology, partly offset by declining legacy data and legacy voice margins.
  • Internet net additions were 33,000 in the first quarter of 2021, an increase of 7,000, reflecting continued net new demand from consumers and businesses for our TELUS PureFibre service as we continued to keep our customers connected through a range of installation options. The increase also reflects lower customer churn resulting from our customers first initiatives and retention programs, the success of our bundled product offerings, including the adoption of the TELUS Whole Home bundle and our bundling of mobility and home services, and reduced switching activity between providers due to the COVID-19 pandemic.
  • TV net additions were 11,000 in the first quarter of 2021, an increase of 3,000, mainly due to a lower customer churn rate from strong retention efforts, the success of our bundled product offerings and reduced switching activity due to the pandemic.
  • Security net additions were 17,000 in the first quarter of 2021, an increase of 2,000, driven by strong growth as we continued to keep our customers connected and protected by offering a range of installation options, and by demand for our bundled product offerings. Our continued focus on connecting more homes and businesses directly to fibre, expanding and enhancing our addressable high-speed internet and Optik TV footprint, and bundling these services together, contributed to combined internet, TV and security subscriber growth of 307,000 over the past 12 months.
  • Residential voice net losses were limited to 10,000 in the first quarter of 2021, compared to residential voice net losses of 13,000 in the first quarter of 2020. The residential voice subscriber losses continue to reflect the trend of substitution to mobile and internet-based services, partially mitigated by our expanding fibre footprint and bundled product offerings, as well as our strong retention efforts, including lower-priced offerings.

Health services

  • Through TELUS Health, we are leveraging technology to deliver connected solutions and services, improving access to care and revolutionizing the flow of information while facilitating collaboration, efficiency, and productivity across the healthcare ecosystem, progressing our vision of transforming healthcare and empowering people to live healthier lives.
  • Health services revenues increased by $11 million or 9.8 per cent in the first quarter of 2021. The increase was driven by business acquisitions, higher revenues from the accelerated adoption of our virtual care solutions, as well as growth in healthcare provider solutions. This was partly offset by the lingering impacts of the pandemic, including reduced health benefits claims and lower in-clinic services in our TELUS Health Care Centres.
  • Virtual care members were 2.0 million as of the end of the first quarter of 2021, an increase of 1.3 million over the past 12 months, mainly due to the accelerated demand for virtual solutions to keep Canadians safely connected with health and wellness care during the pandemic, and a business acquisition in the fourth quarter of 2020. Virtual care member means primary enrolment to receive services on an active TELUS Health virtual care plan.
  • Healthcare lives covered were 17.5 million as of the end of the first quarter of 2021, an increase of 2.9 million over the past 12 months, primarily due to the accelerated demand for virtual solutions. Healthcare lives covered means the number of users (primary members and their dependents) enrolled in various health programs supported by TELUS Health services (e.g. virtual care, health benefits management, preventative care and personal health security).
  • Digital health transactions were 133.3 million in the first quarter of 2021, a decrease of 6.4 million, largely driven by a lower number of adjudication transactions and collaborative health transactions, as plan members chose to defer utilization of elective health services during the pandemic, partly offset by growth in our digital pharmacy business. Digital health transactions means the total number of health claims, dental claims, consultations or other paid transactions facilitated by TELUS Health services.

Digitally-led customer experiences – TELUS International (DLCX)

  • DLCX operating revenues (arising from contracts with customers) increased by $165 million in the first quarter of 2021. The increase was primarily driven by business acquisitions, including one additional month of Competence Call Centre (CCC)’s operating results as the comparative quarter reflected two months of CCC’s operating results, as well as organic growth in our customers, which was due to a combination of new clients as well as growth in the depth and breadth of services offered to our existing customers. This growth was offset in part, by a negative foreign exchange impact in the first quarter of 2021 driven by the strengthening of the Canadian dollar compared to the U.S. dollar, the primary operating currency of DLCX.
  • DLCX other income decreased by $32 million in the first quarter of 2021, largely related to the non-recurrence of the comparative period’s decrease of a provision arising from a business acquisition-related written put options to acquire the remaining non-controlling interest of an acquired subsidiary, Xavient, which was settled in the second quarter of 2020.
  • DLCX EBITDA increased by $17 million or 15.4 per cent and Adjusted EBITDA increased by $5 million or 3.0 per cent in the first quarter of 2021. While EBITDA increased in absolute dollars, EBITDA margin declined by 2.2 percentage points. The decline in EBITDA margin is due to the non-recurrence of the comparative period’s decrease of a provision related to written put options to acquire the remaining non-controlling interest in Xavient, the negative foreign exchange impact as a result of the strengthening of the Canadian dollar compared to the U.S. dollar between the first quarters of 2021 and 2020, and the contribution from Lionbridge AI, which is a lower margin business.

Financial targets for 2021

TELUS’ consolidated financial targets for 2021 are guided by a number of long-term financial objectives, policies and guidelines, which are detailed in Section 4.3 of the 2020 annual MD&A.

As announced on March 25, 2021, TELUS intends to strategically bring forward transformational capital investments in broadband connectivity, including fibre and 5G, to enhance our industry-best customer experience, leading networks and competitive position. Investing from a position of strength and leadership, this accelerated broadband expansion program will significantly enhance TELUS’ fibre buildout across key markets in British Columbia, Alberta and Eastern Quebec, as well as advance investments related to the expansion of our 5G footprint, including network readiness for 5G spectrum and system upgrades. Approximately $750 million of the accelerated capital investments has been earmarked for 2021, over and above our previous target of $2.75 billion, dependent upon our ability to ramp-up resources and suppliers.

As shown in the table below, TELUS’ 2021 consolidated financial targets for Free cash flow and Capital expenditures have been updated to reflect this capital acceleration program.

  Original 2021 targets
($ millions)
Updated 2021 targets

($ millions)
Revenues and other income 8 to 10 per cent 8 to 10 per cent

unchanged

Adjusted EBITDA(1) 6 to 8 per cent 6 to 8 per cent

unchanged
Free cash flow(2) Approximately 1,500 Approximately 750

down 750
Capital expenditures(3) Approximately 2,750 Approximately 3,500

up 750

(1) Adjusted EBITDA excludes the following: restructuring and other costs, and other equity losses related to real estate joint ventures, as well as a retirement of a provision arising from business acquisition-related written put options within DLCX. In 2021, total restructuring and others costs are expected to be approximately $150 million, as compared to $259 million in 2020.
(2) Before dividends paid.
(3) Excludes expenditures for spectrum licences.

In 2021, we expect the COVID-19 pandemic to continue to have significant impacts on our business, primarily in the first half of the year, attributed to economic factors such as continued travel advisories and border restrictions, decreasing business and consumer travel continuing to impact our roaming revenues and subsequent business lockdowns, and/or reduced scope of operations impacting our TELUS Health Care Centres. We expect that the availability, distribution and effectiveness of COVID-19 vaccinations to the general population will occur by the second half of 2021, which will allow for the gradual re-opening of the global economy and areas where we conduct business. We expect that the COVID-19 pandemic impacts in 2021 will be similar to 2020. Our assumptions for 2021 are set out in Section 9.3 TELUS assumptions for 2021 in the 2020 annual MD&A.

The preceding disclosure respecting TELUS’ 2021 financial targets is forward-looking information and is fully qualified by the ‘Caution regarding forward-looking statements’ in the 2020 annual MD&A filed on February 11, 2021 on SEDAR, especially Section 10 Risks and Risk Management thereof which is hereby incorporated by reference, and is based on management’s expectations and assumptions as set out in Section 9.3 TELUS assumptions for 2021 in the 2020 annual MD&A.

TELUS International announces annual guidance

TELUS International (TI) today announced its annual financial targets for 2021. Please refer to TI’s first quarter of 2021 earnings release dated May 7, 2021 for additional details.

Dividend Declaration

The TELUS Board of Directors has declared a quarterly dividend of $0.3162 per share on the issued and outstanding Common Shares of the Company payable on July 2, 2021 to holders of record at the close of business on June 10, 2021. This second quarter dividend for 2021 reflects an increase of 8.6 per cent from the $0.29125 per share dividend declared one year earlier.

Approval of transfer of 3500 MHz spectrum licences

During the quarter, TELUS acquired 3500 MHz spectrum licences via commercial transactions. TELUS acquired 50 MHz in the urban cores of Edmonton, Guelph/Kitchener, London, Ottawa, and Winnipeg, as well as 50 MHz in East Kootenay and 25 MHz in Whistler. The acquisition of 3500 MHz spectrum augments TELUS’ current portfolio of spectrum holdings.

Hazel Claxton and Sean Willy to join TELUS Board of Directors

TELUS is pleased to announce Hazel Claxton and Sean Willy as new nominees to our Board of Directors, to be elected at the TELUS annual general meeting held today, May 7, 2021, further broadening the experience, skills and diversity of our Board.

Hazel is a corporate director. She served as Executive Vice President and Chief Human Resources Officer with Morneau Shepell Inc. from 2013 to 2018. Prior to that, Hazel spent 29 years at PwC Canada where she held several leadership roles including Canadian Leadership Group member, Human Capital leader, and Partner within the Corporate Advisory and Restructuring Group, an area she practiced in for 20 years. Hazel currently sits on the boards of the University Pension Plan Ontario, Unity Health Toronto, and Queen’s University where she is Vice Chair. Previously, she was on the boards of St. Michael’s Hospital and the Shaw Festival Theatre. Hazel holds a Bachelor of Commerce (Honours) from Queen’s University and the ICD.D designation from the Institute of Corporate Directors. She is a Chartered Professional Accountant.

Sean is President and Chief Executive Officer of Des Nedhe Development, the economic development entity for English River First Nation, which includes a broad portfolio of businesses and investments that range from construction and mining to retail and communications, a role he has held since August 2017, and prior thereto he was a Vice-President of Des Nedhe Development since June 2016. From 2010 to 2016, Sean was the Director of Corporate Responsibility for Cameco Corporation, a publicly traded uranium producer. Sean is an experienced business executive, with a 25-year history of creating, developing and leading inclusive practices in the resource sector and building opportunities with Indigenous communities. In his career, Sean has developed and implemented progressive and innovative Indigenous inclusion and value-added corporate social responsibility strategies for two leading resource companies, Rio Tinto and Cameco Corporation. Sean has always worked to ensure Indigenous Peoples are seen as full partners in long-term relationships, and this has led to Sean building partnerships in Australia, the United States and throughout Canada. Sean is currently a member of the Canadian Government’s Indigenous Innovation Housing Committee. In the past, he has served as Chair of the Mining Association of Canada’s Indigenous Affairs Committee, Co-Chair of the Canadian Council for Aboriginal Business, Chair of the successful Northern Career Quest and a board member of Indigenous Works. Sean holds a Bachelor of Commerce from the Edwards School of Business of the University of Saskatchewan.

Corporate Highlights

TELUS makes significant contributions and investments in the communities where team members live, work and serve and to the Canadian economy on behalf of customers, shareholders and team members. These include:

  • Paying, collecting and remitting more than $622 million in taxes in the first quarter of 2021 to federal, provincial and municipal governments in Canada consisting of corporate income taxes, sales taxes, property taxes, employer portion of payroll taxes and various regulatory fees. When including spectrum remittances, we have remitted approximately $35 billion in taxes and spectrum since 2000.
  • Investing approximately $685 million in capital expenditures primarily in communities across Canada in the first quarter of 2021 and approximately $45 billion since 2000.
  • Spending $2.0 billion in total operating expenses in the first quarter of 2021, including goods and service purchased of approximately $1.4 billion. Since 2000, we have spent $134 billion and $90 billion respectively in these areas.
  • Generating a total team member payroll of $0.7 billion in the first quarter of 2021, including payroll taxes of $69 million. Since 2000, total team member payroll totals $51 billion.
  • Returning approximately $807 million in dividends through two quarterly dividend payments declared through April 2021 to individual shareholders, mutual fund owners, pensioners and institutional investors. Since 2004, we have returned over $19 billion to shareholders through our dividend and share purchase programs, including $14 billion in dividends, representing approximately $15 per share.

Community Highlights

Continuing our COVID-19 response

  • The TELUS Friendly Future Foundation (TFFF) and Community Boards are directing all 2021 support to charitable initiatives helping vulnerable populations through the pandemic and recovery process. Year to date, TFFF approved $1.3 million in Community Board grants to 94 charitable projects.
  • Working in partnership with the TFFF to launch our “In Their Honour” campaign, which raised funds to support charitable causes that assist communities most impacted by the pandemic and help vulnerable populations.
  • 230,000 safe Acts of Giving by the TELUS family this quarter, including 61,000 recorded volunteer hours, to help those that need it most.

Prioritizing health and wellbeing

  • Directly supporting COVID-19 health crisis response with five of our 13 clinics now also providing vaccines. Completed 5,000 assessments and over 500 vaccinations in the quarter. Since the start of the pandemic, our mobile clinics have provided 18,000 COVID-19 assessments.
  • Launched two new Health for Good clinics in Vancouver and Toronto.
  • Our 13 mobile health clinics, operating in 11 communities across Canada, supported close to 9,000 visits in the quarter, resulting in over 58,000 cumulative visits since their launch.
  • 62,000 Canadians participated in online TELUS Wise education workshops this quarter, including 47,000 youth attendees at our TELUS Be Brave #EndBullying online event on February 24.

Ensuring access to vital connectivity

  • Added 4,500 new households to Internet for Good this quarter, resulting in 95,000 low income family members and persons with disabilities benefiting from low cost internet since the launch of the program.
  • Across Mobility for Good, added over 3,100 youth and seniors, providing a subsidized wireless plan to stay in touch with loved ones and to maintain vital support networks. Across our broader program, 24,000 Canadians have benefited since the launch of the program.
  • Extended our $0 mobility plan support until August 31 for the more than 14,200 plans and devices donated as part of our Mobility for Good COVID response program, bringing our total value in kind donation to over $16 million.

Driving social innovation

  • This quarter, we announced a TELUS Pollinator Fund for Good investment in Raven Capital’s inaugural Indigenous Impact Fund. Together, we will ensure greater opportunities for Indigenous businesses and entrepreneurs, while helping to bridge the socio-economic digital divide experienced by Indigenous Peoples and communities.

Evolving our brand promise

  • In February, we launched our new brand promise ‘Let’s make the future friendly’- inviting Canadians to join us in creating remarkable human outcomes together; amplifying that every connection with TELUS is a promise to help create a better future for Canadians through our network that gives back.
  • Named Canada’s Most Respected Mobile Service Provider for leadership in customer service and community giving by Canada’s Most Respected Awards program established by DART Insight & Communications, ranking first out of 22 mobile service providers.

Access to Quarterly results information

Interested investors, the media and others may review this quarterly earnings news release, management’s discussion and analysis, quarterly results slides, audio and transcript of the investor webcast call, supplementary financial information at telus.com/investors.

TELUS’ first quarter 2021 conference call is scheduled for Friday, May 7, 2021 at 1:30pm ET (10:30am PT) and will feature a presentation followed by a question and answer period with investment analysts. Interested parties can access the webcast at telus.com/investors. An audio recording will be available approximately 60 minutes after the call until June 7, 2021 at 1-855-201-2300. Please use reference number 1253050# and access code 77377#. An archive of the webcast will also be available at telus.com/investors and a transcript will be posted on the website within a few business days.

Caution regarding forward-looking statements

This news release contains forward-looking statements about expected events and the financial and operating performance of TELUS Corporation. The terms TELUS, we, us and our refer to TELUS Corporation and, where the context of the narrative permits or requires, its subsidiaries.

Forward-looking statements include any statements that do not refer to historical facts. They include, but are not limited to, statements relating to our objectives and our strategies to achieve those objectives, our consolidated financial targets, outlook, updates, our multi-year dividend growth program and our plans and expectations regarding the impact of the COVID-19 pandemic and responses to it. Forward-looking statements are typically identified by the words assumption, goal, guidance, objective, outlook, strategy, target and other similar expressions, or future or conditional verbs such as aim, anticipate, believe, could, expect, intend, may, plan, predict, seek, should, strive and will. These statements are made pursuant to the “safe harbour” provisions of applicable securities laws in Canada and the United States Private Securities Litigation Reform Act of 1995.

By their nature, forward-looking statements are subject to inherent risks and uncertainties and are based on assumptions, including assumptions about future economic conditions and courses of action. These assumptions may ultimately prove to have been inaccurate and, as a result, our actual results or events may differ materially from our expectations expressed in or implied by the forward-looking statements.

The assumptions for our 2021 outlook, as described in Section 9 General trends, outlook and assumptions, and regulatory developments and proceedings of our 2020 annual MD&A, remain the same, except for the following updates:

  • Our revised estimates for 2021 GDP growth in Canada, B.C., Alberta, Ontario and Quebec are 5.9%, 5.7%, 5.6%, 5.7% and 5.8%, respectively (compared to 4.5%, 4.5%, 4.4%, 4.8% and 4.6%, respectively, as reported in our 2020 annual MD&A).
  • Our revised estimates for 2021 annual unemployment rates in Canada, B.C. and Alberta are 7.7%, 6.7% and 9.6%, respectively (compared to 7.8%, 6.9% and 9.9%, respectively, as reported in our 2020 annual MD&A).
  • Our revised estimates for 2021 annual rates of housing starts on an unadjusted basis in Canada, B.C., Alberta, Ontario and Quebec are 232,000 units, 39,000 units, 28,000 units, 82,000 units and 60,000 units, respectively (compared to 202,000 units, 35,000 units, 24,000 units, 77,000 units and 48,000 units, respectively, as reported in our 2020 annual MD&A).

The extent to which these economic growth estimates affect us and the timing of their impact will depend upon the actual experience of specific sectors of the Canadian economy.

Risks and uncertainties that could cause actual performance or events to differ materially from the forward-looking statements made herein and in other TELUS filings include, but are not limited to, the following:

  • The COVID-19 pandemic including its impacts on our customers, suppliers and vendors, our team members and our communities, as well as changes resulting from the pandemic to our business and operations including to the demand for and supply of the products and services that we offer and the channels through which we offer them.
  • Regulatory decisions and developments including: changes to our regulatory regime (the timing of announcement or implementation of which are uncertain) or the outcomes of proceedings, cases or inquiries relating to its application, including but not limited to those set out in Section 9.1 Communications industry regulatory developments and proceedings in our Q1 2021 MD&A, such as the potential for government to allow consolidation of competitors in our industry or conversely for government intervention to further increase competition, for example, through mandated wholesale access; the potential for additional government intervention on pricing, including the March 2020 announcement by the federal government (reiterated in June 2020) targeting a 25% price reduction over a two-year period by the national wireless carriers in postpaid mobile bring-your-own-device wireless plans using between 2 to 6 GB of data; federal and provincial consumer protection legislation and regulation including the introduction by the federal government of Bill C-11, the Digital Charter Implementation Act, 2020, which, aims to give consumers new privacy rights and imposes new monetary penalties for non-compliance; amendments to existing federal legislation; potential threats to unitary federal regulatory authority over communications in Canada; potential threats to the CRTC’s ability to enforce the Wholesale Code, which aims to ensure the fair treatment by vertically integrated firms of rival broadcasting distributors and programming services; regulatory action by the Competition Bureau or other regulatory agencies; spectrum and compliance with licences, including our compliance with licence conditions, changes to spectrum licence fees, spectrum policy determinations such as restrictions on the purchase, sale, subordination and transfer of spectrum licences, the cost, availability and timing of spectrum, and ongoing and future consultations and decisions on spectrum licensing and policy frameworks, auctions and allocation; the impact on us and other Canadian telecommunications carriers of government or regulatory actions with respect to certain countries or suppliers, including U.S. federal regulations pertaining to certain technology transactions deemed to constitute national security risks and the imposition of additional licence requirements on the export, re-export and transfer of goods, services and technology to Huawei Technologies Co. Ltd. and its non-U.S. affiliates, and decisions of other foreign governments, which could result in a general shortage of chip sets and other equipment; restrictions on non-Canadian ownership and control of the common shares of TELUS Corporation (Common Shares) and the ongoing monitoring of and compliance with such restrictions; unanticipated changes to the current copyright regime; and our ability to comply with complex and changing regulation of the healthcare and medical devices industry in the jurisdictions in which we operate, including as an operator of health clinics. The jurisdictions in which we operate, as well as the contracts that we enter into (particularly those of TELUS International (Cda) Inc.’s (TELUS International or TI) business), require us to comply with or facilitate our clients’ compliance with numerous, complex and sometimes conflicting legal regimes, both domestically and internationally. See TELUS International financial performance which impacts our financial performance.
  • Competitive environment including: our ability to continue to retain customers through an enhanced customer service experience that is differentiated from our competitors, including through the deployment and operation of evolving network infrastructure; intense competition, including the ability of industry competitors to successfully combine a mix of new service offerings and, in some cases, under one bundled and/or discounted monthly rate, along with their existing services; the success of new products, services and supporting systems, such as home automation security and Internet of Things (IoT) services for internet-connected devices; continued intense competition across all services among telecommunications companies, cable companies, other communications companies and over-the-top (OTT) services, which, among other things, places pressures on current and future average billing per subscriber per month (ABPU), average revenue per subscriber per month (ARPU), cost of acquisition, cost of retention and churn rate for all services, as do market conditions, government actions, customer usage patterns, increased data bucket sizes or flat-rate pricing trends for voice and data, inclusive rate plans for voice and data and availability of Wi-Fi networks for data; consolidation, mergers and acquisitions of industry competitors; subscriber additions, losses and retention volumes; our ability to obtain and offer content on a timely basis across multiple devices on mobile and TV platforms at a reasonable cost as content costs per unit continue to grow; vertical integration in the broadcasting industry resulting in competitors owning broadcast content services, and timely and effective enforcement of related regulatory safeguards; TI’s ability to compete with professional services companies that offer consulting services, information technology companies with digital capabilities, and traditional contact center and business process outsourcing companies that are expanding their capabilities to offer higher-margin and higher-growth digital services; in our TELUS Health business, our ability to compete with other providers of electronic medical records and pharmacy management products, claims adjudicators, systems integrators and health service providers including those that own a vertically integrated mix of health services delivery, IT solutions, and related services, global providers that could achieve expanded Canadian footprints, and in the provision of virtual healthcare services, preventative health services and personal emergency response services; and in our TELUS Agriculture business, while we maintain a broad solution set as compared to other agriculture technology providers, our ability to compete with focused software and IoT competitors.
  • Technological substitution including: reduced utilization and increased commoditization of traditional fixed voice services (local and long distance) resulting from impacts of OTT applications and mobile substitution; a declining overall market for TV services, including as a result of content piracy and signal theft, a rise in OTT direct-to-consumer video offerings and virtual multichannel video programming distribution platforms; the increasing number of households that have only mobile and/or internet-based telephone services; potential declines in ABPU and ARPU as a result of, among other factors, substitution by messaging and OTT applications; substitution by increasingly available Wi-Fi services; and disruptive technologies, such as OTT IP services, including software-defined networks in the business market, that may displace or cause us to reprice our existing data services, and self-installed technology solutions.
  • Challenges to our ability to deploy technology including: high subscriber demand for data that challenges wireless networks and spectrum capacity levels and may be accompanied by increases in delivery cost; our reliance on information technology and our ability to streamline our legacy systems; the roll-out, anticipated benefits and efficiencies, and the evolution of wireless broadband technologies and systems, including video distribution platforms and telecommunications network technologies (broadband initiatives, such as fibre-to-the-premises (FTTP), wireless small-cell deployment, 5G wireless and availability of resources and our ability to build out adequate broadband capacity); our reliance on wireless network access agreements, which have facilitated our deployment of wireless technologies; our choice of suppliers and those suppliers’ ability to maintain and service their product lines, which could affect the success of upgrades to, and evolution of, technology that we offer; supplier limitations and concentration and market power for products such as network equipment, TELUS TV® and wireless handsets; our expected long-term need to acquire additional spectrum capacity through future spectrum auctions and from third parties to address increasing demand for data and our ability to utilize spectrum we acquire; deployment and operation of new wireline broadband network technologies at a reasonable cost and the availability and success of new products and services to be rolled out using such network technologies; network reliability and change management; and our deployment of self-learning tools and automation that may change the way we interact with customers.
  • Capital expenditure levels and potential outlays for spectrum licences in auctions or purchases from third parties, affect and are affected by: our broadband initiatives, including connecting more homes and businesses directly to fibre; our ongoing deployment of newer wireless technologies, including wireless small cells to improve coverage and capacity; investments in network resiliency and reliability, including to address changes in usage resulting from restrictions imposed in response to COVID-19; the allocation of resources to acquisitions and future wireless spectrum auctions held by Innovation, Science and Economic Development Canada (ISED), including the 3500 MHz spectrum auction scheduled to take place in June 2021 and the millimetre wave spectrum auction, which the Minister of Innovation, Science and Industry stated is expected to commence in 2021, but we believe may not take place until 2023 or later, and the announcement of a formal consultation on the auctioning of the 3800 MHz spectrum, expected to take place in 2023. Our capital expenditure levels could be impacted if we do not achieve our targeted operational and financial results or by changes to our regulatory environment.
  • Operational performance and business combination risks including: our reliance on legacy systems and ability to implement and support new products and services and business operations in a timely manner; our ability to manage the requirements of large enterprise deals; our ability to implement effective change management for system replacements and upgrades, process redesigns and business integrations (such as our ability to successfully complete and integrate acquisitions into our operations and culture, complete divestitures or establish partnerships in a timely manner and realize expected strategic benefits, including those following compliance with any regulatory orders); our ability to identify and manage new risks inherent in new service offerings that we may provide, including as a result of acquisitions, which could result in damage to our brand, our business in the relevant area or as a whole, and additional exposure to litigation or regulatory proceedings; and our ability to effectively manage our infrastructure and team member expansion.
  • Data protection including risks that malfunctions or unlawful acts could result in unauthorized access to, change, loss, or distribution of data, which may compromise the privacy of individuals and could result in financial loss and harm to our reputation and brand.
  • Security threats including intentional damage or unauthorized access or attempted access to our physical assets or our IT systems and networks, which could prevent us from providing reliable service or result in unauthorized access to our information or that of our customers.
  • Ability to successfully implement cost reduction initiatives and realize planned savings, net of restructuring and other costs, without losing customer service focus or negatively affecting business operations. Examples of these initiatives are: our operating efficiency and effectiveness program to drive improvements in financial results; business integrations; business product simplification; business process automation and outsourcing; offshoring and reorganizations; procurement initiatives; and real estate rationalization.
  • Foreign operations and our ability to successfully manage operations in foreign jurisdictions, including managing risks such as currency fluctuations and exposure to various economic, international trade, political and other risks of doing business globally.
  • Business continuity events including: our ability to maintain customer service and operate our network in the event of human error or human-caused threats, such as cyberattacks and equipment failures that could cause various degrees of network outages; technical disruptions and infrastructure breakdowns; supply chain disruptions, delays and economics, including as a result of government restrictions or trade actions; natural disaster threats; extreme weather events; epidemics; pandemics (including the ongoing COVID-19 pandemic); political instability in certain international locations; information security and privacy breaches, including data loss or theft of data; and the completeness and effectiveness of business continuity and disaster recovery plans and responses.
  • TELUS International’s financial performance which impacts our financial performance. Factors that may affect TI’s financial performance are described in TI’s public filings available on SEDAR and EDGAR and may include: intense competition from companies offering similar services; TI’s ability to grow and maintain its profitability as changes in technology and client expectations outpace service offerings and internal tools and processes; TI maintaining its culture as it grows; effects of economic and geopolitical conditions on its clients’ businesses and demand for its services; a significant portion of TI’s revenue being dependent on a limited number of large clients; continued consolidation in many of the verticals in which TI offers services could result in the loss of a client; attracting and retaining qualified team members to support its operations; adverse impacts of COVID-19 on TI’s business and financial results; TI’s business being adversely affected if certain independent contractors were classified as employees, and the costs associated with defending, settling or resolving any future lawsuits (including demands for arbitration) relating to the independent contractor classification; TI’s ability to successfully identify, complete, integrate and realize the benefits of acquisitions and manage associated risks; cyberattacks or unauthorized disclosure resulting in access to sensitive or confidential information and data of its clients or their end customers could have a negative impact on its reputation and client confidence; business development not developing in ways it currently anticipates due to negative public reaction to offshore outsourcing, proposed legislation or otherwise; ability to meet client expectations regarding its content moderation services being adversely impacted due to factors beyond its control and its content moderation team members may suffer adverse emotional or cognitive effects in the course of performing their work; and TI’s lack of history operating as a separate, publicly traded company. The price of the subordinate voting shares of TI (TI Subordinate Voting Shares) may be volatile and is likely to fluctuate due to a number of factors beyond its control, including actual or anticipated changes in profitability; general economic, social or political developments; changes in industry conditions; changes in governance regulation; inflation; the general state of the securities markets; and other material events. TI may choose to publicize targets or provide other guidance regarding its business and it may not achieve such targets. Failure to do so could also result in a reduction in the trading price of the TI Subordinate Voting Shares. A reduction in the trading price of the TI Subordinate Voting Shares due to these or other factors could result in a reduction in the fair value of TI multiple voting shares held by TELUS.
  • Human resource matters including: recruitment, retention and appropriate training in a highly competitive industry (including retention of team members leading recent acquisitions in emerging areas of our business), the level of our employee engagement, our ability to maintain our unique culture as we grow, the risk that certain independent contractors of TI’s Lionbridge AI business could be classified as employees, and the health of our team.
  • Financing and debt requirements including: our ability to carry out financing activities, refinance our maturing debt, lower our net debt to EBITDA ratio to our objective range given the cash demands of spectrum auctions and/or maintain investment grade credit ratings in the range of BBB+ or the equivalent. Our business plans and growth could be negatively affected if existing financing is not sufficient to cover our funding requirements.
  • Lower than planned free cash flow could constrain our ability to invest in operations, reduce leverage or return capital to shareholders, and could affect our ability to sustain our dividend growth program through 2022. This program may be affected by factors such as the competitive environment, economic performance in Canada, our earnings and free cash flow, our levels of capital expenditures and spectrum licence purchases, acquisitions, the management of our capital structure, regulatory decisions and developments, and business continuity events. Quarterly dividend decisions are subject to assessment and determination by our Board of Directors based on our financial position and outlook. Common Shares may be purchased under a normal course issuer bid (NCIB) if and when we implement one and if we consider it opportunistic, based on our financial position and outlook, and the market price of our Common Shares. There can be no assurance that our dividend growth program or that any NCIB will be implemented, maintained, unchanged and/or completed.
  • Taxation matters including: interpretation of complex domestic and foreign tax laws by the relevant tax authorities that may differ from our interpretations; the timing and character of income and deductions, such as tax depreciation and operating expenses; tax credits or other attributes; changes in tax laws, including tax rates; tax expenses being materially different than anticipated, including the taxability of income and deductibility of tax attributes; elimination of income tax deferrals through the use of different tax year-ends for operating partnerships and corporate partners; and changes to the interpretation of tax laws, including those resulting from changes to applicable accounting standards or the adoption of more aggressive auditing practices by tax authorities, tax reassessments or adverse court decisions impacting the tax payable by us.
  • Litigation and legal matters including: our ability to successfully respond to investigations and regulatory proceedings; our ability to defend against existing and potential claims and lawsuits (including intellectual property infringement claims and class actions based on consumer claims, data, privacy or security breaches and secondary market liability), or to negotiate and execute upon indemnity rights or other protections in respect of such claims and lawsuits; and the complexity of legal compliance in domestic and foreign jurisdictions, including compliance with competition, anti-bribery and foreign corrupt practices laws.
  • Health, safety and the environment including: lost employee work time resulting from illness or injury; public concerns related to radio frequency emissions; environmental issues affecting our business, including climate-related risk (such as extreme weather events and other natural hazards), waste and waste recycling, risks relating to fuel systems on our properties, changing government and public expectations regarding environmental matters and our responses; and challenges associated with epidemics or pandemics, including the COVID-19 pandemic and our response to it, which may add to or accentuate these factors.
  • Economic growth and fluctuations including: the state of the economy in Canada, which may be influenced by economic and other developments outside of Canada, including potential outcomes of yet unknown policies and actions of foreign governments and the ongoing COVID-19 pandemic as well as public and private sector responses to the pandemic; expectations of future interest rates; inflation; unemployment levels; effects of fluctuating oil prices; effects of low business spending (such as reducing investments and cost structure); pension investment returns, funding and solvency discount rates; fluctuations in foreign exchange rates of the currencies in the regions in which we operate; sovereign credit ratings and effects on the cost of borrowing; the impact of tariffs on trade between Canada and the U.S.; and global implications of the trade dynamic between major world economies.

These risks are described in additional detail in Section 9 General trends, outlook and assumptions, and regulatory developments and proceedings and Section 10 Risks and risk management in our 2020 annual MD&A. Those descriptions are incorporated by reference in this cautionary statement but are not intended to be a complete list of the risks that could affect TELUS.

Many of these factors are beyond our control or our current expectations or knowledge. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also have a material adverse effect on our financial position, financial performance, cash flows, business or reputation. Except as otherwise indicated in this document, the forward-looking statements made herein do not reflect the potential impact of any non-recurring or special items or any mergers, acquisitions, dispositions or other business combinations or transactions that may be announced or that may occur after the date of this document.

Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements in this document describe our expectations and are based on our assumptions as at the date of this document and are subject to change after this date. Except as required by law, we disclaim any intention or obligation to update or revise any forward-looking statements. The forward-looking statements in this news release are presented for the purpose of assisting our investors and others in understanding certain key elements of our expected 2021 financial results as well as our objectives, strategic priorities and business outlook. Such information may not be appropriate for other purposes.

This cautionary statement qualifies all of the forward-looking statements in this document.

Non-GAAP and other financial measures

We have issued guidance on and report certain non-GAAP measures that are used to evaluate the performance of TELUS, as well as to determine compliance with debt covenants and to manage our capital structure. As non-GAAP measures generally do not have a standardized meaning, they may not be comparable to similar measures presented by other issuers. Securities regulations require such measures to be clearly defined, qualified and reconciled with their nearest GAAP measure. Certain of the metrics do not have generally accepted industry definitions.

Adjusted net income and adjusted basic earnings per share: These measures are used to evaluate performance at a consolidated level and exclude items that, in management’s view, may obscure the underlying trends in business performance. These measures should not be considered alternatives to Net income and basic earnings per share in measuring TELUS’ performance.

Reconciliation of adjusted net income      
  Three months ended
March 31
   
C$ and in millions 2021 2020   Change  
Net income attributable to Common Shares 331 350   (19 )
Add (deduct):      
Restructuring and other costs, after income taxes 27 47   (20 )
Income tax-related adjustments (3 ) 3  
Other equity losses related to real estate joint ventures 1 6   (5 )
Adjusted Net income 359 400   (41 )

Reconciliation of adjusted basic EPS      
  Three months ended
March 31
   
C$ 2021 2020   Change  
Basic EPS 0.25 0.28   (0.03 )
Add:        
Restructuring and other costs, after income taxes, per share 0.02 0.04   (0.02 )
Adjusted basic EPS 0.27 0.32   (0.05 )

EBITDA (earnings before interest, income taxes, depreciation and amortization): We have issued guidance on and report EBITDA because it is a key measure used to evaluate performance at a consolidated level. EBITDA is commonly reported and widely used by investors and lending institutions as an indicator of a company’s operating performance and ability to incur and service debt, and as a valuation metric. EBITDA should not be considered an alternative to Net income in measuring TELUS’ performance, nor should it be used as a measure of cash flow. EBITDA as calculated by TELUS is equivalent to Operating revenues and other income less the total of Goods and services purchased expense and Employee benefits expense.

We also calculate Adjusted EBITDA to exclude items of an unusual nature that do not reflect our ongoing operations and should not, in our opinion, be considered in a long-term valuation metric or should not be included in an assessment of our ability to service or incur debt.

EBITDA reconciliation        
  Three months ended
March 31
 
C$ and in millions 2021   2020  
Net income 333   353  
Financing costs 207   192  
Income taxes 132   139  
Depreciation 524   523  
Amortization of intangible assets 265   202  
EBITDA 1,461    1,409  
Add restructuring and other costs included in EBITDA 41    60  
EBITDA – excluding restructuring and other costs 1,502   1,469  
Add other equity losses related to real estate joint ventures 1   6  
Adjusted EBITDA 1,503    1,475  

Free cash flow: We report this measure as a supplementary indicator of our operating performance, and there is no generally accepted industry definition of free cash flow. It should not be considered an alternative to the measures in the condensed interim consolidated statements of cash flows. Free cash flow excludes certain working capital changes (such as trade receivables and trade payables), proceeds from divested assets and other sources and uses of cash, as found in the condensed interim consolidated statements of cash flows. It provides an indication of how much cash generated by operations is available after capital expenditures (excluding purchases of spectrum licences) that may be used to, among other things, pay dividends, repay debt, purchase shares or make other investments. We exclude impacts of accounting changes that do not impact cash, such as IFRS 15 and IFRS 16. Free cash flow may be supplemented from time to time by proceeds from divested assets or financing activities.

Free cash flow calculation    
  Three months ended
March 31
C$ and in millions 2021   2020  
EBITDA 1,461   1,409  
Deduct non-cash gains from the sale of property, plant and equipment   (3 )
Restructuring and other costs, net of disbursements (12 ) 12  
Effects of contract asset, acquisition and fulfilment (IFRS 15 impact) and TELUS Easy Payment device financing 52   112  
Effects of lease principal (IFRS 16 impact) (123 ) (84 )
Leases formerly accounted for as finance leases (IFRS 16 impact)   27  
Items from the condensed interim consolidated statements of cash flows:    
Share-based compensation, net 35   23  
Net employee defined benefit plans expense 26   27  
Employer contributions to employee defined benefit plans (16 ) (15 )
Interest paid (199 ) (177 )
Interest received 2   3  
Capital expenditures (excluding spectrum licences)1 (685 ) (665 )
Free cash flow before income taxes 541   669  
Income taxes paid, net of refunds (220 ) (124 )
Free cash flow 321   545  

(1) Refer to Note 31 of the consolidated financial statements for further information.

About TELUS
TELUS (TSX: T, NYSE: TU) is a dynamic, world-leading communications technology company with $16 billion in annual revenue and 16 million customer connections spanning wireless, data, IP, voice, television, entertainment, video, and security. We leverage our global-leading technology and compassion to enable remarkable human outcomes. Our longstanding commitment to putting our customers first fuels every aspect of our business, making us a distinct leader in customer service excellence and loyalty. In 2020, TELUS was recognized as having the fastest wireless network in the world, reinforcing our commitment to provide Canadians with access to superior technology that connects us to the people, resources and information that make our lives better. TELUS Health is Canada’s leader in digital health technology, improving access to health and wellness services and revolutionizing the flow of health information across the continuum of care. TELUS Agriculture provides innovative digital solutions throughout the agriculture value chain, supporting better food outcomes from improved agri-business data insights and processes. TELUS International (TSX and NYSE: TIXT) is a leading digital customer experience innovator that delivers next-generation AI and content management solutions for global brands across the technology and games, ecommerce and FinTech, communications and media, healthcare, travel and hospitality sectors. TELUS and TELUS International operate in 25+ countries around the world.

Driven by our passionate social purpose to connect all citizens for good, our deeply meaningful and enduring philosophy to give where we live has inspired TELUS, our team members and retirees to contribute more than $820 million and 1.6 million days of service since 2000. This unprecedented generosity and unparalleled volunteerism have made TELUS the most giving company in the world.

For more information about TELUS, please visit telus.com, follow us @TELUSNews on Twitter, and @Darren_Entwistle on Instagram.

Investor Relations

Robert Mitchell
(647) 837-1606
[email protected]

Media Relations

Steve Beisswanger
(514) 865-2787
[email protected]

 



Granite Reports First Quarter 2021 Results

Granite Reports First Quarter 2021 Results

  • Revenue of $669.9 million, up 5.3% year-over-year
  • Gross profit of $63.3 million, up 166.1% year-over-year
  • Committed and Awarded Projects (“CAP”) (1) of $4.45 billion, up 4% over the fourth quarter of 2020
  • Operating cash flow of $38.1 million, up $58.2 million year-over-year

WATSONVILLE, Calif.–(BUSINESS WIRE)–
Granite Construction Incorporated (NYSE: GVA) today announced results for the first quarter ended March 31, 2021.

First Quarter 2021 Results

Results for the first quarter of 2021 were a net loss of ($66.2) million, or ($1.45) per diluted share, compared to a net loss of ($65.4) million, or ($1.44) per diluted share, in the prior year. Adjusted net loss(2) for the first quarter of 2021, which excludes other costs(3), non-cash impairments of goodwill, Transaction costs(4), and amortization of debt discount related to our 2.75% convertible notes, was ($4.9) million, or ($0.11) per diluted share, compared to an adjusted net loss(2) of ($31.6) million, or ($0.69) per diluted share, in the prior year.

  • Revenue increased 5.3% to $669.9 million compared to $635.9 million in the prior year.
  • Gross profit increased 166.1% to $63.3 million compared to $23.8 million in the prior year. Gross profit margin increased to 9.5% compared to 3.7% in the prior year.
  • Selling, general & administrative (“SG&A”) expenses were $75.7 million or 11.3% of revenue, compared to $73.2 million or 11.5% of revenue in the prior year. The increase was primarily attributable to a change in the fair market value of our Non-Qualified Deferred Compensation plan liability of $5.3 million year-over-year, which is primarily offset in other (income) expense, net.
  • Adjusted EBITDA(2) was $16.9 million compared to ($18.4) million in the prior year.
  • CAP(1) totaled $4.45 billion, up slightly year-over-year and up 4% compared to the fourth quarter of 2020.
  • Operating cash flow increased $58.2 million to $38.1 million compared to ($20.1) million in the prior year.
  • Cash and marketable securities increased $216.6 million to $464.2 million compared to $247.6 million in the prior year, while debt decreased $23.8 million to $340.3 million compared to $364.2 million in the prior year.

“Building on momentum from 2020 to 2021, Granite completed a strong first quarter,” said Kyle Larkin, Granite President. “In our seasonally slowest quarter, we realized continued improvement in the Transportation segment with minimal losses in the Heavy Civil Operating Group Old Risk Portfolio(5) and significant improvement in gross profit in our Specialty segment. We continued to build cash and marketable securities through positive operating cash flow and our balance sheet position remains strong even after considering the previously disclosed settlement agreement. This settlement marks another significant milestone for Granite as we move forward.”

“Additionally, we are encouraged by the bidding activity across the company during the first quarter,” continued Larkin. “Our major markets are healthy with robust opportunities. We are optimistic that the federal government will continue to work towards an infrastructure plan this year, which should only strengthen the environment.”

(1) CAP is comprised of contract backlog (unearned revenue and other awards), as well as awarded construction management/general contractor, construction manager at-risk, and progressive design build projects not yet included in contract backlog.

(2) Adjusted net income (loss), adjusted diluted income (loss) per share, earnings before interest, taxes, depreciation, and amortization (“EBITDA”), EBITDA margin, adjusted EBITDA, and adjusted EBITDA margin are non-GAAP measures. Please refer to the description and reconciliation of non-GAAP measures in the attached tables.

(3) Other costs includes the settlement charge, legal and accounting investigation fees, integration expenses related to the acquisition of the Layne Christensen Company (“Layne”) and restructuring charges related to our Heavy Civil Operating Group.

(4) Transaction costs includes acquired intangible amortization expenses and acquisition related depreciation related to the acquisition of Layne and LiquiForce.

(5) The Heavy Civil Operating Group Old Risk Portfolio include projects with risk criteria that do not align with Granite’s new project selection criteria for the Heavy Civil Operating Group.

First Quarter 2021 Segment Results (Unaudited – dollars in thousands)

Transportation Segment

 

Three Months Ended March 31,

 

2021

 

 

2020

 

 

Change

 

Revenue

 

$

351,029

 

 

$

350,901

 

 

$

128

 

 

 

0.0

%

Gross profit

 

$

35,866

 

 

$

25,369

 

 

$

10,497

 

 

 

41.4

%

Gross profit as a percent of revenue

 

 

10.2

%

 

 

7.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

2021

 

 

2020

 

 

Change

 

Committed and Awarded Projects

 

$

3,028,893

 

 

$

3,487,609

 

 

$

(458,716

)

 

 

(13.2

)%

Transportation revenue was flat year-over-year with a revenue increase from the California Operating Group offsetting a decrease in revenue from the Heavy Civil Operating Group. Gross profit increased year-over-year primarily due to a decrease in losses from the Heavy Civil Operating Group Old Risk Portfolio. In the first quarter of 2021, the Heavy Civil Operating Group Old Risk Portfolio recognized revenue of $104.1 million and a gross loss of ($0.7) million compared to $116.2 million of revenue and a gross loss of ($13.0) million in the first quarter of 2020.

Segment CAP totaled $3.0 billion as of March 31, 2021, which is a decrease of $458.7 million year-over-year primarily due to a decrease in Heavy Civil Operating Group Transportation CAP of $547.3 million.

Water Segment

 

Three Months Ended March 31,

 

2021

 

 

2020

 

 

Change

 

Revenue

 

$

99,753

 

 

$

101,657

 

 

$

(1,904

)

 

 

(1.9

)%

Gross profit

 

$

8,566

 

 

$

9,347

 

 

$

(781

)

 

 

(8.4

)%

Gross profit as a percent of revenue

 

 

8.6

%

 

 

9.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

2021

 

 

2020

 

 

Change

 

Committed and Awarded Projects

 

$

339,030

 

 

$

241,161

 

 

$

97,869

 

 

 

40.6

%

Water revenue decreased slightly as the recovery of the Water and Mineral Services Operating Group continued to build momentum as COVID-19 restrictions lessen. This decrease was partially offset by an increase in revenue in the California Operating Group, which began the year with higher CAP. Gross profit declined primarily due to a temporary increase in resin costs in our cured-in-place-pipe trenchless rehabilitation business.

Segment CAP increased to $339.0 million as of March 31, 2021, primarily reflecting new awards in the Water and Mineral Services Operating Group.

Specialty Segment

 

Three Months Ended March 31,

 

2021

 

 

2020

 

 

Change

 

Revenue

 

$

155,674

 

 

$

133,039

 

 

$

22,635

 

 

 

17.0

%

Gross profit (loss)

 

$

17,325

 

 

$

(10,719

)

 

$

28,044

 

 

 

261.6

%

Gross profit (loss) as a percent of revenue

 

 

11.1

%

 

 

(8.1

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

2021

 

 

2020

 

 

Change

 

Committed and Awarded Projects

 

$

1,083,971

 

 

$

700,588

 

 

$

383,383

 

 

 

54.7

%

Specialty revenue increased due primarily to site development work performed by the Heavy Civil Operating Group. Gross profit increased in 2021 as a result of the absence of a significant write down related to a dispute on a tunneling project which occurred in the first quarter of 2020.

Specialty segment CAP totaled $1.1 billion as of March 31, 2021, driven by a $267 million tunnel project and site development projects in the private and public markets which were booked into CAP in the fourth quarter of 2020 and first quarter of 2021.

Materials Segment

 

Three Months Ended March 31,

 

2021

 

 

2020

 

 

Change

 

Revenue

 

$

63,457

 

 

$

50,330

 

 

$

13,127

 

 

 

26.1

%

Gross profit (loss)

 

$

1,561

 

 

$

(198

)

 

$

1,759

 

 

 

888.4

%

Gross profit (loss) as a percent of revenue

 

 

2.5

%

 

 

(0.4

)%

 

 

 

 

 

 

 

 

Materials revenue and gross profit increased year over year primarily due to higher sales volumes in both aggregates and asphalt across the California and Northwest Operating Groups as the Groups were aided by favorable weather during the quarter.

Outlook

The Company reaffirms our guidance for 2021:

  • Low- to mid-single digit revenue growth
  • Adjusted EBITDA margin of 5.5% to 7.5%

Conference Call

Granite will conduct a conference call today, May 7, 2021, at 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time to discuss the results of the three months ended March 31, 2021. The Company invites investors to listen to a live audio webcast on its Investor Relations website, https://investor.graniteconstruction.com. The live call is available by calling 1-866-807-9684; international callers may dial 1-412-317-5415. An archive of the webcast will be available on the website approximately one hour after the call. A replay will be available after the live call through May 14, 2021, by calling 1-877-344-7529, replay access code 10155456; international callers may dial 1-412-317-0088.

About Granite

Granite is America’s Infrastructure Company™. Incorporated since 1922, Granite (NYSE:GVA) is one of the largest diversified construction and construction materials companies in the United States as well as a full-suite provider in the transportation, water infrastructure and mineral exploration markets. Granite’s Code of Conduct and strong Core Values guide the Company and its employees to uphold the highest ethical standards. Granite is an industry leader in safety and an award-winning firm in quality and sustainability. For more information, visit the Granite website, and connect with Granite on LinkedIn, Twitter, Facebook and Instagram.

Forward-looking Statements

Any statements contained in this news release that are not based on historical facts, including statements regarding future events, occurrences, circumstances, activities, performance, growth, demand, strategic plans, outcomes, outlook, guidance, backlog, Committed and Awarded Projects (“CAP”), results and the settlement agreement, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are identified by words such as “future,” “outlook,” “assumes,” “believes,” “expects,” “estimates,” “anticipates,” “intends,” “plans,” “appears,” “may,” “will,” “should,” “could,” “would,” “continue,” and the negatives thereof or other comparable terminology or by the context in which they are made. These forward-looking statements are estimates reflecting the best judgment of senior management and reflect our current expectations regarding future events, occurrences, circumstances, activities, performance, growth, demand, strategic plans, outcomes, outlook, guidance, backlog, CAP, results and the settlement agreement. These expectations may or may not be realized. Some of these expectations may be based on beliefs, assumptions or estimates that may prove to be incorrect. In addition, our business and operations involve numerous risks and uncertainties, many of which are beyond our control, which could result in our expectations not being realized or otherwise materially affect our business, financial condition, results of operations, cash flows and liquidity. Such risks and uncertainties include, but are not limited to, court approval of the settlement agreement and those described in greater detail in our filings with the Securities and Exchange Commission, particularly those specifically described in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Due to the inherent risks and uncertainties associated with our forward-looking statements, the reader is cautioned not to place undue reliance on them. The reader is also cautioned that the forward-looking statements contained herein speak only as of the date of this news release and, except as required by law; we undertake no obligation to revise or update any forward-looking statements for any reason.

GRANITE CONSTRUCTION INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited – in thousands, except share and per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2021

 

 

December 31, 2020

 

 

March 31, 2020

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

452,928

 

 

$

436,136

 

 

$

242,604

 

Short-term marketable securities

 

 

 

 

 

 

 

 

5,000

 

Receivables, net

 

 

475,160

 

 

 

540,812

 

 

 

477,718

 

Contract assets

 

 

185,220

 

 

 

164,939

 

 

 

226,518

 

Inventories

 

 

86,611

 

 

 

82,362

 

 

 

98,765

 

Equity in construction joint ventures

 

 

186,536

 

 

 

188,798

 

 

 

190,458

 

Other current assets

 

 

64,286

 

 

 

42,199

 

 

 

60,001

 

Total current assets

 

 

1,450,741

 

 

 

1,455,246

 

 

 

1,301,064

 

Property and equipment, net

 

 

528,173

 

 

 

527,016

 

 

 

534,958

 

Long-term marketable securities

 

 

11,300

 

 

 

5,200

 

 

 

 

Investments in affiliates

 

 

75,159

 

 

 

75,287

 

 

 

73,249

 

Goodwill

 

 

116,807

 

 

 

116,777

 

 

 

248,339

 

Right of use assets

 

 

57,050

 

 

 

62,256

 

 

 

72,945

 

Deferred income taxes, net

 

 

41,361

 

 

 

41,839

 

 

 

51,675

 

Other noncurrent assets

 

 

93,093

 

 

 

96,375

 

 

 

102,145

 

Total assets

 

$

2,373,684

 

 

$

2,379,996

 

 

$

2,384,375

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Current maturities of long-term debt

 

$

8,700

 

 

$

8,278

 

 

$

8,253

 

Accounts payable

 

 

306,834

 

 

 

359,160

 

 

 

312,105

 

Contract liabilities

 

 

160,149

 

 

 

171,321

 

 

 

133,811

 

Accrued expenses and other current liabilities

 

 

524,452

 

 

 

404,497

 

 

 

355,393

 

Total current liabilities

 

 

1,000,135

 

 

 

943,256

 

 

 

809,562

 

Long-term debt

 

 

331,647

 

 

 

330,522

 

 

 

355,911

 

Long-term lease liabilities

 

 

41,707

 

 

 

46,769

 

 

 

57,985

 

Deferred income taxes, net

 

 

3,167

 

 

 

3,155

 

 

 

3,318

 

Other long-term liabilities

 

 

65,833

 

 

 

64,684

 

 

 

57,795

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock, $0.01 par value, authorized 3,000,000 shares, none outstanding

 

 

 

 

 

 

 

 

 

Common stock, $0.01 par value, authorized 150,000,000 shares; issued and outstanding: 45,791,712 shares as of March 31, 2021, 45,668,541 shares as of December 31, 2020 and 45,592,292 shares as of March 31, 2020

 

 

458

 

 

 

457

 

 

 

457

 

Additional paid-in capital

 

 

554,186

 

 

 

555,407

 

 

 

551,189

 

Accumulated other comprehensive loss

 

 

(3,714

)

 

 

(5,035

)

 

 

(6,538

)

Retained earnings

 

 

352,610

 

 

 

424,835

 

 

 

522,639

 

Total Granite Construction Incorporated shareholders’ equity

 

 

903,540

 

 

 

975,664

 

 

 

1,067,747

 

Non-controlling interests

 

 

27,655

 

 

 

15,946

 

 

 

32,057

 

Total equity

 

 

931,195

 

 

 

991,610

 

 

 

1,099,804

 

Total liabilities and equity

 

$

2,373,684

 

 

$

2,379,996

 

 

$

2,384,375

 

GRANITE CONSTRUCTION INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited – in thousands, except per share data)

Three Months Ended March 31,

 

2021

 

 

2020

 

Revenue

 

 

 

 

 

 

 

 

Transportation

 

$

351,029

 

 

$

350,901

 

Water

 

 

99,753

 

 

 

101,657

 

Specialty

 

 

155,674

 

 

 

133,039

 

Materials

 

 

63,457

 

 

 

50,330

 

Total revenue

 

 

669,913

 

 

 

635,927

 

Cost of revenue

 

 

 

 

 

 

 

 

Transportation

 

 

315,163

 

 

 

325,532

 

Water

 

 

91,187

 

 

 

92,310

 

Specialty

 

 

138,349

 

 

 

143,758

 

Materials

 

 

61,896

 

 

 

50,528

 

Total cost of revenue

 

 

606,595

 

 

 

612,128

 

Gross profit

 

 

63,318

 

 

 

23,799

 

Selling, general and administrative expenses

 

 

75,728

 

 

 

73,216

 

Non-cash impairment charges

 

 

 

 

 

24,413

 

Other costs

 

 

75,835

 

 

 

5,165

 

Gain on sales of property and equipment

 

 

(2,554

)

 

 

(623

)

Operating loss

 

 

(85,691

)

 

 

(78,372

)

Other (income) expense

 

 

 

 

 

 

 

 

Interest income

 

 

(256

)

 

 

(1,291

)

Interest expense

 

 

5,381

 

 

 

4,994

 

Equity in income of affiliates, net

 

 

(1,808

)

 

 

(46

)

Other (income) expense, net

 

 

(1,230

)

 

 

5,219

 

Total other expense

 

 

2,087

 

 

 

8,876

 

Loss before benefit from income taxes

 

 

(87,778

)

 

 

(87,248

)

Benefit from income taxes

 

 

(22,455

)

 

 

(14,710

)

Net loss

 

 

(65,323

)

 

 

(72,538

)

Amount attributable to non-controlling interests

 

 

(872

)

 

 

7,168

 

Net loss attributable to Granite Construction Incorporated

 

$

(66,195

)

 

$

(65,370

)

 

 

 

 

 

 

 

 

 

Net loss per share attributable to common shareholders

 

 

 

 

 

 

 

 

Basic

 

$

(1.45

)

 

$

(1.44

)

Diluted

 

$

(1.45

)

 

$

(1.44

)

Weighted average shares of common stock

 

 

 

 

 

 

 

 

Basic

 

 

45,697

 

 

 

45,520

 

Diluted

 

 

45,697

 

 

 

45,520

 

Dividends per common share

 

$

0.13

 

 

$

0.13

 

GRANITE CONSTRUCTION INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited – in thousands)

Three Months Ended March 31,

 

2021

 

 

2020

 

Operating activities

 

 

 

 

 

 

 

 

Net loss

 

$(65,323

)

 

$

(72,538

)

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

Depreciation, depletion and amortization

 

24,581

 

 

 

28,447

 

Amortization related to the 2.75% Convertible Notes

 

2,314

 

 

 

2,463

 

Gain on sales of property and equipment, net

 

(2,554

)

 

 

(623

)

Stock-based compensation

 

1,065

 

 

 

2,398

 

Equity in net (income) loss from unconsolidated joint ventures

 

(418

)

 

 

11,816

 

Non-cash impairment charges

 

 

 

 

24,413

 

Changes in assets and liabilities

 

78,422

 

 

 

(16,501

)

Net cash provided by (used in) operating activities

 

38,087

 

 

 

(20,125

)

Investing activities

 

 

 

 

 

 

 

 

(Purchases) maturities of marketable securities

 

(5,000

)

 

 

5,000

 

Proceeds from called marketable securities

 

 

 

 

20,000

 

Purchases of property and equipment

 

(18,777

)

 

 

(21,435

)

Proceeds from sales of property and equipment

 

3,004

 

 

 

3,865

 

Other investing activities, net

 

4,470

 

 

 

(1,528

)

Net cash (used in) provided by investing activities

 

(16,303

)

 

 

5,902

 

Financing activities

 

 

 

 

 

 

 

 

Debt principal repayments

 

(2,150

)

 

 

(2,105

)

Cash dividends paid

 

(5,937

)

 

 

(5,915

)

Repurchases of common stock

 

(2,299

)

 

 

(653

)

Contributions from non-controlling partners

 

8,361

 

 

 

3,750

 

Distributions to non-controlling partners

 

(2,902

)

 

 

(1,470

)

Other financing activities, net

 

(65

)

 

 

(7

)

Net cash used in financing activities

 

(4,992

)

 

 

(6,400

)

Net increase (decrease) in cash, cash equivalents and restricted cash

 

16,792

 

 

 

(20,623

)

Cash, cash equivalents and $1,512 and $5,835 in restricted cash at beginning of period

 

437,648

 

 

 

268,108

 

Cash, cash equivalents and $1,512 and $4,881 in restricted cash at end of period

 

$454,440

 

 

$

247,485

 

Non-GAAP Financial Information

The tables below contain financial information calculated other than in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). Specifically, management believes that non-GAAP financial measures such as EBITDA and EBITDA margin are useful in evaluating operating performance and are regularly used by securities analysts, institutional investors and other interested parties, and that such supplemental measures facilitate comparisons between companies that have different capital and financing structures and/or tax rates. We are also providing adjusted EBITDA and adjusted EBITDA margin non-GAAP measures to indicate the impact of:

  • Other costs which includes the settlement charge, legal and accounting investigation fees, integration expenses related to the acquisition of the Layne Christensen Company (“Layne”) and restructuring charges related to our Heavy Civil Operating Group;
  • Non-cash impairments related to goodwill and investments in affiliates in 2020;

We provide adjusted loss before benefit from income taxes, adjusted benefit from income taxes, adjusted net loss attributable to Granite Construction Incorporated and adjusted diluted net loss per share, non-GAAP measures, to indicate the impact of the following:

  • Other costs which includes the settlement charge, legal and accounting investigation fees, integration expenses related to the acquisition of the Layne and restructuring charges related to our Heavy Civil Operating Group;
  • Non-cash impairments related to goodwill and investments in affiliates in 2020;
  • Transaction costs which includes acquired intangible amortization expenses and acquisition related depreciation related to the acquisition of Layne and LiquiForce; and
  • Amortization of debt discount related to our 2.75% convertible notes.

Management believes that these additional non-GAAP financial measures facilitate comparisons between industry peer companies and management uses these non-GAAP financial measures in evaluating the Company’s performance. However, the reader is cautioned that any non-GAAP financial measures provided by the Company are provided in addition to, and not as alternatives for, the Company’s reported results prepared in accordance with U.S. GAAP. Items that may have a significant impact on the Company’s financial position, results of operations and cash flows must be considered when assessing the Company’s actual financial condition and performance regardless of whether these items are included in non-GAAP financial measures. The methods used by the Company to calculate its non-GAAP financial measures may differ significantly from methods used by other companies to compute similar measures. As a result, any non-GAAP financial measures provided by the Company may not be comparable to similar measures provided by other companies. The Company does not provide a reconciliation of forward-looking adjusted EBITDA margin to the most directly comparable forward-looking GAAP measure of net income (loss) attributable to Granite Construction Incorporated because the timing and amount of the excluded items are unreasonably difficult to fully and accurately estimate.

GRANITE CONSTRUCTION INCORPORATED

EBITDA(1)

(Unaudited – dollars in thousands)

Three Months Ended March 31,

 

 

2021

 

 

2020

 

Net loss attributable to Granite Construction Incorporated

 

$

(66,195

)

 

$

(65,370

)

Depreciation, depletion and amortization expense(2)

 

 

24,581

 

 

 

28,447

 

Benefit from income taxes

 

 

(22,455

)

 

 

(14,710

)

Interest expense, net of interest income

 

 

5,125

 

 

 

3,703

 

EBITDA(1)

 

$

(58,944

)

 

$

(47,930

)

EBITDA margin(1)(3)

 

 

(8.8

)%

 

 

(7.5

)%

 

 

 

 

 

 

 

 

 

Other costs

 

$

75,835

 

 

$

5,165

 

Non-cash impairment charges

 

 

 

 

 

24,413

 

Adjusted EBITDA(1)

 

$

16,891

 

 

$

(18,352

)

Adjusted EBITDA margin(1)(3)

 

 

2.5

%

 

 

(2.9

)%

(1) We define EBITDA as U.S. GAAP net loss attributable to Granite Construction Incorporated, adjusted for net interest expense, taxes, depreciation, depletion and amortization. Adjusted EBITDA and adjusted EBITDA margin exclude the impact of other costs and non-cash impairment charges.

(2) Amount includes the sum of depreciation, depletion and amortization which are classified as cost of revenue and selling, general and administrative expenses in the condensed consolidated statements of operations of Granite Construction Incorporated.

(3) Represents EBITDA and Adjusted EBITDA divided by consolidated revenue of $0.7 billion and $0.6 billion for the three months ended March 31, 2021 and 2020, respectively.

GRANITE CONSTRUCTION INCORPORATED

Adjusted Net Loss Reconciliation

(Unaudited – in thousands, except per share data)

Three Months Ended March 31,

 

2021

 

 

2020

 

Loss before benefit from income taxes

 

$

(87,778

)

 

$

(87,248

)

Other costs

 

 

75,835

 

 

 

5,165

 

Non-cash impairment charges

 

 

 

 

 

24,413

 

Transaction costs

 

 

5,250

 

 

 

5,914

 

Amortization of debt discount

 

 

1,715

 

 

 

1,607

 

Adjusted loss before benefit from income taxes

 

$

(4,978

)

 

$

(50,149

)

 

 

 

 

 

 

 

 

 

Benefit from income taxes

 

$

(22,455

)

 

$

(14,710

)

Tax effect of adjusting items(1)

 

 

21,528

 

 

 

3,298

 

Adjusted benefit from income taxes

 

$

(927

)

 

$

(11,412

)

 

 

 

 

 

 

 

 

 

Net loss attributable to Granite Construction Incorporated

 

$

(66,195

)

 

$

(65,370

)

After-tax adjusting items

 

 

61,272

 

 

 

33,801

 

Adjusted net loss attributable to Granite Construction Incorporated

 

$

(4,923

)

 

$

(31,569

)

 

 

 

 

 

 

 

 

 

Diluted net loss per share attributable to common shareholders

 

$

(1.45

)

 

$

(1.44

)

After-tax adjusting items per share attributable to common shareholders

 

 

1.34

 

 

 

0.75

 

Adjusted diluted net loss per share attributable to common shareholders

 

$

(0.11

)

 

$

(0.69

)

(1) The tax effect of adjusting items was calculated using the Company’s estimated annual statutory tax rate.

Source: Granite Construction Incorporated

Investors

Wenjun Xu, 831-761-7861

Or

Media

Erin Kuhlman, 831-768-4111

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Other Construction & Property Construction & Property Natural Resources Mining/Minerals

MEDIA:

Logo
Logo

JDDJ and Vinda jointly launched Super Brand Day in more than 200 cities in China

PR Newswire

SHANGHAI, May 7, 2021 /PRNewswire/ — Dada Group (Nasdaq: DADA) (“Dada”), China’s leading local on-demand delivery and retail platform, and Vinda, a leading hygiene company in Asia, are pleased to announce that they have successfully launched the Super Brand Day marketing event on JDDJ, Dada’s on-demand retail platform. Themed of “Vinda’s Space Tour in China“, this online and offline event covered more than 200 cities nationwide, and released the movie about Mars exploration, firstly introducing China Aerospace Creation intellectual property into the O2O marketing.

At the Super Brand Day event held by JDDJ and Vinda, the brand spokesperson of Vinda called on the whole family to discover Vinda’s products. Meanwhile, as the brand partner of China Aerospace, Vinda released a movie themed Mars exploration, and launched new tissue product with four layers. It also selected China Aerospace’s iconic scenes of “space travel” and “space exploration” for packaging purposes.

Moreover, this Super Brand Day event has launched innovative online and offline activities, with the omni-channel marketing in an effort to attract customers. Besides, advertisements on WeChat Moments and short videos on Douyin have been targeted at JDDJ and Vinda’s users, improving the brand exposure and efficient marketing.

Nowadays, as the concept of high-quality consumption gains popularity among consumers, they expect household paper of higher value. Leveraging over 100,000 offline stores on its platform, JDDJ has strengthened partnership with Vinda to provide more consumers with high-quality products and one-hour delivery service.

About Dada Group

Dada Group is a leading platform of local on-demand retail and delivery in China. It operates JDDJ, one of China’s largest local on-demand retail platforms for retailers and brand owners, and Dada Now, a leading local on-demand delivery platform open to merchants and individual senders across various industries and product categories. The Company’s two platforms are inter-connected and mutually beneficial. The Dada Now platform enables improved delivery experience for participants on the JDDJ platform through its readily accessible fulfillment solutions and strong on-demand delivery infrastructure. Meanwhile, the vast volume of on-demand delivery orders from the JDDJ platform increases order volume and density for the Dada Now platform. In June 2020, Dada Group began trading on the Nasdaq Global Market, under the ticker symbol “DADA.”

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/jddj-and-vinda-jointly-launched-super-brand-day-in-more-than-200-cities-in-china-301286551.html

SOURCE Dada Group

NHC Reports First Quarter 2021 Earnings

NHC Reports First Quarter 2021 Earnings

MURFREESBORO, Tenn.–(BUSINESS WIRE)–National HealthCare Corporation (NYSE American: NHC), the nation’s oldest publicly traded senior health care company, announced today net operating revenues and CARES Act income for the quarter ended March 31, 2021 totaled $250,973,000 compared to $256,124,000 for the quarter ended March 31, 2020, a decrease of 2.0%. The CARES Act funding is intended to partially offset COVID-19 expenses and lost revenues. For the first time since the beginning of the COVID-19 pandemic, the census in our skilled nursing facilities increased approximately 3.5% from the beginning of January 2021 through the end of March 2021.

For the quarter ended March 31, 2021, the reported GAAP net income attributable to NHC was $21,267,000 compared to a GAAP net loss attributable to NHC in the amount of $26,852,000 for the same period in 2020. Excluding the unrealized gains and losses in our marketable equity securities portfolio and other non-GAAP adjustments, adjusted net income for the quarter ended March 31, 2021 was $16,592,000 compared to $17,070,000 for the same period in 2020 (*). GAAP diluted earnings per share was $1.38 for the quarter ended March 31, 2021 compared to a GAAP diluted loss per share of $1.76 for the same period in 2020. Adjusted diluted earnings per share were $1.08 and $1.11 for the quarters ended March 31, 2021 and 2020, respectively (*).

(*) – See the tables below that provide a reconciliation of GAAP to non-GAAP items.

About NHC

NHC affiliates operate for themselves and third parties 75 skilled nursing facilities with 9,463 beds. NHC affiliates also operate 24 assisted living communities, five independent living communities, one behavioral health hospital and 35 homecare programs. NHC’s other services include Alzheimer’s and memory care units, hospice services, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Forward-Looking Statements

Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q and 10-K, and include, among others, the following: liabilities and other claims asserted against us and patient care liabilities, as well as the resolution of current litigation; availability of insurance and assets for indemnification; national and local economic conditions; including their effect on the availability and cost of labor, utilities and materials; the effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations; changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries; and other factors referenced or incorporated by reference in the S.E.C. filings. The risks included here are not exhaustive. All forward-looking statements represent NHC’s best judgment as of the date of this release.

   
Consolidated Statements of Operations    
(in thousands, except share and per share amounts)    
  Three Months Ended
  March 31
 

2021

 

2020

  (unaudited)
Revenues and grant income:    
Net patient revenues  

$

216,855

 

 

$

244,095

 

Other revenues  

 

11,369

 

 

 

12,029

 

Government stimulus income  

 

22,749

 

 

 

 

Net operating revenues and grant income  

 

250,973

 

 

 

256,124

 

     
Costs and expenses:    
Salaries, wages and benefits  

 

145,130

 

 

 

147,469

 

Other operating  

 

70,153

 

 

 

71,668

 

Facility rent  

 

10,063

 

 

 

10,332

 

Depreciation and amortization  

 

10,161

 

 

 

10,438

 

Interest  

 

244

 

 

 

412

 

Total costs and expenses  

 

235,751

 

 

 

240,319

 

     
Income from operations  

 

15,222

 

 

 

15,805

 

     
Non-operating income  

 

6,260

 

 

 

8,146

 

Unrealized gains/(losses) on marketable equity securities  

 

7,059

 

 

 

(60,392

)

     
Income/(loss) before income taxes  

 

28,541

 

 

 

(36,441

)

Income tax (provision)/benefit  

 

(7,233

)

 

 

9,625

 

Net income/(loss)  

 

21,308

 

 

 

(26,816

)

     
Net income attributable to noncontrolling interest  

 

(41

)

 

 

(36

)

     
Net income/(loss) attributable to National HealthCare Corporation  

$

21,267

 

 

$

(26,852

)

     
Net income/(loss) per common share    
Basic  

$

1.39

 

 

$

(1.76

)

Diluted  

$

1.38

 

 

$

(1.76

)

     
Weighted average common shares outstanding    
Basic  

 

15,327,520

 

 

 

15,294,777

 

Diluted  

 

15,390,076

 

 

 

15,294,777

 

     
Dividends declared per common share  

$

0.52

 

 

$

0.52

 

     
     
Balance Sheet Data   March 31   Dec. 31
(in thousands)  

2021

 

2020

  (unaudited)  
     
Cash, cash equivalents and marketable securities  

$

318,845

 

 

$

323,445

 

Restricted cash, cash equivalents and marketable securities  

 

166,750

 

 

 

158,162

 

Current assets  

 

464,618

 

 

 

456,755

 

Property and equipment, net  

 

514,484

 

 

 

520,318

 

Total assets  

 

1,355,312

 

 

 

1,362,132

 

Current liabilities  

 

265,846

 

 

 

281,228

 

NHC stockholders’ equity  

 

807,064

 

 

 

795,177

 

     
   
Selected Operating Statistics    
  Three Months Ended
  March 31
 

2021

 

2020

  (unaudited)
Skilled Nursing Per Diems:    
Medicare  

$

537.97

 

 

$

506.02

 

Managed Care  

 

415.44

 

 

 

402.78

 

Medicaid  

 

218.08

 

 

 

201.09

 

Private Pay and Other  

 

247.49

 

 

 

251.61

 

   
Average Skilled Nursing Per Diem  

$

298.29

 

 

$

279.07

 

   
Skilled Nursing Patient Days:    
Medicare  

 

91,327

 

 

 

105,543

 

Managed Care  

 

61,911

 

 

 

61,556

 

Medicaid  

 

279,101

 

 

 

344,526

 

Private Pay and Other  

 

132,967

 

 

 

171,307

 

   
Total Skilled Nursing Patient Days  

 

565,306

 

 

 

682,932

 

   
The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts):
  Three Months Ended
  March 31
 

2021

 

2020

  (unaudited)
   
Net income/(loss) attributable to National Healthcare Corporation  

$

21,267

 

 

$

(26,852

)

Non-GAAP adjustments    
Unrealized (gains)/losses on marketable equity securities  

 

(7,059

)

 

 

60,392

 

Operating results for newly opened facilities not at full capacity (1)  

 

245

 

 

 

203

 

Gain on acquisition of equity method investment  

 

 

 

 

(1,707

)

Stock-based compensation expense  

 

496

 

 

 

466

 

Income tax (benefit)/provision on non-GAAP adjustments  

 

1,643

 

 

 

(15,432

)

Non-GAAP Net income  

$

16,592

 

 

$

17,070

 

   
GAAP diluted earnings/(loss) per share  

$

1.38

 

 

$

(1.76

)

Non-GAAP adjustments    
Unrealized (gains)/losses on marketable equity securities  

 

(0.33

)

 

 

2.92

 

Operating results for newly opened facilities not at full capacity (1)  

 

0.01

 

 

 

0.01

 

Gain on acquisition of equity method investment  

 

 

 

 

(0.08

)

Stock-based compensation expense  

 

0.02

 

 

 

0.02

 

Non-GAAP diluted earnings per share  

$

1.08

 

 

$

1.11

 

   
(1) The newly opened facilities not at full capacity for the 2021 period presented consist of operations opened from 2019 through 2021. The newly opened facilities for the 2020 period presented consist of operations opened from 2018 through 2020. For both of the periods presented, one memory care facility was opened during these years.

 

Brian F. Kidd, SVP/Controller

Phone: (615) 890-2020

KEYWORDS: United States North America Tennessee

INDUSTRY KEYWORDS: Managed Care Hospitals Health Nursing

MEDIA:

Logo
Logo

Northern Oil and Gas, Inc. Announces First Quarter 2021 Results

Northern Oil and Gas, Inc. Announces First Quarter 2021 Results

HIGHLIGHTS

  • First quarter production of 38,417 Boe per day, up 7.5% sequentially from the fourth quarter of 2020
  • First quarter GAAP cash flow from operations of $62.8 million inclusive of changes in net working capital and Free Cash Flow (non-GAAP) of $41.7 million. See “Non-GAAP Financial Measures” below
  • Total capital expenditures of $38.1 million, down 22% from the fourth quarter of 2020
  • The Board of Directors has authorized the payment of all accrued and cash dividends on the Series A Preferred Stock in the aggregate amount of $22.0 million to be paid on May 15, 2021
  • The Board of Directors has also declared Northern’s first ever quarterly common stock dividend of $0.03 per share payable July 30, 2021 to stockholders of record on June 30, 2021
  • Closed Appalachian Basin acquisition from Reliance Marcellus, LLC on April 1, 2021
  • Liquidity and balance sheet strengthened through debt and equity offerings with gross proceeds of $690 million in the first quarter. On May 15, Northern will have retired all near term debt maturities

MINNEAPOLIS–(BUSINESS WIRE)–
Northern Oil and Gas, Inc. (NYSE American: NOG) (“Northern”) today announced the company’s first quarter results.

MANAGEMENT COMMENTS

“The first quarter performance was above our internal expectations across all metrics as our core Williston & Permian properties continued to deliver,” commented Nick O’Grady, Northern’s Chief Executive Officer. “The Company generated $41.7 million of Free Cash Flow, approximately 6% of our total quarter end market capitalization — in a single quarter. I am also very excited that we were able to continue to improve our liquidity and balance sheet with the completion of our financings in February. These transactions along with the continued growth of our business should provide us with sufficient cash flow to continue our strategy of making additional accretive acquisitions, reducing debt and providing returns to our stockholders. Our first ever quarterly dividend is the culmination of a tireless multi-year effort to put the Company in a position to return cash to its stockholders. As we achieve our targets, we believe we can provide meaningful cash returns to investors over the coming years.”

FIRST QUARTER FINANCIAL RESULTS

Oil and natural gas sales for the first quarter were $157.3 million. First quarter GAAP net loss, inclusive of a $128.6 million non-cash net mark-to-market loss on derivatives, was $90.4 million or $1.66 per diluted share. First quarter Adjusted Net Income was $40.2 million or $0.62 per diluted share, up from $21.7 million or $0.44 per diluted share in the prior year. Adjusted EBITDA in the first quarter was $98.8 million. See “Non-GAAP Financial Measures” below.

PRODUCTION

First quarter production was 38,417 Boe per day, a 7.5% increase from the fourth quarter of 2020. Oil represented 76% of total production in the first quarter. Northern estimates that curtailments and shut-ins still reduced the Company’s average daily production by an average of approximately 2,000 Boe per day in the first quarter, but that was a significant improvement from the fourth quarter of 2020. Northern had 6.7 net wells turned online during the first quarter, compared to 6.9 net wells turned online in the fourth quarter of 2020.

PRICING

During the first quarter, NYMEX West Texas Intermediate (“WTI”) crude oil averaged $58.13 per Bbl, and NYMEX natural gas at Henry Hub averaged $3.37 per million cubic feet (“Mcf”). Northern’s unhedged net realized oil price in the first quarter was $51.57, representing a $6.56 differential to WTI prices. Northern’s unhedged net realized gas price in the first quarter was $4.37 per Mcf, representing approximately 130% realizations compared with Henry Hub pricing.

OPERATING COSTS

Lease operating costs were $34.3 million in the first quarter of 2021, or $9.92 per Boe, up 15.6% on a per unit basis compared to the fourth quarter of 2020. This is consistent with Northern’s prior commentary of extensive workover expense related to bringing curtailed and shut-in production back to sales, and is expected to be transitory in nature. First quarter general and administrative (“G&A”) costs totaled $6.8 million or $1.96 per Boe. This includes $2.5 million of legal and other transaction expenses in connection with the Reliance acquisition and $0.8 million of non-cash stock-based compensation. Northern’s G&A costs excluding these amounts totaled $3.5 million or $1.01 per Boe in the first quarter. Northern expects approximately $2.5 – $3.5 million in additional non-recurring advisory and other transaction costs related to the Reliance acquisition to be incurred in the second quarter of 2021.

CAPITAL EXPENDITURES AND ACQUISITIONS

Capital spending for the first quarter was $38.1 million, made up of $33.1 million of organic drilling and completion (“D&C”) capital and $5.0 million of total acquisition spending and other items, inclusive of ground game D&C spending. Northern added 6.7 net wells to production in the first quarter, and wells in process decreased to 22.7 net wells, down 5.4 net wells from the prior quarter as well completions accelerated. On the ground game acquisition front, Northern closed on 6 transactions during the first quarter totaling 1.3 net wells and 186 net mineral acres.

MARCELLUS SHALE ACQUISITION

On February 3, 2021, Northern announced a definitive agreement to acquire assets from Reliance Marcellus, LLC, a subsidiary of Reliance Industries, Ltd., for $175.0 million in cash plus 3.25 million common stock warrants. The acquisition has an effective date of July 1, 2020 and closed on April 1, 2021. EQT Corporation, the operator of substantially all the assets, elected to exercise its preferential purchase right on a portion of the assets, which (together with the exercise of other preferential purchase rights) reduced the cash purchase price, net to Northern, by approximately $48.6 million, or 28%. Northern retained approximately 99% of the inventory on the assets. Northern has provided guidance for the acquired assets in the guidance section below, identical to what was provided in its fourth quarter 2020 earnings release.

LIQUIDITY AND CAPITAL RESOURCES

Northern had total liquidity of $417.2 million as of March 31, 2021, consisting of cash of $2.7 million, the Reliance acquisition deposit of $17.5 million, and $397.0 million of borrowing availability under the revolving credit facility.

On January 4, 2021, Northern retired $65 million, or 50% of its VEN Bakken Note. In February 2021, Northern additionally strengthened its balance sheet through common equity and debt transactions alongside of its announcement of the Reliance Marcellus acquisition. Northern issued 14.3 million shares of common equity for gross proceeds of $140.3 million. Northern also issued $550 million of 8.125% Senior Unsecured Notes due 2028. With the net proceeds from these transactions, Northern retired the remaining $65 million of its VEN Bakken Note and retired $272.1 million, or 95% of its remaining Senior Secured Notes due 2023 on February 18, 2021. Northern will call the remaining $15.7 million of 2023 Notes on or about May 15, 2021. Northern used the remainder of the proceeds to retire debt under its revolving credit facility and for cash on hand.

On April 1, 2021, upon closing of the Reliance acquisition, Northern funded the adjusted cash purchase price of $120.9 million with cash on hand, the $17.5 million deposit made during the first quarter, and borrowings under its credit facility. The cash purchase price included typical closing adjustments, including a reduction for the net cash flows already received by Reliance from the properties since the effective date, which was July 1, 2020. Northern expects additional cash purchase price reductions to be received over the next several months for net cash flows generated after the effective date, but not received by Reliance prior to the closing date.

STOCKHOLDER RETURNS

On April 23, 2021, Northern’s Board of Directors declared all current and accrued cash dividends for Northern’s Series A Preferred Stock, to be paid on May 15, 2021 in the total amount of $22.0 million.

On May 6, 2021, Northern’s Board of Directors declared its first ever regular quarterly cash dividend for Northern’s common stock of $0.03 per share for stockholders of record as of June 30, 2021, payable July 30, 2021.

2021 ESTIMATED GUIDANCE — WILLISTON AND PERMIAN PROPERTIES

2021 Guidance Ranges:

 

Annual Production (Boe per day)

37,750 – 42,750

Net Wells Added to Production

32 – 34

Operating Expenses Guidance:

 

Production Expenses (per Boe)

$8.75 – $9.75

Production Taxes

10% of Net Oil Revenues, $0.06 per Mcf for Natural Gas

Oil as a Percentage of Sales Volumes

78 – 80%

Average Differential to NYMEX WTI

$6.50 – $8.50

2021 ESTIMATED GUIDANCE — RELIANCE MARCELLUS PROPERTIES (FULL YEAR)

2021 Guidance Ranges:

 

Annual Production (Mmcf per day)

75 – 85

Net Wells Added to Production

3.5 – 3.8

Operating Expenses Guidance:

 

Production, Asset G&A and Marketing Expenses (per Mcf)

$0.85 – $0.95

Average Differential to NYMEX Henry Hub (per Mcf)

$0.55 – $0.65

2021 ESTIMATED GUIDANCE — CORPORATE

 

Full Year 2021

General and Administrative Expense (per Boe):

 

Cash (excluding any one-time transaction costs)

$0.80 – $0.90

Non-Cash

$0.20

Total Capital Expenditures (in millions)

$200 – $250

FIRST QUARTER 2021 RESULTS

The following tables set forth selected operating and financial data for the periods indicated.

 

Three Months Ended March 31,

 

2021

 

2020

 

% Change

Net Production:

 

 

 

 

 

Oil (Bbl)

2,630,178

 

 

3,138,380

 

 

(16)

%

Natural Gas and NGLs (Mcf)

4,964,263

 

 

5,049,120

 

 

(2)

%

Total (Boe)

3,457,555

 

 

3,979,900

 

 

(13)

%

 

 

 

 

 

 

Average Daily Production:

 

 

 

 

 

Oil (Bbl)

29,224

 

 

34,488

 

 

(15)

%

Natural Gas and NGLs (Mcf)

55,158

 

 

55,485

 

 

(1)

%

Total (Boe)

38,417

 

 

43,735

 

 

(12)

%

 

 

 

 

 

 

Average Sales Prices:

 

 

 

 

 

Oil (per Bbl)

$

51.57

 

 

$

37.07

 

 

39

%

Effect of Gain (Loss) on Settled Oil Derivatives on Average Price (per Bbl)

(2.32)

 

 

10.04

 

 

 

Oil Net of Settled Oil Derivatives (per Bbl)

49.25

 

 

47.11

 

 

5

%

 

 

 

 

 

 

Natural Gas and NGLs (per Mcf)

4.37

 

 

2.75

 

 

59

%

Effect of Gain (Loss) on Settled Natural Gas Derivatives on Average Price (per Mcf)

(0.24)

 

 

 

 

 

Natural Gas and NGLs Net of Settled Natural Gas Derivatives (per Mcf)

4.13

 

 

2.75

 

 

50

%

 

 

 

 

 

 

Realized Price on a Boe Basis Excluding Settled Commodity Derivatives

45.50

 

 

32.71

 

 

39

%

Effect of Gain (Loss) on Settled Commodity Derivatives on Average Price (per Boe)

(2.11)

 

 

7.92

 

 

 

Realized Price on a Boe Basis Including Settled Commodity Derivatives

43.39

 

 

40.63

 

 

7

%

 

 

 

 

 

 

Costs and Expenses (per Boe):

 

 

 

 

 

Production Expenses

$

9.92

 

 

$

9.38

 

 

6

%

Production Taxes

3.89

 

 

2.99

 

 

30

%

General and Administrative Expenses

1.96

 

 

1.22

 

 

61

%

Depletion, Depreciation, Amortization and Accretion

9.03

 

 

15.53

 

 

(42)

%

 

 

 

 

 

 

Net Producing Wells at Period End

482.3

 

 

464.8

 

 

4

%

HEDGING

Northern hedges portions of its expected production volumes to increase the predictability of its cash flow and to help maintain a strong financial position. The following table summarizes Northern’s open crude oil commodity derivative swap contracts scheduled to settle after March 31, 2021.

Crude Oil Commodity Derivative Swaps(1)

Contract Period

 

Volume (Bbls)

 

Volume (Bbls/Day)

 

Weighted Average Price (per

Bbl)

2021:

 

 

 

 

 

 

Q2

 

2,179,458

 

23,950

 

$56.38

Q3

 

2,154,410

 

23,418

 

$54.41

Q4

 

2,131,706

 

23,171

 

$53.93

2022:

 

 

 

 

 

 

Q1

 

1,447,000

 

16,078

 

$53.40

Q2

 

1,274,000

 

14,000

 

$53.75

Q3

 

1,058,000

 

11,500

 

$51.71

Q4

 

1,058,000

 

11,500

 

$51.63

2023:

 

 

 

 

 

 

Q1

 

112,500

 

1,250

 

$51.65

_____________

(1)

 

This table does not include volumes subject to swaptions and call options, which could increase the amount of volumes hedged at the option of Northern’s counterparties. This table also does not include basis swaps. For additional information, see Note 11 to our financial statements included in our Form 10-Q filed with the SEC for the quarter ended March 31, 2021.

The following table summarizes Northern’s open natural gas commodity derivative swap contracts scheduled to settle after March 31, 2021.

Natural Gas Commodity Derivative Swaps

Contract Period

 

Gas (MMBTU)

 

Volume (MMBTU/Day)

 

Weighted Average Price (per

Mcf)

2021:

 

 

 

 

 

 

Q2

 

5,924,507

 

65,104

 

$2.74

Q3

 

8,979,028

 

97,598

 

$2.82

Q4

 

8,784,210

 

95,481

 

$2.82

2022:

 

 

 

 

 

 

Q1

 

3,600,000

 

40,000

 

$3.00

Q2

 

910,000

 

10,000

 

$2.61

Q3

 

920,000

 

10,000

 

$2.61

Q4

 

920,000

 

10,000

 

$2.61

The following table presents Northern’s settlements on commodity derivative instruments and unsettled gains and losses on open commodity derivative instruments for the periods presented, which is included in the revenue section of Northern’s statement of operations:

 

 

Three Months Ended

March 31,

(In thousands)

 

2021

 

2020

Cash Received (Paid) on Derivatives:

 

$

(7,297)

 

 

$

31,506

 

Non-Cash Gain (Loss) on Derivatives:

 

(128,638)

 

 

345,075

 

Gain (Loss) on Derivative Instruments, Net

 

$

(135,935)

 

 

$

376,581

 

CAPITAL EXPENDITURES & DRILLING ACTIVITY

(In millions, except for net well data)

 

Three Months Ended

March 31, 2021

Capital Expenditures Incurred:

 

Organic Drilling and Development Capital Expenditures

 

$

33.1

Ground Game Drilling and Development Capital Expenditures

 

$

1.8

Ground Game Acquisition Capital Expenditures

 

$

2.6

Other

 

$

0.6

 

 

 

Net Wells Added to Production

 

6.7

 

 

Net Producing Wells (Period-End)

 

482.3

 

 

Net Wells in Process (Period-End)

 

22.7

Decrease in Wells in Process over Prior Period

 

5.4

 

 

Weighted Average Gross AFE for Wells Elected to

 

$6.9 million

FIRST QUARTER 2021 EARNINGS RELEASE CONFERENCE CALL

In conjunction with Northern’s release of its financial and operating results, investors, analysts and other interested parties are invited to listen to a conference call with management on Friday, May 7, 2021 at 10:00 a.m. Central Time.

Those wishing to listen to the conference call may do so via webcast or phone as follows:

Webcast: https://78449.themediaframe.com/dataconf/productusers/nog/mediaframe/44884/indexl.html

Dial-In Number: (866) 373-3407 (US/Canada) and (412) 902-1037 (International)

Conference ID: 13719253 – Northern Oil and Gas, Inc. First Quarter 2021 Earnings Call

Replay Dial-In Number: (877) 660-6853 (US/Canada) and (201) 612-7415 (International)

Replay Access Code: 13719253 – Replay will be available through May 14, 2021

UPCOMING CONFERENCE SCHEDULE

SPE A&D Symposium

Houston, TX

May 13, 2021

UBS Global Oil and Gas Conference

May 26, 2021

Wells Fargo Energy Conference

June 2-3, 2021

Stifel Cross Sector Insight Conference

June 8, 2021

RBC Energy Conference

June 9, 2021

ABOUT NORTHERN OIL AND GAS

Northern Oil and Gas, Inc. is a company with a primary strategy of investing in non-operated minority working and mineral interests in oil & gas properties, with a core area of focus in the premier basins within the United States. More information about Northern Oil and Gas, Inc. can be found at www.northernoil.com.

SAFE HARBOR

This press release contains forward-looking statements regarding future events and future results that are subject to the safe harbors created under the Securities Act of 1933 (the “Securities Act”) and the Securities Exchange Act of 1934 (the “Exchange Act”). All statements other than statements of historical facts included in this release regarding Northern’s financial position, operating and financial performance, business strategy, plans and objectives of management for future operations, industry conditions, and indebtedness covenant compliance are forward-looking statements. When used in this release, forward-looking statements are generally accompanied by terms or phrases such as “estimate,” “project,” “predict,” “believe,” “expect,” “continue,” “anticipate,” “target,” “could,” “plan,” “intend,” “seek,” “goal,” “will,” “should,” “may” or other words and similar expressions that convey the uncertainty of future events or outcomes. Items contemplating or making assumptions about actual or potential future production and sales, market size, collaborations, and trends or operating results also constitute such forward-looking statements.

Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond Northern’s control) that could cause actual results to differ materially from those set forth in the forward-looking statements, including the following: changes in crude oil and natural gas prices; the pace of drilling and completions activity on Northern’s properties and properties pending acquisition; Northern’s ability to acquire additional development opportunities; potential or pending acquisition transactions; Northern’s ability to consummate pending acquisitions, and the anticipated timing of such consummation; the projected capital efficiency savings and other operating efficiencies and synergies resulting from Northern’s acquisition transactions; integration and benefits of property acquisitions, or the effects of such acquisitions on Northern’s cash position and levels of indebtedness; changes in Northern’s reserves estimates or the value thereof; disruptions to Northern’s business due to acquisitions and other significant transactions; infrastructure constraints and related factors affecting Northern’s properties; ongoing legal disputes over and potential shutdown of the Dakota Access Pipeline; the COVID-19 pandemic and its related economic repercussions and effect on the oil and natural gas industry; general economic or industry conditions, nationally and/or in the communities in which Northern conducts business; changes in the interest rate environment, legislation or regulatory requirements; conditions of the securities markets; Northern’s ability to raise or access capital; changes in accounting principles, policies or guidelines; and financial or political instability, health-related epidemics, acts of war or terrorism, and other economic, competitive, governmental, regulatory and technical factors affecting Northern’s operations, products and prices.

Northern has based these forward-looking statements on its current expectations and assumptions about future events. While management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond Northern’s control. Northern does not undertake any duty to update or revise any forward-looking statements, except as may be required by the federal securities laws.

CONDENSED STATEMENTS OF OPERATIONS

(UNAUDITED)

   

 

 

Three Months Ended

March 31,

(In thousands, except share and per share data)

 

2021

 

2020

Revenues

 

 

 

 

Oil and Gas Sales

 

$

157,331

 

 

$

130,196

 

Gain (Loss) on Commodity Derivatives, Net

 

(135,935)

 

 

376,581

 

Other Revenue

 

1

 

 

8

 

Total Revenues

 

21,397

 

 

506,785

 

 

 

 

 

 

Operating Expenses

 

 

 

 

Production Expenses

 

34,312

 

 

37,335

 

Production Taxes

 

13,453

 

 

11,896

 

General and Administrative Expense

 

6,782

 

 

4,871

 

Depletion, Depreciation, Amortization and Accretion

 

31,221

 

 

61,809

 

Total Operating Expenses

 

85,768

 

 

115,911

 

 

 

 

 

 

Income (Loss) From Operations

 

(64,371)

 

 

390,875

 

 

 

 

 

 

Other Income (Expense)

 

 

 

 

Interest Expense, Net of Capitalization

 

(13,510)

 

 

(16,551)

 

Gain (Loss) on Unsettled Interest Rate Derivatives, Net

 

240

 

 

(677)

 

Loss on Extinguishment of Debt, Net

 

(12,594)

 

 

(5,527)

 

Contingent Consideration Loss

 

(125)

 

 

 

Other Income (Expense)

 

3

 

 

 

Total Other Income (Expense)

 

(25,986)

 

 

(22,755)

 

 

 

 

 

 

Income (Loss) Before Income Taxes

 

(90,357)

 

 

368,120

 

 

 

 

 

 

Income Tax Provision (Benefit)

 

 

 

(166)

 

 

 

 

 

 

Net Income (Loss)

 

$

(90,357)

 

 

$

368,286

 

 

 

 

 

 

Cumulative Preferred Stock Dividend

 

(3,830)

 

 

(3,729)

 

 

 

 

 

 

Net Income (Loss) Attributable to Common Stockholders

 

$

(94,188)

 

 

$

364,557

 

 

 

 

 

 

Net Income (Loss) Per Common Share – Basic*

 

$

(1.73)

 

 

$

9.03

 

Net Income (Loss) Per Common Share – Diluted*

 

$

(1.73)

 

 

$

7.33

 

Weighted Average Common Shares Outstanding – Basic*

 

54,538,099

 

 

40,366,253

 

Weighted Average Common Shares Outstanding – Diluted*

 

54,538,099

 

 

49,721,264

 

___________

*Adjusted for the 1-for-10 reverse stock split.

CONDENSED BALANCE SHEETS

(In thousands, except par value and share data)

 

March 31, 2021

 

December 31, 2020

Assets

 

(Unaudited)

 

 

Current Assets:

 

 

 

 

Cash and Cash Equivalents

 

$

2,729 

 

 

$

1,428 

 

Accounts Receivable, Net

 

94,804 

 

 

71,015 

 

Advances to Operators

 

431 

 

 

476 

 

Prepaid Expenses and Other

 

2,455 

 

 

1,420 

 

Derivative Instruments

 

2,005 

 

 

51,290 

 

Total Current Assets

 

102,424 

 

 

125,629 

 

 

 

 

 

 

Property and Equipment:

 

 

 

 

Oil and Natural Gas Properties, Full Cost Method of Accounting

 

 

 

 

Proved

 

4,431,977 

 

 

4,393,533 

 

Unproved

 

9,621 

 

 

10,031 

 

Other Property and Equipment

 

2,502 

 

 

2,451 

 

Total Property and Equipment

 

4,444,100 

 

 

4,406,015 

 

Less – Accumulated Depreciation, Depletion and Impairment

 

(3,701,715)

 

 

(3,670,811)

 

Total Property and Equipment, Net

 

742,385 

 

 

735,204 

 

 

 

 

 

 

Derivative Instruments

 

356 

 

 

111 

 

Acquisition Deposit

 

17,500 

 

 

— 

 

Other Noncurrent Assets, Net

 

10,578 

 

 

11,145 

 

 

 

 

 

 

Total Assets

 

$

873,243 

 

 

$

872,089 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity (Deficit)

Current Liabilities:

 

 

 

 

Accounts Payable

 

$

40,788 

 

 

$

35,803 

 

Accrued Liabilities

 

72,667 

 

 

68,673 

 

Accrued Interest

 

5,769 

 

 

8,341 

 

Derivative Instruments

 

35,108 

 

 

3,078 

 

Contingent Consideration

 

618 

 

 

493 

 

Current Portion of Long-term Debt

 

— 

 

 

65,000 

 

Other Current Liabilities

 

1,018 

 

 

1,087 

 

Total Current Liabilities

 

155,968 

 

 

182,475 

 

 

 

 

 

 

Long-term Debt

 

817,061 

 

 

879,843 

 

Derivative Instruments

 

61,987 

 

 

14,659 

 

Asset Retirement Obligations

 

18,884 

 

 

18,366 

 

Other Noncurrent Liabilities

 

26 

 

 

50 

 

 

 

 

 

 

Total Liabilities

 

$

1,053,926 

 

 

$

1,095,393 

 

 

 

 

 

 

Commitments and Contingencies (Note 8)

 

 

 

 

 

 

 

 

 

Stockholders’ Equity (Deficit)  

 

 

 

Preferred Stock, Par Value $.001; 5,000,000 Shares Authorized; 

2,218,732 Series A Shares Outstanding at 3/31/2021

2,218,732 Series A Shares Outstanding at 12/31/2020

 

 

 

 

Common Stock, Par Value $.001; 135,000,000* Shares Authorized;

 60,361,547* Shares Outstanding at 3/31/2021

 45,908,779* Shares Outstanding at 12/31/2020

 

462 

 

 

448 

 

Additional Paid-In Capital

 

1,689,567 

 

 

1,556,602 

 

Retained Deficit

 

(1,870,714)

 

 

(1,780,356)

 

Total Stockholders’ Equity (Deficit)

 

(180,682)

 

 

(223,304)

 

Total Liabilities and Stockholders’ Equity (Deficit)

 

$

873,243 

 

 

$

872,089 

 

__________

*Adjusted for the 1-for-10 reverse stock split.

Non-GAAP Financial Measures

Adjusted Net Income, Adjusted EBITDA and Free Cash Flow are non-GAAP measures. Northern defines Adjusted Net Income (Loss) as net income (loss) excluding (i) (gain) loss on unsettled commodity derivatives, net of tax, (ii) loss on extinguishment of debt, net of tax, (iii) contingent consideration loss, net of tax, (iv) acquisition transaction costs, net of tax, and (v) gain on unsettled interest rate derivatives, net of tax. Northern defines Adjusted EBITDA as net income (loss) before (i) interest expense, (ii) income taxes, (iii) depreciation, depletion, amortization and accretion, (iv) non-cash stock-based compensation expense, (v) loss on extinguishment of debt, (vi) contingent consideration loss, (vii) acquisition transaction costs, (viii) (gain) loss on unsettled commodity derivatives, and (ix) gain on unsettled interest rate derivatives. Northern defines Free Cash Flow as cash flows from operations before changes in working capital and other items, less (i) capital expenditures, excluding non-budgeted acquisitions and (ii) preferred stock dividends. A reconciliation of each of these measures to the most directly comparable GAAP measure is included below.

Management believes the use of these non-GAAP financial measures provides useful information to investors to gain an overall understanding of current financial performance. Management believes Adjusted Net Income and Adjusted EBITDA provide useful information to both management and investors by excluding certain expenses and unrealized commodity gains and losses that management believes are not indicative of Northern’s core operating results. Management believes that Free Cash Flow is useful to investors as a measure of a company’s ability to internally fund its budgeted capital expenditures, to service or incur additional debt, and to measure success in creating stockholder value. In addition, these non-GAAP financial measures are used by management for budgeting and forecasting as well as subsequently measuring Northern’s performance, and management believes it is providing investors with financial measures that most closely align to its internal measurement processes. The non-GAAP financial measures included herein may be defined differently than similar measures used by other companies and should not be considered an alternative to, or more meaningful than, the comparable GAAP measures. From time to time Northern provides forward-looking Free Cash Flow estimates or targets; however, Northern is unable to provide a quantitative reconciliation of the forward looking non-GAAP measure to its most directly comparable forward looking GAAP measure because management cannot reliably quantify certain of the necessary components of such forward looking GAAP measure. The reconciling items in future periods could be significant.

Reconciliation of Adjusted Net Income

   

 

 

Three Months Ended

March 31,

(In thousands, except share and per share data)

 

2021

 

2020

Net Income (Loss)

 

$

(90,357)

 

 

$

368,286

 

Add:

 

 

 

 

Impact of Selected Items:

 

 

 

 

(Gain) Loss on Unsettled Commodity Derivatives

 

128,638

 

 

(345,075)

 

Loss on Extinguishment of Debt

 

12,594

 

 

5,527

 

Contingent Consideration Loss

 

125

 

 

 

Acquisition Transaction Costs

 

2,511

 

 

 

Gain on Unsettled Interest Rate Derivatives

 

(240)

 

 

 

Selected Items, Before Income Taxes

 

143,627

 

 

(339,549)

 

Income Tax of Selected Items(1)

 

(13,051)

 

 

(7,041)

 

Selected Items, Net of Income Taxes

 

130,576

 

 

(346,589)

 

Adjusted Net Income

 

$

40,219

 

 

$

21,696

 

 

 

 

 

 

Weighted Average Shares Outstanding – Basic

 

54,538,099

 

 

40,366,253

 

Weighted Average Shares Outstanding – Diluted

 

64,537,237

 

 

49,721,264

 

 

 

 

 

 

Net Income (Loss) Per Common Share – Basic

 

$

(1.66)

 

 

$

9.12

 

Add:

 

 

 

 

Impact of Selected Items, Net of Income Taxes

 

2.40

 

 

(8.58)

 

Adjusted Net Income Per Common Share – Basic

 

$

0.74

 

 

$

0.54

 

 

 

 

 

 

Net Income (Loss) Per Common Share – Diluted

 

$

(1.40)

 

 

$

7.41

 

Add:

 

 

 

 

Impact of Selected Items, Net of Income Taxes

 

2.02

 

 

(6.97)

 

Adjusted Net Income Per Common Share – Diluted

 

$

0.62

 

 

$

0.44

 

______________

(1)

 

For the three months ended March 31, 2021, this represents a tax impact using an estimated tax rate of 24.5%, which includes an adjustment of $22.1 million, for a change in valuation allowance.  For the three months ended March 31, 2020, this represents a tax impact using an estimated tax rate of 24.5%, which includes an adjustment of 90.2 million, for a change in valuation allowance.

Reconciliation of Adjusted EBITDA

 

 

 

Three Months Ended

March 31,

(In thousands)

 

2021

 

2020

Net Income (Loss)

 

$

(90,357)

 

 

$

368,286

 

Add:

 

 

 

 

Interest Expense

 

13,510

 

 

16,551

 

Income Tax Provision (Benefit)

 

 

 

(166)

 

Depreciation, Depletion, Amortization and Accretion

 

31,221

 

 

61,809

 

Non-Cash Stock-Based Compensation

 

769

 

 

1,079

 

Loss on Extinguishment of Debt

 

12,594

 

 

5,527

 

Contingent Consideration Loss

 

125

 

 

 

Acquisition Transaction Costs

 

2,511

 

 

 

Gain on Unsettled Interest Rate Derivatives

 

(240)

 

 

 

(Gain) Loss on Unsettled Commodity Derivatives

 

128,638

 

 

(345,075)

 

Adjusted EBITDA

 

$

98,770

 

 

$

108,010

 

Reconciliation of Free Cash Flow

 

 

 

Three Months Ended

March 31,

(In thousands)

 

2021

Net Cash Provided by Operating Activities

 

$

62,766

 

Exclude: Changes in Working Capital and Other Items

 

20,814

 

Less: Capital Expenditures (1)

 

(38,085)

 

Less: Series A Preferred Dividends

 

(3,830)

 

Free Cash Flow

 

$

41,664

 

_______________

 

(1) Capital expenditures are calculated as follows:

 

 

Three Months Ended

March 31,

(In thousands)

 

2021

Cash Paid for Capital Expenditures

 

$

52,672

 

Less: Non-Budgeted Acquisitions

 

(17,500)

 

Plus: Change in Accrued Capital Expenditures and Other

 

2,913

 

Capital Expenditures

 

$

38,085

 

 

Mike Kelly, CFA

Chief Strategy Officer

952-476-9800

[email protected]

KEYWORDS: United States North America Minnesota

INDUSTRY KEYWORDS: Oil/Gas Energy

MEDIA:

Logo
Logo

Thinkific Ranked #2 on 2021 List of Best Workplaces™ in Canada

PR Newswire

VANCOUVER, BC, May 7, 2021 /PRNewswire/ – Thinkific Labs Inc. (“Thinkific” or the “Company”) (TSX: THNC), is proud to announce that it has been ranked #2 on the 2021 list of Best Workplaces™ in Canada, in the 100-999 employee category.

“At Thinkific, our exceptional team is at the core of everything we do, from each product initiative we launch to every entrepreneur we’re able to help,” said Greg Smith, Co-Founder & CEO of Thinkific. “We are deeply committed to our people and over the last year, have seen them show incredible resilience and innovation while demonstrating our core values like ‘Succeed Together’, Learn and Grow’, and ‘Strive for Equality’. The fact that this accolade is largely driven by direct feedback from our team members about their experience working at Thinkific, makes this award even more special. We’re actively recruiting across Canada and are excited to add even more incredible people to our team.”

The annual list is compiled by the Great Place to Work® Institute, a global authority on workplace culture. The selection process is employee driven with two-thirds of the total score coming from confidential employee survey results and the remaining one-third from an in-depth review of the organization’s culture. This process offers a rigorous representation of the organization from an employee perspective, and an overall portrait of the workplace culture. This year’s list captured the experience and sentiment of over 82,000 employees, rolling out to impact over 300,000 Canadian employees.*

Thinkific was also recently recognized by the Great Place to Work® Institute as one of the Best Workplaces in Technology, one of the Best Workplaces for Women, and one of the Best Workplaces in British Columbia in addition to being named one of Canada’s Top Small & Medium Employers.

Standout aspects of Thinkific’s workplace, as recognized by team members, include:

  • A robust work-from-home culture: Thinkific provided significant support as its team transitioned to remote working during the pandemic and has continued to build upon this as they’ve shifted to a distributed-first team—helping to set up home offices, providing meal kits and care packages, and hosting regular social events.
  • Flexible working hours and holidays: Thinkific provides an open vacation policy and allows employees to adjust working hours as needed to fit their lifestyles.
  • Continued education and development resources: Thinkific provides a multitude of opportunities for ongoing development and growth, including leadership training, an annual education stipend, and regular lunch and learns on topics ranging from accessibility and wellness to aboriginal heritage and inclusion training.
  • Additional mental health and discretionary spending: Thinkific employees are provided with a competitive benefits package, including $2,000 worth of support specifically for mental health care and have access to 24/7 support through the Company’s Employee and Family Assistance Program.
  • Inclusive company and diverse team: Thinkific’s workforce comes from a wide range of different backgrounds. 48% of its team identifies as women (including 50% of the leadership team), and the Company provides paid parental leave top-ups.

*sentiment of over 82,000 employees, impacting over 300,000 Canadian employees numbers quoted from Best Workplaces in Canada 2021 press release.

About Great Place to Work®:
Great Place to Work® is the global authority on high-trust, high performance workplace cultures. It is a global research and consulting firm with a mission to build a better society by helping companies transform their workplaces. Great Place to Work® provides the benchmarks, framework, and expertise needed to create, sustain, and recognize outstanding workplace cultures. In Canada, Great Place to Work® produces both industry and demographic specific Best Workplace™ lists. This is part of the world’s largest annual workplace study, which culminates in a series of national lists in over 50 countries, including the study’s flagship list of 100 Best Companies published annually in Fortune magazine.

Globally, this survey represents the voices of 11 million employees, which are the primary determinant used in selecting winners. There’s only one way to get on this list – your employees have to put you on it.

Check out www.greatplacetowork.ca

About Thinkific
Thinkific [TSX:THNC] makes it simple for entrepreneurs and established businesses of any size to scale and generate revenue by teaching what they know. Our platform gives businesses everything they need to build, market, and sell online courses and other learning products, and to run their business seamlessly under their own brand, on their own site. In 2020 alone, Thinkific’s 50,000 active course creators earned hundreds of millions of dollars in direct course sales while teaching tens of millions of students. Thinkific is headquartered in Vancouver, Canada, with a distributed and growing team.

Thinkific is currently hiring for roles across Canada—learn more about these job opportunities at thinkific.com/careers. Stay up to date with #TeamThinkific on Facebook, LinkedIn, Instagram, and Twitter. For more information, please visit www.thinkific.com.

This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws (“forward-looking statements”), including statements with regard to the growth in the number of our employees. Words such as “expects”, “anticipates” and “intends” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions and no assurance can be given that these trends will continue. Thinkific undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thinkific-ranked-2-on-2021-list-of-best-workplaces-in-canada-301286539.html

SOURCE Thinkific Labs Inc.